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Abstract 
Pregnancy is a complex state characterised by changes in maternal physiology to favour the 
development and growth of the developing foetus. This is mainly achieved by the placenta, 
a pregnancy specific temporary organ. In human’s, the placenta is a highly specialised organ 
that acts as an interface for the exchange of nutrients, gaseous products, wastes and hormones 
between the mother and the foetus. Most importantly, the fate of human pregnancy relies on 
the successful invasion of early placental precursor cells called extravillous trophoblasts. 
These highly invasive cells, form a “plug” into material spiral arteries. This transforms the 
placental circulation from high-resistant low flow to low-resistant high flow state. 
Inadequate remodelling of the maternal spiral arteries can cause pregnancy complications 
such as pre-eclampsia, miscarriage and foetal/maternal death. The main cause for the 
incomplete transformation of spiral arteries is believed to be placental oxidative stress during 
early gestation. Therefore, measures to reduced early trophoblast oxidative stress have taken 
precedence in placental research. It has been hypothesised that the introduction of non-
enzymatic dietary antioxidants such as flavonoids, metal chelates and vitamins may prevent 
this oxidative stress, especially during early pregnancy.  
Flavonoids are phenolic compounds derived from fruits and vegetable and possess 
antioxidant properties. In fact, normal pregnant mothers usually “crave” for certain plant 
products (such as fruits) which apparently have high flavonoids concentrations. Although, 
their antioxidant properties have been well documented in myocardial and neuronal cells, 
their role in the prevention of trophoblast oxidative stress is unknown. Thus, exploring the 
antioxidative oxidative effects of selected flavonoids, their metabolites alone or in 
combination is deemed essential.  
This study aims to understand the antioxidative properties of selected flavonoids (and their 
metabolite combinations) on a transformed early extravillous trophoblast cell line HTR-
8/SVneo. It also explores the cytoprotective effects of these flavonoids during in vitro 
trophoblast invasion. To achieve this aim, optimisation of the non-toxic concentrations of 
flavonoids (quercetin, morin, naringin and hesperidin)/metabolites (Q3G, naringenin and 
hesperetin) on HTR-8/SVneo cells was carried out using MTT and CellTox™ green 
cytotoxicity assays. Afterwards, oxidative stress model for HTR-8/SVneo cells was 
established by hypoxia reoxygenation (HR). The effects of 24 h pre-treatment with 
flavonoids prior to HR-induced oxidative stress on HTR-8/SVneo cell viability was assessed 
using MTT and CellTiter-Glo® assays. Further investigation on the antioxidative effects of 
xv | P a g e  
 
flavonoids was carried out by assessing their effects on glutathione levels, nicotinamide 
adenine dinucleotide phosphate system, H2O2 scavenging and apoptosis. Flavonoid 
involvement in the modulation of protein kinases (ERK1/2, PKB, JNK/SAPK and p38 
MAPK), trophoblast invasion and migration as well as spheroid formation/invasion was also 
investigated. 
Flavonoids/metabolites below 10 µM were well tolerated by HTR-8/SVneo cells and pre-
treatment with 3 µM flavonoid or 1 µM metabolite shown significant protection against H/R 
insult. Further investigation revealed that flavonoid cytoprotective effects against H/R insult 
were associated with their ability to interact with other antioxidant systems such as 
increasing GSH and decreasing GSSG levels, redox balancing (restoring NADP/NADPH 
ratio), inhibition of apoptosis by decreasing caspase 3/7 activity, and scavenging of H2O2. 
The data from this study also indicates that flavonoid pre-treatment significantly inhibited 
HR-induced protein kinase activation/phosphorylation (p<0.0001), enhanced HTR-8/SVneo 
invasive capacity (p<0.0001) and increased spheroid formation and invasion (p<0.001). 
In summary, the study has shown for the first time that 24 h pre-treatment with flavonoids, 
their metabolites or in combination on HTR-8/SVneo cells significantly protected against 
HR-induced oxidative stress. Most importantly these combinations have enhanced 
trophoblast cell line invasion by reducing oxidative stress. These findings suggest that the 
ingestion of flavonoid rich foods during pregnancy may benefit placental development and 
health. 
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1.0 Introduction 
Understanding the relationship between placental/or foetal development, increased oxidative 
stress and the cytoprotective effects of natural and/or synthetic antioxidants during early 
gestation can lead to the advancement of new concepts on preventing pregnancy 
complications such as pre-eclampsia and intrauterine growth restriction. Placental oxidative 
stress is a result of reduced antioxidant activities or inability of antioxidants to scavenge free 
radicals leading to shallow trophoblast invasion and slow development of the placenta, 
which then results in pregnancy complications (Wu et al., 2016; Burton and Jauniaux, 2011). 
However, the exploitation of edible plants and vegetables that are rich in antioxidants such 
as flavonoids may help improved placental health during early gestation. This study aims to 
explore the cytoprotective effects of various classes and subclasses of flavonoids on a 
trimester trophoblast cell line, subjected to oxidative stress. 
1.1 Human Placenta 
The word placenta is derived from both the Latin (“a flat cake”) and Greek (“plakoenta – 
meaning flat) (www1). The placenta is a highly specialised multifunctional transient organ 
that forms during pregnancy to support and maintain the development and growth of the 
foetus, by acting as a medium of exchange between the mother and developing foetus 
(Pereira et al., 2015; Yoshizawa, 2013; Ji et al., 2013). In fact, the health of the mother and 
foetus during pregnancy is paramount to proper development and function of the human 
placenta (Pereira et al., 2015). The placenta forms the maternal-foetal interface and regulates 
the in utero environment by the dense network of blood vessels that are responsible for the 
exchange of respiratory gases, nutrients and waste products between the maternal and foetal 
tissues throughout pregnancy. Furthermore, the vasculature of the human placenta evolves 
throughout the pregnancy to accommodate the increase demand of the developing foetus. 
Therefore both intrinsic and extrinsic stress to the placenta can also impact its development, 
structure and function (Pereira et al., 2015). Due to the central role of the placenta throughout 
gestation, the placenta is often referred to as the “diary” of pregnancy (Yoshizawa, 2013). 
The cross section of a term placenta is shown in figure 1.1 (Pereira et al., 2015; Ji et al., 
2013). 
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Figure 1.1: The materno-foetal interface of the human placenta  
This image reveals the localisation of the placenta in the in utero environment and the cross-
section showing the blood circulation. Figure adapted from www2 
 
1.1.1 Functions of the human placenta 
The placenta acts as a medium of exchange between the mother and the developing foetus 
throughout gestation. The multifaceted nature of the human placenta has proved to be 
important for the health and survival of the foetus and mother (Ji et al., 2013). The placenta 
is involved in the following functions; 
o Exchange of gases 
As the foetal lungs do not take part in respiration while in utero, the placenta is wholly 
responsible for respiratory gas exchange (oxygen and carbon dioxide) to and from the 
developing foetus via diffusion (Donnelly and Campling, 2016; Vause and Saroya, 2005; 
Griffiths and Campbell, 2015). The rate and quantity of gaseous exchange is dependent on 
the concentration of both maternal and foetal side of the placenta, and dissociation curve in 
either sides of the blood circulation (Vause and Saroya, 2005). Oxygen transfer to the 
developing foetus is enhanced by the Bohr effect; the haemoglobin of the foetus has higher 
affinity for oxygen than that of maternal haemoglobin (Griffiths and Campbell, 2015). 
Carbon dioxide (CO2) exchange across the placenta is via passive diffusion, which is 
dependent on mainly the partial pressure gradient for CO2 between foetal blood at the 
umbilical arteries and maternal blood at the intervillous space; this exchange is facilitated 
by Haldane effects (Donnelly and Campling, 2016).  
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o Metabolic transfer 
Metabolic transfer across the human placenta includes the transfer of glucose, amino acids, 
fatty acids, electrolytes, vitamins and water (Donnelly and Campling, 2016). Since the 
developing foetus has very little or no capacity for gluconeogenesis, maternal glucose is 
transferred to the foetus via the placenta (Vause and Saroya, 2005; Donnelly and Campling, 
2016). 
o Endocrine and immunological functions 
The human placenta is an endocrine organ which secretes very important peptides and 
hormones as well as performing some immunological functions (Donnelly and Campling, 
2016). Human chorionic gonadotropin hormone (hCG) and human placental lactogen (hPL) 
are the two major peptide hormones secreted by the placenta (Donnelly and Campling, 
2016). hCG  is produced in early gestation by the syncytiotrophoblast, and is responsible for  
extending the lifespan of the corpus luteum and secretion of progesterone, which prevents 
shedding of the endometrium, hence sustaining the viability of pregnancy (Donnelly and 
Campling, 2016; Griffiths and Campbell, 2015). hPL also secreted by the synctiotrophoblast, 
is responsible for the growth of breast tissue in preparation for lactation (Vause and Saroya, 
2005). Maternal antibodies such as immunoglobulin G (IgG) cross the placenta by 
pinocytosis to provide immunity for the foetus. Other endocrine functions of the placenta 
include the transfer/secretion of human placental lactogen, human growth hormone variants, 
oestrogens and progesterone (Donnelly and Campling, 2016; Vause and Saroya, 2005; 
Griffiths and Campbell, 2015). 
o Placental drug transfer  
The transplacental passage of drugs can have some beneficial or teratogenic effects. Drug 
transfer from the maternal to the foetal circulation must be carried into the intervillous space 
and pass via the syncytiotrophoblast, endothelium of the foetal capillaries and foetal 
connective tissues. There are three types of transplacental passage of drug that have been 
identified, which are; (a) complete transfer (such as type 1 drugs; thiopental drugs), (b) 
exceeding transfer (such as type 2 drugs; ketamine) and (c) incomplete transfer (type 3 drugs; 
succinylcholine) (Griffiths and Campbell, 2015). Physical factors such as placental surface 
area, metabolism, thickness,  and pharmacological factors such as molecular weights of 
drugs, protein binding, liquid solubility, can affect drug transfer across the placenta 
(Donnelly and Campling, 2016; Griffiths and Campbell, 2015)  
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In addition, there are four major mechanisms of drugs transfer across the placenta, namely: 
simple diffusion, facilitated diffusion, active transport and pinocytosis (Griffiths and 
Campbell, 2015)  
1.1.2 Structure of full term human placenta 
The architecture of the full term human placenta can be described as a disc-shaped organ 
with a diameter of 15 – 22 cm, a thickness of 2 – 3 cm, a surface area of 10 – 15 m2 and a 
weight of between 470 – 500 g (Huppertz, 2008; Griffiths and Campbell, 2015). These 
parameters differ from one placenta to another, with the mode of delivery being a major 
factor in these variations. However, the weight of the placenta is directly related to the size 
of the foetus (Huppertz, 2008). The main structural unit of the human placenta is the 
chorionic villus, which are the vascular representation of the foetal tissue surrounded by 
chorions. These chorions consist of two layers, namely; the outer syncytiotrophoblast and 
inner cytotrophoblast layers (Griffiths and Campbell, 2015). The placental 
membrane/barrier separates the maternal circulation in the intervillous space as well as the 
foetal circulation in the maternal-foetal environment (Gude et al., 2004). At full term, the 
placental membrane consist of two surfaces; (a) foetal surface/membrane and (b) maternal 
surface/membrane as shown in figure 1.2 (Gude et al., 2004; Huppertz, 2008). 
    
Figure 1.2: Graphical representation of placental surfaces. 
 (A) represents the foetal surface; (B) represents the maternal surface. Figure was slightly 
modified from www3. 
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 Foetal surface 
The foetal surface also known as the chorionic plate is covered by the amnions as seen in 
figure 1.2, A. These amnions consist of a single layer of epithelium and amniotic 
mesenchyme (connective tissue) (Huppertz, 2008). Attached to the chorionic plate in an 
eccentric position is the umbilical cord with continuous chorionic vessels arising from the 
chronic mesenchyme. The chorionic artery is derived from the two umbilical arteries, which 
supplies the villous trees (Gude et al., 2004; Huppertz, 2008). In addition, the chorionic veins 
arises from the veins of the villous trees which give rise to the single umbilical vein 
(Huppertz, 2008). 
 Maternal surface 
The maternal surface is an artificial surface arising from the separation of the placenta from 
the uterine wall during delivery. This surface consists of a mixture of foetal extravillious 
trophoblasts and maternal cells such as macrophages, natural killer cells and stroma cells 
(Gude et al., 2004; Huppertz, 2008). In addition, large amounts of extracellular matrix, 
fibroid and blood clots can be found on the maternal surface (Huppertz, 2008). The maternal 
surface is subdivided by a system of flat grooves or deeper clefts into 10 – 40 slightly 
heightened regions called lobes as seen in figure 1.2, B (Huppertz, 2008).  
 
1.1.3 Development of the human placenta 
Placentation and other early pregnancy processes such as pre-implantation and implantation 
are the most crucial determinants of pregnancy outcome (Anin et al., 2004). The formation 
and development of the placenta first requires successful fertilization of the ovum by a sperm 
followed by tightly regulated molecular and cellular processes /or factors such as uterus, 
blastocyst into maternal decidua, and invasion of the trophoblast cells (Anin et al., 2004; 
Pereira et al., 2015). Human implantation can be defined as interstitial implantation, a 
process where the embryo is completely embedded with the endometrium without being 
destroyed (Su and Fazleabas, 2015). The next section aims to discuss the intricate sequence 
of events leading to the formation and development of the human placenta. 
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1.1.3.1  Pre-implantation events 
Fertilization of the haploid oocyte by the spermatozoa occurs between 24 to 48 h after 
conception in the fallopian tube which results in the formation of a diploid zygote. This stage 
is usually referred to as day 0 of placental development and pregnancy (Imakawa et al., 
2004). The diploid zygote moves along the fallopian tube into the uterus during which it 
undergoes several stages including cleavage and differentiation (Norwitz et al., 2001). The 
diploid zygote undergoes the first cleavage on day 1 leading to mitotic division of two cells 
and four cell stages on day 2. These divisions continue to day 4 where the 8-cell 
uncompacted morula becomes compacted (Norwitz et al., 2001; Imakawa et al., 2004).  
On day 5, the 32- cell (8-cell compacted) morula enters the uterine cavity, the appearance of 
a blastocoel (fluid-filled inner cavity) marks the transition of morula to early blastocyst that 
is accompanied by cellular differentiation such as trophoblast (embryonic structure; 
placenta), and the inner mass cells (which results to the embryo) (Norwitz et al., 2001). 
Within 24 to 48 h (day 6-7) of the blastocyst entering the uterus, it hatches from the 
surrounding zona pellucida (late stage blastocyst) by constant contraction and expansion, 
thereby  exposing the outer surface of the multinucleated (syncytial) trophoblasts which 
leads to the implantation of the blastocyst in the uterine wall (Red-Horse et al., 2004; 
Norwitz et al., 2001). Figure 1.3 illustrates the series of events and their position in the 
female reproductive tracts during pre-implantation. 
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Figure 1.3: Diagrammatic illustration of the events leading to placentation.  
(A) Image represents the entire female reproductive tract; (B) represents a zoomed section 
and series of events from day 0 – 9. Figure was slightly modified from www4. 
 
1.1.3.2  Implantation 
In humans, the implantation process is one of the most important biological events as it is 
considered as the first biological interaction between the developing foetus (blastocyst) and 
uterus. Implantation of the blastocyst usually commences from about day 6 when the 
blastocyst differentiate into early embryonic structures (such as inner {embryo} and outer 
{trophoblasts} cell masses) (Gude et al., 2004; Norwitz et al., 2001; Su and Fazleabas, 
2015). The period in which implantation occurs is relatively short and is often referred to as 
the window of receptivity/implantation (Su and Fazleabas, 2015). During this window 
period, the endometrium, primed by oestrogen and progesterone, undergoes extensive 
changes (intensive morphological, biochemical and molecular) (Su and Fazleabas, 2015). 
The process of implantation in human consist of three stages, namely; (i) apposition, (ii) 
adhesion and (iii) invasion (Staun-Ram and Shalev, 2005). See figure 1.4 for diagrammatic 
representations  
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• Apposition stage: This stage is the first connection between the blastocyst and the 
maternal uterine wall, during which the blastocyst finds a location to implant, guided 
by the maternal endometrium (Su and Fazleabas, 2015). At this stage the blastocyst 
dislodges from the uterine surfaces by flushing the uterus without bringing damage 
to itself. Herein, the pinopodes, which are the micro protrusions from the apical 
surface of the maternal uterine epithelium engage with the microvilli on the apical 
surface of the syncytiotrophoblast of the blastocyst (Norwitz et al., 2001; Staun-Ram 
and Shalev, 2005). The apposition stage usually takes place in the fundal (upper 
posterior wall) of the uterus. See figure 1.4A for illustration. 
• Adhesion stage: The next step is referred to as the stable adhesion stage. This stage 
shows stronger physical connection between blastocyst and the maternal uterine 
epithelium (Staun-Ram and Shalev, 2005). During this stage, there is direct 
interaction between the endometrial epithelium and the trophoblast without 
dislodging the blastocyst, as seen in figure 1.4A (Su and Fazleabas, 2015).  
• Invasion stage: The invasion stage takes place shortly after the stable adhesion stage, 
which is estimated to take place on day 10 after fertilisation (Staun-Ram and Shalev, 
2005). This stage begins with the trophoblasts (extravillious cytotrophoblast) 
penetrating and infiltrating the entire endometrium as well as the inner third of the 
myometrium and uterine vasculature to reach the maternal blood vessels as revealed 
in figure 1.4B (Staun-Ram and Shalev, 2005). The invasion process that occurs at 
this stage is called the interstitial and endovascular invasion (Norwitz et al., 2001). 
This stage allows the trophoblast cells to come into direct contact with maternal 
blood, thereby establishing uteroplacental circulation. See section 1.1.3.4.2 for the 
details of interstitial and endovascular trophoblast cells.
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Figure 1.4: Images showing detailed illustration of blastocyst implantation stages. 
Image showing the series of events that occurs during apposition, adhesion and invasion 
stage. Figure was adapted from www5. 
1.1.3.3  Trophoblast differentiation 
As previously described in section 1.1.3.2, the trophectoderm (also known as the 
trophoblast) of the blastocyst is the first cell lineage that exhibits an extensive proliferation 
and differentiation function during gestation (Ji et al., 2013). During implantation, 
trophoblast invasion and migration is tightly regulated by components of the maternal 
microenvironment and the trophoblast itself, via cellular and molecular interaction (Ji et al., 
2013). These interactions are the major determinants for a successful pregnancy (Staun-Ram 
and Shalev, 2005). Shortly after implantation, the trophectoderm gives rise to diverse 
trophoblast cells by undergoing differentiation that results in the formation of the 
multinucleated syncytiotrophoblasts (STBs). These STBs are mainly involved in the 
exchange of nutrients, waste products, and hormone production between the developing 
foetus and mother (Ji et al., 2013; Huppertz, 2008). The remaining mononucleated 
trophoblast cells are called the cytotrophoblasts (CTBs), which are usually seen in the second 
layer and are never in contact with the maternal tissues (Huppertz, 2008). The CTB forms 
the anchoring villi that attach to the maternal uterine walls and also act as stem cells, which 
are responsible for the continuous expansion of the STBs by rapidly dividing and fusing with 
STBs (Huppertz, 2008). The differentiation of trophoblast cells during placental 
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development is tightly controlled by various growth factors, hormones and environmental 
factors such as oxygen concentration within the maternal-foetal interface (Ji et al., 2013). 
Fluid-filled spaces appear within the STB on the 8th day after fertilization which are 
important in the development of the villous trees of the human placenta and the identification 
of the three fundamental zones (chorionic plate, villous trees and basal plate) of the placenta 
(Huppertz, 2008).  
1.1.3.4  Trophoblast cell differentiation pathways 
The human trophoblast progenitor cells differentiate via two pathways; (1) non-invasive 
villous trophoblasts and (2) the invasive extravillous trophoblasts (Ji et al., 2013) 
1.1.3.4.1 Villous trophoblast differentiation pathway 
In this pathway, the mononucleated CTBs integrate with the multinucleated STBs to form 
the syncytial layer that house the placental villous tree, therefore consisting of both CTBs 
and STBs (Ji et al., 2013). The villous trophoblasts are involved in gaseous, waste and 
nutrient exchange within the maternal-foetal interface (Gude et al., 2004). They also play an 
important role in the maintenance of pregnancy by producing the necessary hormones such 
hCG and hPL (Gude et al., 2004; Ji et al., 2013). In addition, the STB are usually in contact 
with the maternal circulation and exhibit some degree of immune tolerance. Since STBs are 
non-proliferative, they rely on the fusion with CTB for continuous  replenishment and 
syncytial knots (shedding of the aged portion) throughout gestation (Ji et al., 2013). See 
figure 1.5 and figure 1.6 for events leading trophoblast differentiation and function. 
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Figure 1.5: Trophoblast differentiation pathways and functions. 
The blastocyst on day 5 gives rise to the trophectoderm (trophoblast) and inner cell mass 
(embryoblast). The cytotrophoblast differentiates into two distinct pathways with 
autonomous functions. Figure was reconstructed from (Gude et al., 2004; Huppertz, 2011) 
 
1.1.3.4.2 Extravillous trophoblast differentiation pathway 
Extravillous trophoblasts (EVTs) are the highly invasive, proliferative and migrative 
trophoblast population. They are responsible for the development of the floating villi and 
anchoring villi that invade into the maternal uterine wall for the purpose of remodelling the 
maternal spiral arteries, which is important for the sustenance of the developing foetus (Gude 
et al., 2004; Ji et al., 2013). The EVTs are mainly mononucleated cells that can be found in 
the smooth chorion, chorionic plate and basal plate.  
For the successful invasion into the maternal uterine wall, EVT performs several functions. 
These includes remodelling of the maternal spiral arteries, proliferation, differentiation, 
programmed cell death (apoptosis), tolerance to hypoxia, adherence and digestion of the 
extracellular matrix, as well as migration and maternal immune evasion (Anin et al., 2004). 
A tightly regulated invasion of the EVTs is a main step in placentation and it is therefore 
necessary for a successful pregnancy (Gude et al., 2004). EVTs within the maternal 
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compartment consist of several different populations of trophoblast cells with different 
phenotypes with regards to functions and morphology. These populations of EVTs are 
distinguished based on their location within the maternal uterine tissues (Hammer, 2011). 
The three sub-populations of EVT are; (i) interstitial EVT (iEVT), (ii) endovascular EVT 
(enEVT) and (iii) endoglandular EVT (egEVT) (Huppertz, 2011).  
i. Interstitial extravillous trophoblast (iEVT) 
iEVT is the main source of all other subtypes of the EVTs and they invade as deep as the 
inner third of the maternal myometrium, migrate towards the spiral arteries as well as 
differentiate into giant multinuclear cells (Anin et al., 2004; Huppertz, 2011). iEVT consist 
of three structurally and functionally distinct subtypes, namely; large polygonal, small 
spindle-shaped and multinucleated giant cells iEVT. 
• Large polygonal iEVTs also referred to as X cells and are suggested to stay around 
the transition phase of placental-decidua (Huppertz, 2007). They are also involved in 
securing appropriate placentation of the uterus during the entire gestational period 
by secreting “trophoblast glue” composed of matrix-type fibrinoid (Ji et al., 2013). 
This subpopulation are rarely seen in early gestation, but increase significantly from 
45% (in weeks 9-12) to 69% (in weeks 16-24) and eventually reach about 90% (in 
weeks 31-39) (Huppertz, 2007). These iEVTs are evenly distributed across the basal 
plate and invade as far as the superficial third of the maternal myometrium (less 
invasive but more differentiative) and it is the more abundant phenotype seen in term 
placenta (Huppertz, 2007). 
• Small spindle-shaped iEVTs are highly invasive and have been proposed to invade 
deeper into the decidua, up until the inner third of the myometrium (Ji et al., 2013). 
This subtype is similar to that of large polygonal iEVT based on their spatial 
distribution patterns (Huppertz, 2011). They can be described morphologically as 
small ovoid nuclei, elongated and partly filiform bodies (mostly observed on the 
uterine wall). This subpopulation reduces significantly towards term time from 55% 
(first trimester) to 31% (second trimester) and eventually 11% (term time) (Huppertz, 
2007). Small spindle-shaped iEVTs mostly form loose arranged arrays of cells in the 
mist of extracellular matrix and are separated from each other by decidua, 
myometrial cells and large polygonal iEVTs (Huppertz, 2007). 
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• Multinucleated giant cells also called placental bed giant cells are derived from 
invading iEVTs differentiation and they play a role in the maintenance of pregnancy 
by secreting both hPL and hCG hormones (Ji et al., 2013).  
By secreting protease inhibitors, they are also involved in regulating trophoblast 
invasion (by ensuring that the invasion do not exceed the myometrium) (Huppertz, 
2007). The major difference between these subtypes and others (large polygonal and 
small spindle-shaped iEVTs), is that the multinucleated giant cells consist of over ten 
irregular shaped nuclei of various sizes (Huppertz, 2007). See figure 1.5 and figure 
1.6 for events leading to trophoblast differentiation and function flowchart. 
 
Figure 1.6: Events involved in extravillous trophoblast differentiation. 
(A) Foetus anchored to the uterine walls via the formation of the placenta.  (B)  
Magnification of the chorionic membrane that contains the trophoblast and further 
differentiation of the trophoblast.  (C)  Magnification of the floating villus with the 
mononucleated CTBs covered by multinucleated STBs.  (D)  Magnification of the anchoring 
villus.  At anchoring villus, the active proliferating CTBs form column CTBs which detach 
from the villus at the distal portion of the column and migrate into the maternal decidua. 
CTB- cytotrophoblast cell, STB- syntiotrophoblast cell, egEVT- endoglandular extravillous 
trophoblast, enEVT- endovascular extravilous trophoblast, iEVT- interstitial extravillous 
trophoblast. Figure was modified from (Ji et al., 2013). 
 
ii. Endovascular extravillous trophoblast (enEVT) 
This category of EVTs make up the loose plugs seen in the apical portion of the maternal 
spiral arteries. They are situated either in the wall of the spiral arteries or substituting the 
endothelial surface of the spiral arteries through a process known as pseudo-
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vasculogenesis/vascular mimicry (Huppertz, 2011; Khankin et al., 2010). enEVTs are 
believed to play a major role in the remodelling of the maternal spiral arteries starting from 
week 8 to approximately week 22 (Ji et al., 2013). They play a vital role in transforming the 
maternal spiral arteries from “high-resistance-low flow”, to “low-resistance-high-flow” sac-
like vessels. This is accomplished by the destruction of the arterial layer and enEVTs 
replacing the endothelium vessels (Huppertz, 2007). This transformation is necessary for the 
normal growth and development for both the foetus and placenta (Ji et al., 2013). In fact, 
maternal uterine spiral artery remodelling occurs in five stages, namely: 
 Decidua-associated early vascular remodelling 
 iEVTs-associated vascular remodelling 
 migration of enEVTs 
 plugin of enEVTs 
 maternal vascular repairs (Pijnenborg et al., 2006). See figure 1.7 for illustrations. 
The spiral artery remodelling is explained further in section 1.1.4. 
 
 
Figure 1.7: The various stages involved in maternal spiral artery remodelling.  
Figure is slightly modified from (Pijnenborg et al., 2006). 
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iii. Endoglandular extravillous trophoblast (egEVT) 
Recent evidence suggests  the existence of  a third subpopulation of EVT, which are the 
endoglandular EVTs (Ji et al., 2013). egEVT are derived from iEVT and they mainly 
differentiate and migrate towards the maternal uterine glands via penetration of their 
basement membrane (Ji et al., 2013; Huppertz, 2011). It is believed that egEVT mediate 
histiotrophic nutrition of the embryo prior to the completion of the maternal spiral artery 
remodelling as well as opening the maternal uterine glands to the intervillous space 
(Huppertz, 2011; Ji et al., 2013). 
1.1.4 Trophoblast cell regulation 
The differentiation of the highly proliferative EVTs into migratory and invasive trophoblasts 
is tightly regulated by numbers of factors acting such as environmental factors (oxygen), 
hormones, cytokines, proteases (matrix metalloproteinase), and growth factors (Ji et al., 
2013). These factors are most likely to be derived from uterine stromal and glandular cells, 
trophoblast cells, myometrial cells, villous mesenchymal cells, endothelial cells and several 
immune cells within the maternal-foetal interface (Ji et al., 2013). 
Oxygen tension is highly considered to play a major role in the balancing of trophoblast cell 
proliferation and differentiation using hypoxia-inducible factors as oxygen sensors (Ji et al., 
2013). During gestation, the partial pressure of oxygen in the intervillous space constantly 
varies until the completion of maternal spiral artery remodelling. Oxygen pressure at 8-10 
weeks of pregnancy is estimated to be as low as 17.9 – 39.6 mmHg (Ji et al., 2013). This 
values increases to about 80 -100 mmHg after spiral artery remodelling by the endovascular 
EVTs (Ji et al., 2013; Pollheimer and Knöfler, 2012). Initial implantation, placentation and 
trophoblast invasions takes place in a physiological hypoxic environment estimated to be 
around 1 – 2% oxygen (Anin et al., 2004; James et al., 2006). Other factors involve in the 
regulation of trophoblast differentiation and invasion as well as their functions are 
summarised in table 1.1. 
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Table 1.1: Summary of important factors involved in trophoblast differentiation and 
invasion.  
Factors Function 
Vascular Endothelial 
Growth Factor 
Vascular development, stimulates cell proliferation, 
induces endothelial division, migration and survival, and 
activation MAP kinases. 
Epidermal Growth Factor Endocrine functions such as stimulating the secretion of 
hCG, induces trophoblast differentiation, proliferation, 
invasion and implantation. 
Transforming Growth 
Factor β 
Inhibits trophoblast proliferation and invasion, induces 
syncytialization. 
Hepatocyte Growth 
Factor 
Increases proliferation, migration, invasion by targeting 
HIF-1α. 
Notch signalling Promoting vascular invasion and proliferation of 
trophoblast cells. 
Wnt signalling Controls invasion of trophoblast in paracrine manner. 
Gonadotropin-releasing 
hormone 
Enhances EVT invasion 
Human Chorionic 
Gonadotropin 
Maintenance of corpus luteum, syncytialization process. 
Integrins Embryo implantation via adhesive molecules such as E-
cadherin. 
Mucin 1 Provide barrier to trophoblast invasion, acts as anti-
adhesive molecules hindering blastocyst attachment until 
the 3rd day. 
Leukaemia inhibitory 
factor 
Involve in implantation and immune tolerance. 
*Table adapted from (Staun-Ram and Shalev, 2005; Ji et al., 2013). 
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1.1.5 Complications during placentation 
Failure in controlled implantation and placentation processes can lead to placental 
insufficiency resulting in reduced nutrient and waste exchange between the foetal and 
maternal circulations (Ji et al., 2013). One key process that can result in placenta 
insufficiency is altered uteroplacental haemodynamic (impairment of the maternal spiral 
arteries) or shallow invasion of the trophoblast cells which can result in spontaneous 
miscarriages, pre-eclampsia, intrauterine growth restriction, stillbirth, and preterm delivery 
(Malhotra et al., 2016; Pereira et al., 2015). In addition, chromosomal anomalies and 
insufficient maternal arteriole plugging have also been associated with early pregnancy 
complications such as miscarriage (Malhotra et al., 2016). However, the cause of impaired 
spiral arteries remodelling or shallow trophoblast invasion is not fully understood, placental 
oxidative stress has been proposed to a major key factor in the pathophysiology of pregnancy 
complications (Malhotra et al., 2016; Pereira et al., 2015; Aouache et al., 2018). 
1.1.5.1  Oxidative stress 
Oxidative stress can be described as an imbalance in the production of oxidants (reactive 
oxygen species) and the ability of antioxidants to scavenge them, resulting in a disruption of 
redox signalling, control and/or molecular damage as demonstrated in figure 1.9 (Myatt and 
Cui, 2004; Aouache et al., 2018). Reactive oxygen species (ROS) refers to molecules derived 
from the oxygen that have gained an extra electron and have the ability to oxidize other 
molecules (Sullivan and Chandel, 2014). ROS is one of the main types of free radical species 
and they are known to be very unstable and reactive (Agarwal and Gupta, 2005). A schematic 
representation of the interplay between ROS and anti-oxidants in normal cells is shown in 
figure 1.8 
 
Figure 1.8: Overview of oxidative stress. 
In healthy/normal cells, ROS and antioxidants remain in balance whereas, during oxidative 
stress there is an imbalance because of increased ROS production or depletion of antioxidant 
defence system resulting in cellular damage and death. Figure was slightly modified from 
(Sullivan and Chandel, 2014). 
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There are three major types of ROS, namely; superoxide (O2•-), hydrogen peroxide (H2O2) 
and hydroxyl (OH•) which are generated in cells (Ashok Agarwal, Sajal Gupta, 2005). The 
most common being superoxide (O2•-), which is formed as the first step in the leakage of 
electrons from the electron transport chain, particularly from complex I and III or from 
endoplasmic reticulum (one electron reduction from oxygen). The reactivity is created as the 
result of the unpaired electron in O2•- which leads to the formation of H2O2 and OH• (Myatt 
and Cui, 2004; Ashok Agarwal, Sajal Gupta, 2005). Hydrogen peroxide is formed from the 
dismutation of superoxide i.e. two molecules of O2•- being converted to H2O2 and water 
(H2O) by superoxide dismutases (SODs) as shown in figure 1.10. The hydroxyl radical is 
formed when H2O2 accepts another electron from ferrous ion (Fe2+) mediated by the Fenton 
reaction. Hydroxy radical is very reactive and can result in DNA damage by causing strand 
breaks  (Ashok Agarwal, Sajal Gupta, 2005). These major types of ROS have varied 
reactivity and can result in different physiological and cellular effects. See figure 1.10 for 
the summary of ROS subtypes formation. 
 
Figure 1.9: Formation and interconversion of ROS.  
Figure adapted from (Sullivan and Chandel, 2014). 
 
The primary site for ROS production is the mitochondria, where the majority of oxygen 
consumption and ATP generation takes place. The major source of intracellular ROS is the 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (Sullivan and Chandel, 
2014). NADPH oxidases catalyses the formation of superoxide from oxygen and NADPH 
and are capable of generating increase amount of ROS as they are present in several tissues 
in the human body (Sullivan and Chandel, 2014). 
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Oxidative stress has been implicated in over 100 diseases including several types of cancers, 
diabetes, cardiovascular diseases and pregnancy disorders (Aouache et al., 2018; Sullivan 
and Chandel, 2014; Daubney et al., 2015). Bodies of evidence from both human and animal 
studies have shown the presence of ROS in female reproductive tracts such as fallopian 
tubes, ovaries, placenta and embryos (Ashok Agarwal, Sajal Gupta, 2005; Aouache et al., 
2018). When ROS is maintained at a reduced or moderate amount, they can play beneficial 
roles in cellular and molecular processes. For instance, ROS is required for the synthesis of 
cellular structures (phagocytes) used to combat pathogen by the host immune system 
(Pizzino et al., 2017). Other beneficial functions of ROS at low or moderate amount include, 
activation of mitogen-activated protein kinase (ERK1/2, SAPK-JNK, p38MAPK), and 
redox-sensitive transcription factors (p53, NF-κB) (Burton and Jauniaux, 2011). 
 
1.1.6.1  Implication of ROS in pregnancy 
Pregnancy is considered to be a state of oxidative stress as a result of increased placental 
mitochondrial activity and formation of ROS, especially superoxide anion (Myatt and Cui, 
2004). ROS produced by the placenta are important for trophoblast proliferation, 
differentiation and vasculogenesis (Myatt and Cui, 2004). The excessive production of ROS, 
which overwhelms the antioxidant capacity (oxidative stress), results in several pregnancy 
complications as summarised in figure 1.11. 
 
Figure 1.10: Contribution of oxidative stress during pregnancy. Figure was adapted 
from (Lázár, 2012). 
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1.1.6.1.2 Pre-eclampsia 
Pre-eclampsia (PE) is major disease of human pregnancy characterised by hypertension 
(160/110 mmHg) and proteinuria (>300 mg/24 h) developing after 20 weeks of gestation 
(Aouache et al., 2018). PE is estimated to affect about 3 – 14 % of pregnant women 
worldwide and the incidence varies according to time of the year, geographical location, 
nutrition, and race/ethnicity (Aouache et al., 2018). It is the leading cause of perinatal and 
maternal mortality and morbidity worldwide (Fayyad and Harrington, 2005). Low birth 
weight, prematurity and death are potential outcomes of foetal complications whilst 
haemolysis, thrombocytopenia, elevated liver enzymes/liver failure, seizures and death 
potential outcomes of maternal complications (Mutter and Karumanchi, 2008).  
The exact etiology of PE is still unknown. However, PE has been classified into two subtypes 
by some researchers, namely; (a) early-onset PE and (b) late-onset PE, developing after 34 
weeks (Huppertz, 2011; Poon and Nicolaides, 2014).  
Early-onset PE can be defined as PE that develops before the 34 weeks of gestation. Early-
onset PE accounts for a small proportion of about 5 – 20% of all cases and it is associated 
with changes in blood circulation within the maternal uterine arteries (Poon and Nicolaides, 
2014). This alteration can be linked to incomplete conversion of the maternal spiral arteries 
by impaired trophoblast invasion as seen in figure 1.12. Early-onset PE is the most severe 
clinical variant and it is associated with neonatal morbidity and mortality (Gomathy et al., 
2018). On the other hand, the late-onset of PE develops after 34 weeks of gestation and 
accounts for about 80% of PE cases (Raymond and Peterson, 2011). This case is associated 
with maternal morbidity (such as impaired glucose tolerance, obesity, chronic hypertension, 
metabolic syndrome), normal placental weight and volume, and normal birth weight 
(Huppertz, 2011; Gomathy et al., 2018). Although the clinical features of both early and 
late-onset PE overlap, there are differences in prognosis, perinatal and maternal outcome 
(Raymond and Peterson, 2011).  
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Figure 1.11: Preeclampsia associated with spiral artery remodelling. 
Inadequate remodelling of the maternal spiral arteries by the trophoblasts cells will result in 
high blood pressure and reduced blood flow, which eventually leads to preeclampsia. Figure 
adapted from (Moffett et al., 2015). 
 
1.1.6.1.3 Pathophysiology of pre-eclampsia 
The exact aetiology of PE still remains a mystery, however it is almost certain that the 
pathology is caused by the placenta (Irminger-Finger et al., 2008). It has been proposed that 
the physiopathological mechanism originates from the inadequate invasion of the 
trophoblast cells into spiral arteries as a result of severe hypoxia triggering hypoxia/ 
reoxygenation-induced  oxidative stress (Irminger-Finger et al., 2008; Ji et al., 2013). 
Placenta has been reported to be solely involved in placenta PE rather than the foetus, as 
studies has shown that removing the foetus alone was not sufficient to stop the symptoms of 
PE until the placenta was delivered (Petla et al., 2013). Incomplete or reduced spiral arteries 
remodelling as shown in figure 1.11, will lead to placental insufficiency, increased placental 
apoptosis and necrosis, endothelial dysfunction and abnormal increase in inflammatory 
responses (Petla et al., 2013). Endothelium is responsible for the regulation of vessel 
permeability and platelet adhesion, hence this dysfunctionality will lead to an imbalance in 
vasoconstriction, intravascular coagulation and thrombocytopenia (Irminger-Finger et al., 
2008). See figure 1.12 for summary of the pathogenesis of PE. 
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Figure 1.12: Pathogenesis of preeclampsia. 
Oxidative stress resulting for severe hypoxic or hypoxia reoxygenation within maternal 
foetal interface leads to reduced trophoblast invasion which results in incomplete 
remodelling of the maternal spiral arteries. Figure modified from (Irminger-Finger et al., 
2008). 
 
1.1.6.1.4  Pre-eclampsia and hypertension  
Although the exact cause of hypertension is not fully understood, it is clear the pathological 
changes within placenta are the main contributors. According to latest theory, PE is believed 
to result from shallow/reduced trophoblast invasion into the maternal uterine wall leading to 
placental ischemia, which initiates the release of antiangiogenic factors such as soluble fms-
like tryrosine kinase-1 (sFlt-1) and soluble endoglin (sEng) (Enkhmaa et al., 2016). sFlt-1 
binds and halt angiogenic factors including VEGF and placental growth factors (PIGF) while 
sEng binds and inhibits TGF-β leading to an imbalance in angiogenic factors depriving the 
maternal vascular endothelium and resulting in systemic endothelial dysfunction, 
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hypertension, proteinuria(Enkhmaa et al., 2016; Maynard et al., 2003). Elevated levels of 
sFlt-1 and sEng have been seen in preeclamptic patients (Maynard et al., 2003).  
 
1.2 Antioxidants 
Antioxidants are scavenging molecules that are capable of preventing and slowing the 
oxidation of other molecules by converting ROS to H2O, thereby preventing ROS 
overproduction (Ashok Agarwal, Sajal Gupta, 2005; Siddiqui et al., 2010). This process is 
accomplished by terminating the ROS cascade reaction and elimination of free radical 
intermediates followed by the inhibition of other oxidation reactions (Siddiqui et al., 2010). 
This shows that antioxidants are central in the protection of cells from oxidative stress 
(Khera et al., 2013).  
There are two types of antioxidants namely; enzymatic and non-enzymatic (Aouache et al., 
2018). Enzymatic antioxidants also referred to as natural antioxidants include superoxide 
dismutase, catalase, glutathione peroxidase, glutathione reductase, thioredoxin, and 
hemoxygenase (Aouache et al., 2018; Ashok Agarwal, Sajal Gupta, 2005). Non-enzymatic 
antioxidants are mainly dietary supplements or synthetic antioxidants such as vitamins (A, 
C, E), minerals (zinc, selenium), glutathione, nicotinamide adenine dinucleotide system and 
flavonoids (Birben et al., 2012; Aouache et al., 2018; Pizzino et al., 2017).  
1.2.1 Pre-eclampsia and antioxidant therapy 
To date, the only known solution to PE is preterm delivery or termination of pregnancy to 
safeguard mother’s life. Therefore, prevention and treatment are of major clinical importance 
and research focus. Since PE has been linked to oxidative stress, research to date, has focused 
on reducing and/ preventing placental oxidative stress using antioxidant (non-enzymatic) 
therapy (Aouache et al., 2018; Kiondo et al., 2014). Several researchers have focussed on 
the use of vitamin C and E alone or in combinations (Basaran et al., 2010; Rossi and Mullin, 
2011; Fu et al., 2018). 
In a clinical trial conducted by Kiondo et al. 2014 on the effect of vitamin C supplements on 
PE in Kampala, Uganda has shown that supplementation with vitamin C did not prevent or 
reduce the incidence of PE nor reduce the adverse maternal neonatal outcome. This clinical 
trial consisted of 932 pregnant women with half of them randomised to vitamin C and the 
other half on placebo. 
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Clinical trials by Stratta et al. 1994 and Bastani et al. 2011, concluded that vitamin E 
supplement did not appear to decrease PE outcome or occurrence and failed to improve foetal 
outcome.In addition, clinical trial by Basaran et al. 2010 investigating the combination of 
vitamin C and E supplementation for the prevention of PE also conducted that these 
combination does not decrease the onset/risk of PE and should not be offered to pregnant 
women for the prevention of PE or other pregnancy combination. This conclusion was drawn 
with data from 9 independent studies consisting of about 20,000 pregnant women. 
Interestingly, Chen et al, 2012 carried out extensive clinical study to investigate the effects 
of pregnant women consuming  pomegranate juice (rich in polyphenolic antioxidant) to 
attenuate oxidative stress and trophoblast apoptosis. This study involved tissue samples from 
12 patients (35weeks of gestation till birth) with the daily consumption (8 oz/day) of 
pomegranate juice. They concluded that pomegranate juice reduces placental oxidative stress 
in vivo and in vitro. 
 
1.2.2 Flavonoids 
Flavonoids are large group of naturally occurring phenolic compounds with significant 
antioxidant and chelating properties ubiquitously distributed in plants (Erlund, 2004; Panche 
et al., 2016). To date, there are more than 8000 identified flavonoids, although only a small  
number are relevant from a dietary point of view (Erlund, 2004). They are low molecular 
weight and widely distributed in barks, seeds, leaves and flowers of plants and vegetables 
(Heim et al., 2002). Flavonoids have been associated with a large spectrum of health 
promoting effects such  as anti-cancer, cardio-protection, neuroprotection, anti-
inflammatory and antioxidant properties (Heim et al., 2002; Panche et al., 2016). The dietary 
intake of flavonoids varies by geographical location and cultural practices such as tea or 
wine drinking (Heim et al., 2002). The average intake of flavonoids in developed countries 
(e.g. Netherland, USA, and Italy) is estimated to be between 23 – 38 mg/day (Erlund, 2004). 
1.2.3 Chemical structure and classification of flavonoid 
The chemical structure of flavonoids is based on their degree of polymerization, structural 
class, degree of hydroxylation, other substitutions and conjugations (Yao et al., 2004). 
Although flavonoids vary in structure  they all consist of a two phenyl chromone parent 
compound (A and C) connected to a phenolic ring (B) as shown in figure 1.14 (Yao et al., 
2004; Erlund, 2004).  
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Figure 1.13: The basic structure of flavonoid.  
Figure adapted from (Heim et al., 2002).  
 
These phenolic and pyrane rings all exhibit several levels of hydroxylation and 
methoxylation (Yao et al., 2004). The biochemical properties and functions of 
flavonoids/their metabolites relies on their chemical structure and the position of various 
moieties in the structure (Erlund, 2004; Yao et al., 2004). Flavonoids can be classified as 
either 3-hydroxyflavonoids (flavonoids containing hydroxyl group in position C-3 of the C 
ring) or 3-desoxyflavonoids (flavonoids with the absence of an hydroxyl group in position 
C-3 of the C ring) (Erlund, 2004). In addition, classifications are also based on the presence 
and position of additional hydroxyl or methyl groups (Erlund, 2004). Flavonols, 
anthocyanidins, leucoanthocyanidins and flavan-3-ol are subclasses of 3-hydroxyflavonoids 
while flavonones and flavones are subclasses of 3-desoxyflavonoids (Erlund, 2004). 
Isoflavonoids are different from other groups due to the fact that their B ring is attached to 
position C-3 instead of C-2 (Erlund, 2004). This study will be emphasising on flavonols and 
flavanones. See table 1.2 for details of other subclasses of flavonoids. 
• Flavonols: Flavonols are the most abundant of flavonoids and quercetin is the most 
common flavonol.  It is present in numerous fruits and vegetables with onion having 
the highest concentrations (Erlund, 2004). In addition, the source of quercetin varies 
according to the country, for example, the main source of quercetin in Japan and 
Netherland is tea, while in Italy, quercetin is predominantly found in wine. In the 
USA, Finland and Greece, the major source of quercetin is apple and onion (Erlund, 
2004; Panche et al., 2016). Kaemferol and myricetin are the two other common 
flavonols which are mostly found in broccoli and berries respectively (Yao et al., 
2004). The chemical structure of quercetin can be found in table 1.2. 
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• Flavanones: These are another important subclass that are predominantly found in 
citrus fruits (with the highest concentrations seen in solid tissues) and considerable 
amounts have also been found in juices as well (Panche et al., 2016). Hesperidin is 
the major flavonoids in this subclass and it is mainly found in oranges and mandarins. 
Naringin is another example of a flavanone and it is mainly found in grapefruits. 
Others examples of flavanones includes hesperetin and naringenin (tomatoes) 
(Erlund, 2004). See table 1.2 for chemical structures. 
Table 1.2: subclasses of flavonoids, food sources and chemical structures 
Flavonoid 
subclasses 
Example 
compound 
Dietary 
source 
Structures 
Flavonols  Quercetin, 
kaempferol, 
myricetin, 
isorhamnetin 
Onions, 
berries, 
broccoli, tea, 
wine, apples, 
kale, lectuce 
 
Quercetin: R1=OH, R2=OH, 
R4=OH. 
Myricetin: R1=OH, R2=OH, 
R3 =OH, R4=OH. 
Kaempferol: R2=OH, R4=OH. 
Flavanones 
 
 
 
 
 
Hesperidin, 
naringin, 
hesperitin, 
naringenin 
Oranges, 
grapefruits, 
tomatoes 
 
Hesperidin: R1=6-O-α-L-
rhammosyl-D-glucose, 
R2=OH, R3=OCH3. 
 
Naringin: R1=2-O-α-L-
rhammosyl-D-glucose, 
R3=OH. 
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Hesperetin: R1=OH, R2=OH, 
R3= OCH3. 
Naringenin: R1=OH, R3=OH. 
Flavan-3-ols Catechin, 
epicatechin 
Apples, pear, 
grapes, 
peaches, cocoa 
or dark 
chocolate, red 
wine, green 
tea. 
 
Flavones Apigenin, luteolin, 
tangeretin 
Red pepper, 
celery, 
chamomile tea, 
herbs (parsley). 
 
Apigenin: R2=OH 
Luteolin: R1=OH, R2=OH 
Anthocyanidins Pelargonidin, 
cyanidin, 
delphinidin, 
malvidin 
Plum, apples, 
eggplant, 
berries 
 
Pelargonidin: R2=OH. 
Cyanidin: R1=OH, R2=OH. 
Malvidin: R1=OCH3, R2=OH, 
R3=OCH3. 
Isoflavonoids Genistein, 
daidzein,  
Soybean, soy 
products (tofu, 
tempeh, miso) 
 
Ideas were adapted from (Hui et al., 2013; Erlund et al., 2001; Panche et al., 2016) and 
structures were sketched using ChemSpider, UK. 
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1.2.4 Absorption and metabolism of flavonoids 
Ingestion of dietary flavonoids from fruits and vegetables is mainly by oral route, and their 
absorption is dependent on their physico-chemical properties like molecular weight, 
lipophilicity, structural configuration, solubility and acid dissociation constant (pKa) 
(Kumar and Pandey, 2013). The main site for flavonoid absorption is the gastrointestinal 
tract (small intestine and colon), and therefore is influenced by the form of flavonoids 
whether they are glycoside or aglycone. Aglycones are readily absorbed by the small 
intestine, whereas glycosides are converted into aglycones before they can be absorbed 
(Kumar and Pandey, 2013). In order for flavonoids to be absorbed, conjugated, metabolised 
and/or excreted,  they have to be degraded into phenyl acids (mainly by the colonic bacteria) 
by splitting them into heterocyclic rings (Yao et al., 2004). Flavonoids in the form of 
glycosides are rapidly deglycosylated. The rate and extent of this deglycosylation is 
dependent on the position or nature of sugar attached to the flavonoid as well as the structure 
of the flavonoid (Yao et al., 2004). The mechanisms and events leading to flavonoid 
absorption are poorly understood and are a matters of debate. It was previously thought that 
flavonoids are absorbed in the large intestine only (Erlund, 2004). Recent evidence has 
shown that flavonoids are metabolised in the liver, small intestine and colon by O-
methylation, glucuronidation and sulphation (Bentz, 2009; Thilakarathna and Vasantha 
Rupasinghe, 2013). Flavonoid conjugation takes place in the small intestine followed by the 
liver for further metabolism. Liver metabolism produces sulphates and glucuronide 
derivatives, and excretion occurs via urine or bile. Flavonoids that are not processed in the 
intestine will reach the colon, where they will undergo structural modifications by colonic 
microflora. Some flavonoid glucuronides re-enter the enterohepatic circulation via bile 
excretion where they are hydrolysed to aglycones by the microbiota. Aglycones are further 
metabolised to low molecular weight compounds for easy absorption. Plasma and urine 
measurement of flavonoids after ingestion revealed that absorption of flavonoids is rapid 
and  flavonoids are present in systemic circulation shortly after ingestion (Yao et al., 2004). 
See figure 1.15 for summary of flavonoids absorption and metabolism. 
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Figure 1.14: Schematic representation of flavonoids metabolism.  
Ingestion flavonoids undergoes intestinal biotransformation producing metabolites. These 
metabolites are transported to the liver through the hepatic portal vein. Metabolites in the 
liver are then transferred to target tissues and cells or excreted to bile for enterohepatic re-
circulation or eliminated through faeces or urine. Flavonoids aglycones or metabolites that 
get to the colon undergo degradation by microbial population and then reabsorbed. LPH: 
lactase-phlorizin hydrolase. Figure adapted from (Thilakarathna and Vasantha Rupasinghe, 
2013) with modifications. 
 
1.2.5 Bioavailability of flavonoids 
Bioavailability can be defined as “the rate and extent to which an active moiety or active 
ingredient is absorbed from a drug product and becomes available at the site of action” (U.S 
Food and drug Administration). This same principle can be applicable to flavonoids as the 
rate of absorption and presence at the site of action is crucial for them to be effective in the 
biological system. Flavonoid bioavailability is low and varies among different flavonoid 
subclasses and individual flavonoid compounds (Panche et al., 2016).  
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For instance the absorption of quercetin from onion is fourfold greater than that from apples 
or tea (Yao et al., 2004). According to Crozier, Del Rio and Clifford (2010).  Flavonoids 
with complex structures and higher molecular weights have lower bioavailability. In a 
clinical study, quercetin from onion powder consumption showed faster absorption, increase 
plasma concentrations and greater bioavailability when compared to apple peel powder 
(Banjarnahor and Artanti, 2014). Study from Erlund et al, (2001) has also shown that 
bioavailability and pharmacokinetics of flavanones (hesperidin and narigin) varies in 
different studies. For example, hesperetin recovery was 3% after 500 mg of hesperidin in 
one study and in another 24% was recovered in 5 subjects ingesting 1250 ml of oranges. 
Similar observations was seen in naringenin recovery, 5% in one subject and 15% in two 
subjects after a single ingestion of naringin (214-700 mg) (Bentz, 2009; Crozier et al., 2010).   
1.2.6 Flavonoids as prooxidants 
As explained above (section1.2.5) flavonoids can be beneficiary, however they also can 
produce deleterious effects on the dells by exhibiting prooxidant properties (Eghbaliferiz 
and Iranshahi, 2016). The prooxidant properties of flavonoids has been proposed to be 
directly proportional to the total number of hydroxyl groups in the structure of flavonoid as 
multiple hydroxyl groups in the B ring significantly elevates the production of the hydroxyl 
radical in Fenton reaction (Procházková et al., 2011). Evidence has also revealed that the 
presence of 2,3-double bond and 4-oxo structural arrangement of flavones may increase the 
chances of ROS production stimulated by divalent copper and oxygen (Eghbaliferiz and 
Iranshahi, 2016). They are also known for their metal chelating ability which can be 
deleterious when flavonoids mediate the reduction of Cu(II) to Cu(I) resulting to the 
development of ROS and other organic compound that can harm lipids (Eghbaliferiz and 
Iranshahi, 2016). Flavonoid prooxidant properties is also concentration dependent; the 
prooxidant properties of four flavonoids (quercetin, morin naringenin and hesperetin) was 
investigated by Yen et al, (2003) in human lymphocyte system. In this study, when 
flavanones (namely naringenin and hesperetin) were added in a concentration range from 0 
– 200 µM, intracellular H2O2 production could not be detected whereas addition of quercetin 
and morin in concentration range 25 – 200 µM and 125 – 200 µM respectively increased the 
concentration of H2O2. Another  mechanism for prooxidant effects of flavonoids involves 
several peroxidases that catalyse the oxidation of polyphenols such as inducing lipid 
peroxidation and co-oxidising of GSH to thiol radical formation (Procházková et al., 2011). 
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Prooxidant properties of flavonoids are also considered to be one of many mechanisms in 
which flavonoids promote apoptosis, bactericidal activity and inhibit mitochondrial 
breathing (Eghbaliferiz and Iranshahi, 2016; Procházková et al., 2011).  
1.2.7 Flavonoids as antioxidants 
Flavonoids have shown both antioxidant and prooxidant properties in animal and in vitro 
models. Their antioxidant property has been labelled as high level natural antioxidant due to 
following reasons (Yao et al., 2004; Procházková et al., 2011); 
 Direct involvement in scavenging ROS: Flavonoids are capable of scavenging free 
radicals due to their ability to donate hydrogen atom due to their high reactivity of 
the hydroxyl group, hence resulting less-reactive and stable free radicals (Panche et 
al., 2016). Some flavonoids have been found to directly scavenge superoxide while 
others scavenge peroxynitrite, a highly reactive oxygen derived radical (Panche et 
al., 2016). In vitro studies of flavonoids have shown that their f antioxidant properties 
depend on the structural arrangement of functional groups as well as both the total 
number of hydroxyl groups and their configuration. The most significant determinant 
of ROS scavenging by flavonoids is the configuration of the B ring hydroxyl group 
(Bentz, 2009). However, inserting the hydroxy group in ring A and C has little or no 
impact on superoxide scavenging effect.  Other structural features of flavonoids in 
combating free radicals include the following;  the presence of catechol (ortho-
dihydroxy) structure in the B ring which is responsible for delocalization of electron, 
presence of hydroxyl group at positive 5 (A ring) and 3 (C ring) which is responsible 
for providing hydrogen bond to the oxo group and the presence of 2,3-double bond 
in combination with a 4-oxo function the C ring which is responsible for the 
delocalization of election from the B ring (Procházková et al., 2011; Robert J. 
Williams et al., 2004). 
 Activation of antioxidant enzymes: Flavonoids can indirectly scavenge free 
radicals by interacting various antioxidant enzymes such as glutathione and 
nicotinamide adenine dinucleotide phosphate system (Panche et al., 2016). This can 
be achieved by their ability to induce phase II detoxifying enzymes like NAD(P)H-
quinone oxidoreductase, and glutathione S-transferase, which are the main defence 
enzymes against oxidative stress and electrophilic toxicants (Procházková et al., 
2011).  
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 Flavonoids with the hydroxy functional group at position C-3 (e.g. quercetin) are 
more effective in the activation of other antioxidant mechanisms and effective 
inducer of electrophile-responsive element (Brunetti et al., 2013). 
 Metal chelating potentials: Flavonoids have shown the ability to chelate iron and 
copper, thereby deleting a causal factor for the formation of free radicals 
(Procházková et al., 2011). Quercetin was found to prevent oxidative cellular injury 
by a number of oxidising agents  (such as acrolein) that influenced the release of iron 
in its redox form in erythrocyte membrane (Procházková et al., 2011). According to 
Pietta (2000), the binding site for trace metal in the flavonoid structure are the 3-
hydroxyl and 4-oxo group in the C ring, catechol moiety in the B ring, and 4-oxo and 
5-hydroxyl groups in the A and C ring. The main contributor of the metal chelation 
is the catechol moiety in the B ring due to its ability to chelate cupric cation (Brunetti 
et al., 2013). 
 Inhibition of oxidases: Flavonoids have the ability to inhibit enzymes such as 
xanthine oxidases and protein kinase C that are responsible for the generation of 
superoxide (Panche et al., 2016). Flavonoids have also shown to be potent inhibitors 
of cyclooxygenase, microsomal succinoxidase, lipoxygenase and NADH oxidase 
(Banjarnahor and Artanti, 2014). Based on structural function of flavonoids, luteolin 
a member of the subclass flavone was found to be the most potent inhibitor of 
xanthine oxidase which eventually led to the decreased oxidative cellular injury 
(Procházková et al., 2011). 
Other antioxidant properties of flavonoids include; increasing uric acid levels, mitigating 
oxidative stress as a of nitric oxide, reduction of α-tocopheryl radicals, and modification of 
prooxidant properties of low molecular antioxidants (Panche et al., 2016). As can be seen 
above (state sections 1.1.6.1.2) oxidative stress is found to be main contributor to several 
diseases which include pregnancy related disorders. It is also known that the flavonoids in 
edible plants and fruits do have protective effects against oxidative stress mainly by 
preventing the formation of intracellular ROS. Interestingly, scientific research is now 
concentrating on the use of natural food supplementations to prevent many of these 
disorders. In fact, several studies have been carried out on the antioxidant effects of 
flavonoids in cancer, cardiovascular diseases, neurodegeneration, anti-inflammatory, 
diabetes, and anti-bacterial (Panche et al., 2016; Eghbaliferiz and Iranshahi, 2016; Hwang 
and Yen, 2011; Bournival et al., 2009).  
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However, no study has explored the antioxidant effects of flavonoids during early gestational 
disorders (such as pre-eclampsia), which result from placental oxidative stress. Perhaps, the 
main reason for these are due to the ethical constraints of performing clinical trials on 
pregnant women. Although it is possible to study the overall effects of ingesting edible 
plants, and/or fruits to prevent early pregnancy disorders, it is virtually impossible to extract 
a particular ingredient (such as flavonoids) from other bio-protective substances (such as 
vitamins) without affecting their biological activities. The best alternative to this is to use in 
vitro studies using cell lines originated from early trophoblast. 
1.2.8 The role of flavonoids in vasculo-endothelial functions 
Endothelial dysfunction is a significant event in the pathogenesis of pre-eclampsia, 
cardiovascular disease (atherosclerosis) and cancer (Aouache et al., 2018; Bondonno et al., 
2012; Franses et al., 2013). Healthy endothelial cells promote vascular repairs  and enhances 
trophoblast  invasion by maintaining vascular homeostasis and regulation of vascular tone 
(Aouache et al., 2018; Loke et al., 2008). This maintenance is achieved by balancing the 
production of vasodilators such as nitric oxide. Dietary flavonoids increase the nitric oxide 
level which enhances endothelial function by increasing the production endogenous nitric 
oxide and reducing their breakdown (Bondonno et al., 2012). Human clinical trials have 
shown that flavonoids improve endothelial functions in acute and short-term intervention 
(Hodgson and Croft, 2006; Chen et al., 2012). The improvement of endothelial – dependent 
and nitric oxide – dependent vasodilation have been proposed to be one of the possible 
mechanism of flavonoid involvement in endothelial and vascular function (Loke et al., 
2008). The improvement in endothelial function can also contribute to lower blood pressure. 
1.2.9 The role of flavonoids in glucose and lipid metabolism 
Lipids and glucose are important macromolecules required for the maintaining various 
physiologic, homeostatic and cellular processes in the human body. Dysfunction in lipid, 
lipoprotein and glucose metabolism have been linked in the pathogenesis of several diseases 
including obesity, cardiovascular diseases, diabetes and inflammation(Assini et al., 2013; 
Jung et al., 2006). Flavonoids from citrus origin (especially naringin) have been found to 
exhibit lipid-lowering properties in humans by significantly reducing plasma triglyceride 
and apolipoprotein B levels in hypertriglyceridemic patients (Assini et al., 2013). Citrus 
flavonoid (naringin) was found to significantly lower plasma low density lipoprotein (LDL) 
in a clinical trial involving hypercholesterolemic patients (Jung et al., 2003). The lipid 
lowering mechanism of citrus flavonoids have been fully established in human subjects. 
However, other studies exhibited inhibitory effect on hepatic HMG-CoA (3-hydroxy-3-
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methyl-glutaryl-coenzyme A) reductase and acyl CoA (Jung et al., 2003). In fact flavonoids’ 
cholesterol lowering properties have been attributed to their direct binding to/interaction 
with oestrogen receptors (Bok et al., 2000).  
Flavonoids have also been identified as an antidiabetic agent, the mechanisms in which they 
exert their hypoglycaemic and hypolipidemic effects in type-2 diabetes have not been well 
documented (Jung et al., 2006). Although, animal studies shows that hesperidin and naringin 
significantly increases glucokinase mRNA, as well as markedly reducing the mRNA 
expression of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase in the liver of 
C57BL/KsJ-db/db mice (Jung et al., 2006). 
1.3 Trophoblast models 
Lack of suitable animal model has made the investigation on the pathogenesis of PE more 
difficult. There were several attempts to create animal models using rats, rabbits, dogs, and 
guinea pigs and nonhuman primates (Lu et al., 2007). These attempts failed due to the nature 
of surgical and methodological interventions that altered the vascular functions (Lu et al., 
2007). It should be noted PE is a human specific disease, therefore establishing animal 
models needs to be carried out either by surgical interventions (such as renal artery ligation) 
or dietary modifications (high salt diet) Since the 1890s, there have been increasing interest 
in the isolation of trophoblasts from human placenta for the purpose of primary culture. 
However, isolated primary trophoblast culture has its setback of being very difficult to 
maintain in culture due to their short lifespan (maximum of 7 days) and inability to 
subculture (Rothbauer et al., 2017; Barrak et al., 2016). These disadvantage inspired the 
generation trophoblast cell lines that able to differentiate, invade and migrate (Abou-Kheir 
et al., 2017). Different cell lines were developed to study the function of the placenta 
including BeWo, JEG-3 and JAR from choriocarcinomas, HTR-8/SVneo, TEV-1, SW71 
from first trimester EVTs (Rothbauer et al., 2017; Abou-Kheir et al., 2017; Barrak et al., 
2016) 
HTR-8/SVneo was the main cell line used for this study, as it is a well-established 
extravillious cytotrophoblast (EVTs) cell line. It was generated from the isolation of evCTB 
from the first trimester placenta tissue and transfected with a plasmid (simian virus 40 large 
T antigen) by Graham et al. (Abou-Kheir et al., 2017; see also Graham et al., 1993). Also, it 
has been validated as trophoblast cell line with extended lifespan and shares phenotypic 
features with primary cytotrophoblast cell cultures such as E-cadherin, vimentin, cytokeratin 
7, hCG production and the expression of type IV collagenase and cytokeratin (Abou-Kheir 
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et al., 2017; Kilburn, 2000). The study also initially considered using TEV-1 and Swan 71 
(SW71) evCTB first trimester trophoblast cell lines. However, HTR-8/SVneo cell line was 
found to generate consistent and reproducible results. In fact  HTR-8/SVneo cells are the 
most commonly used in vitro model to study trophoblast/placental physiology and 
development such as proliferation, invasion, migration and regulation (Abou-Kheir et al., 
2017). 
1.4 Aims 
The aims of this in vitro study using transformed first trimester early extra-villous 
trophoblast cell line (HTR-8/Svneo) are to; 
 Optimise a range of non-toxic concentrations of flavonoids, their metabolites alone 
or combination that is tolerated by these cells. 
 Establish an oxidative stress model in this cell line 
 Investigate the cytoprotective effects of flavonoids against oxidative stress  
 Investigate the intracellular mechanisms associated with flavonoid-mediated 
cytoprotection. 
 Study the effects of flavonoids on intra-cellular protein kinase(s) activation and 
apoptosis pathways with/without oxidative stress 
 Study the effects of flavonoids on trophoblast cell invasions using 2D and 3D models 
as well as stem cell generation. 
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2.1 Materials 
All the chemicals and compounds used in this study are analytical grade. Thiazolyl Blue 
Tetrazolium bromide (MTT) and all flavonoids/metabolites used in this study were 
purchased from Sigma-Aldrich®, UK. Dimethyl sulfoxide (DMSO) and bovine serum 
albumin (fractive V, heat shock treated) were purchased from Fisher Scientific, UK. 
CellTox™ green cytotoxicity, CellTiter-Glo® luminescent cell viability, NADP/NADPH-
Glo™, ROS-Glo™, and GSH/GSSG-Glo™ assays were purchased from Promega, UK. RPMI-
1640, trypsin (0.05% w/v) - EDTA (0.02% w/v) solution, penicillin (100 U/ml) and 
streptomycin (100 µg/ml) were purchased from Lonza, UK. Foetal bovine serum (FBS) was 
purchased from Gibco®, UK. Invasion and migration 96-well plates were purchased from 
Corning®, UK. Cultrex® Basement Membrane Matrix (3D spheroid invasion kit) was 
purchased from AMS Biotechnology, UK. Tissue culture flasks (T75 and T25) were 
purchased from Sarstedt AG and Co. KG, Germany. Modular incubator chamber was 
purchased from Billups-Rothenberg Inc., USA. Gas mixture of 0.5% O2, 5% CO2 and 94.8% 
N2 was bought from BOC limited, UK and certified by HiQ®, UK. Absorbance, fluorescence 
and luminescence were measured using FLUOstar Omega plate reader (BMG LABTECH, 
UK). 
2.1.1 Buffers and Solutions 
Buffers and solutions used for western blotting were prepared using sterile glassware and 
Millipore water (where necessary). They were stored at the recommended temperature 
(usually 4⁰C or room temperature) when not used while some of them needed to be prepared 
fresh. Table 2.1 summarise the list of buffers and solutions. 
 
Table 2.1: Buffers and Solutions 
Reagent Recipe 
TBS 10X 24.9 g Tris HCl, 5.6 g Tris base, 88 g NaCl, 1 L millipore H2O 
TBS-Tween 20 (0.1% v/v) 100 ml TBS (10X), 900 ml millipore H2O, 1 ml Tween 20, pH 7.6 
Electrophoresis Buffer 10X 
Electrophoresis Buffer 1X 
30.3 g Tris base, 143 g Glycine, 10 g SDS, 1 L millipore H2O 
 
100 ml 10X, 900 ml Millipore H2O, pH 8.3 
Transfer buffer 10X 
Transfer buffer 1X 
30.3 g Tris base, 143 g Glycine, 1 L millipore H2O 
100 ml 10X, 200 ml methanol, 700 ml Millipore H2O, pH 8.3 
SDS – Sodium dodecyl sulphate, TBS – Tris-buffered saline, NaCl – Sodium Chloride, H2O - Water 
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2.1.2 Antibodies 
All antibodies were prepared and stored in accordance with manufacturer’s instructions and 
was used before their expiration date. All antibodies were prepared in either 3% (w/v) BSA 
or 5% (w/v) non-fat milk dissolved in TBS-Tween 20 (0.1% v/v plus 0.02% (w/v) sodium 
azide) Abcam, UK and their dilutions are summarised in table 2.2. Prism ultra protein ladder 
(10-245 kDa), Abcam, UK was also used to identify protein positions and ensure proper 
separation of proteins. 
Table 2.2: Details of antibodies with their dilutions 
Primary antibodies Description Supplier Antibody dilution 
Rabbit Anti-AKT1/2/3 Monoclonal Abcam WB, 1:10000 
Rabbit Phospho-AKT (Ser473)  Monoclonal CST WB, 1:2000 
Rabbit Anti-ERK1/2 Polyclonal Abcam WB, 1:1000 
Rabbit Phospho-ERK1 
(T202/Y205) + ERK2 
(T185/Y187) 
Monoclonal Abcam WB, 1:5000 
Rabbit Anti-JNK1/2/3 Monoclonal Abcam WB, 1:1000 
Rabbit Phospho-SAPK/JNK 
(Thr183/Tyr185) 
Monoclonal CST WB, 1:1000 
Rabbit p38 MAPK Monoclonal CST WB, 1:1000 
Rabbit Phospho-p38 MAPK Monoclonal CST WB, 1:1000 
Rabbit Anti-Beta Actin Polyclonal Abcam 1:5000 
Rabbit GAPDH Monoclonal CST 1:1000 
Rabbit Beta Tubulin Monoclonal CST 1:1000 
 
Secondary antibody Description Supplier Antibody dilution 
Goat Anti-Rabbit IgH H&L 
(HRP) 
Polyclonal Abcam WB, 1:3000 
CST: Cell Signalling Technology®, WB: Western Blot 
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2.2 Methods 
2.2.1 In vitro cell culture - Cell revival and maintenance  
The transformed first trimester human trophoblast cell line (HTR-8/SVneo) was kindly 
provided by Dr Charles Graham, University of Kingston, Canada. Cells were cultured in 
growth medium; RPMI-1640 with L-glutamine (Lonza UK) supplemented with 10% (v/v) 
Foetal Bovine Serum (FBS), penicillin (100 U/ml) and streptomycin (100 µg/ml) and 
maintained in a humidified incubator (95% air/5% CO2 at 37οC). The cells were retrieved 
from the liquid nitrogen and thawed. The cells were thawed by adding 10 ml of growth 
medium to eliminate the cytotoxic effects of freeze medium and centrifuged in a Harrier 
15/80 centrifuge (Sanyo) at 1000 x g for 3 min. Supernatant was discarded and pellet 
(containing cells) was re-suspended in 1ml growth medium before being transferred to 
Sarstedt T25 flasks. Daily checks were carried out and growth medium (RPMI-1640) was 
changed every 2 days (or as appropriate).  
Sub-culturing was carried out when cells reached 70-95% confluency, by discarding the 
growth medium and washing the cells three times with 1X PBS (Lonza, UK). Cells were 
detached from the flask by adding 1X trypsin (Sigma-Aldrich, UK) and placed at 37°C for 
2-3 min, checking for cell detachment every 30 secs using an inverted light microscope 
(AE2000, Scientific Laboratory Supplies Ltd). Afterwards, RPMI-1640 growth medium was 
added to the flask to inhibit the effect of trypsin before collecting the cells in a Sterilin® tube 
(Sarstedt, UK) and centrifuged in a Harrier 15/80 centrifuge (Sanyo) at 1000 x g for 5 min. 
The supernatant was discarded, and the cell pellet was resuspended in 1ml RPMI-1640 
growth medium to achieve a single cell suspension. Total number of cells and viability were 
determined using trypan blue exclusion (0.4% v/v trypan blue, Sigma-Aldrich, UK), 100µl 
of cell suspension was added to 300 µl of trypan blue before vortexing briefly. The cell 
(10µl) was transferred into a haemocytometer for counting. The total number of cells were 
estimated using the formula below.  
            
These cells were either bulked up into T75 flask (Sarstedt, UK), used for further experiments 
or frozen as described below. The same protocol was followed in all subsequent cell culture 
experiments unless stated otherwise.  
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2.2.1.1 Cryopreservation of HTR-8/SVneo cells 
HTR-8/SVneo cells were cryopreserved in liquid nitrogen. Following centrifugation (as 
described in section 2.2.1) the cell pellet was resuspended in freeze medium (FBS, 92%; 
DMSO, 8%) and then aliquoted into cryogenic storage vials. Cryogenic storage vials were 
placed in -20⁰C for 2 h before transferring to -80⁰C for another 22 h. After a total of 24 h, 
cryogenic storage vials were transferred to liquid nitrogen for long term storage. 
2.2.2 Flavonoids and Metabolites preparation 
Stock solution for both flavonoids (quercetin, morin, naringin and hesperidin) and their 
respective metabolites (Quercetin-3-O-β-glucuronide [Q3G], naringenin and hesperetin) 
were prepared to the concentration of 10 mM dissolved in dimethyl sulfoxide (DMSO) and 
stored in the -20⁰C freezer. Further dilution (working concentrations) to 1, 3, 10, 20 and 40 
µM in RPMI-1640 growth medium to a final DMSO concentration of 0.1% (v/v) was carried 
out before treating the cells. HTR-8/SVneo cells were treated with indicated working 
concentrations of flavonoids for 24 and 48 h to achieve an optimal non-toxic concentration. 
Control cells were supplemented with growth medium. MTT and CellTox™ green 
cytotoxicity assays were used to determine the non-toxic concentrations for further studies. 
2.2.3 Establishing oxidative stress model 
Stage 1 (Hypoxic conditions): To induce oxidative stress, HTR-8/SVneo cells were seeded 
at the density of 5 x 104 in a 24 well plate (Sarstedt, UK) and allowed to attain 70-80% 
confluency before exposure to hypoxia (either 0.5% or 2% O2). Hypoxia was achieved by 
placing cultured cells (24-well plate) in a humidified modular incubator chamber (Billups-
Rothenberg, USA) that was flushed with a gas mixture of 0.5% O2, 5% CO2 and 94.5% N2 
(BOC/HiQ®, UK). An electronic oxygen analyser (Teledyne Analytical Instruments, UK) 
was used to confirm O2 concentrations before sealing the chamber and subsequent 
incubation at 37οC for the desired duration of experiment/exposure.  
 Stage 2 (conditions for hypoxia-reoxygenation): Herein, the same procedure from stage 
1 was adopted, but hypoxia was established for 2 h or 4 h followed by re-oxygenation for 6 
h in a humidified incubator (95% air/5% CO2 at 37οC). Both hypoxic and re-oxygenation 
conditions were carried out in glucose and serum free Gibco® RPMI-1640 medium 
(ThermoFisher Scientific, UK). 
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2.2.4 Cell viability assays 
Cell viability was performed using 3-(4,5-Dimethylthiazol-2-yl)-2,5 Diphenyltetrazolium 
Bromide (MTT), CellTox™ green cytotoxicity and CellTiter-Glo® luminescent cell viability 
assays. 
2.2.4.1  3-(4,5-Dimethylthiazol-2-yl)-2,5 Diphenyltetrazolium Bromide (MTT) 
The viability of HTR-8/SVneo cells in culture was assessed by MTT assay (Sigma-Aldrich, 
UK). This assay is based on the reduction of 3-(4,5-Dimethylthiazol-2-yl)-2,5 
Diphenyltetrazolium Bromide to violet formazan crystals by both mitochondrial and extra-
mitochondrial dehydrogenases. In the MTT assay, formazan formation is the direct 
representation of viable cells.  
HTR-8/SVneo cells were seeded at a density of 5 × 104 cells/well in a 24-well flat-bottomed 
plate and incubated overnight in fully supplemented RPMI-1640 growth medium. Following 
treatments HTR-8/SVneo cells were incubated for 1 h in 5 mg/ml of MTT solution 
(dissolved in 1X PBS) at 37⁰C. The culture medium in each well was aspirated without 
disturbing the blue, insoluble formazan crystals. Dissolving the formazan crystal was 
achieved by adding 500 µl of DMSO (Fisher Scientific, UK), and was agitated in a plate 
shaker to dissolve the crystals wrapped in aluminium foil. 200 µl of the resulting solution 
was transferred into a 96-well plate (Sarstedt, UK) and then absorbance was read at 570 nm 
using a FLUOstar Omega (BMG LABTECH) plate reader. The absorbance of the DMSO 
blank was subtracted from each reading assay absorbance.  
2.2.4.2  CellTox™ reagent preparations and storage 
CellTox™ green cytotoxicity assay components (CellTox™ green dye, 1000X; assay buffer 
and lysis solution) were thawed in a 37⁰C water bath. Afterwards, each component was 
vortexed briefly to ensure homogeneity and briefly centrifuged.  To create CellTox™ green 
reagent, 20 µl of the CellTox™ green dye was transferred into 10 ml assay buffer (2 X 
solution). Unused CellTox™ green dye (2X) was stored at 4⁰C for up to 7 days and stock 
reagent was stored at -20⁰C.  
2.2.4.2.1 CellTox™ Green Cytotoxicity Assay 
CellTox™ green cytotoxicity (Promega, UK) assesses the changes in membrane integrity 
that occur as a result of cell death. This assay uses a propriety asymmetric cyanine dye that 
stains dead cells’ DNA but is excluded from viable cells. 
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HTR-8/SVneo cells were cultured in a 96-well black with clear bottom plate (Falcon®) at a 
density of 2 × 104 cells/well (100 µl) and was incubated overnight to allow cells to adhere 
before treating with the indicated flavonoids or metabolites for further 24 h or 48 h. The 
cytotoxic effects of different concentrations of flavonoids or hypoxia/re-oxygenation was 
assessed by CellTox™ green cytotoxicity assay. CellTox™ green reagent (2X) was prepared 
according to the manufacturer’s instructions (see section 2.2.4.2) to achieve a 1:1 mixture 
with treatment medium. The addition of 100 µl CellTox™ green dye (2X) to experimental 
wells was carried out and the plate was placed in an orbital shaker briefly before allowing to 
incubate at room temperature for 15 min covered in aluminium foil. Afterwards, 
fluorescence was read at 485 nmEX / 520 nmEM using FLUOstar Omega (BMG LABTECH) 
plate reader (see figure 2.1 for assay flowchart). 
 
Figure 2.1: Overview of CellTox™ green cytotoxicity assay protocol 
Primary control (toxicity control) for necrosis was performed by the addition of lysis solution 
which represented the maximum dead-cell signal from non-proliferating cells. The untreated 
cells represented the minimum signal obtainable from proliferating cells. Blank wells 
(medium containing treatment and CellTox™ green dye 2X) represent background signals 
which was subtracted from experimental readings. 
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2.2.4.3  CellTiter-Glo® Luminescent Cell Viability Assay 
This assay is a homogeneous method to determine the number of viable cells based on 
quantitation of the Adenosine Triphosphate (ATP) present. The presence of ATP signals 
represent metabolically active cells. CellTiter-Glo® assay is a luciferase-based assay and 
relies on cell lysis and generation of luminescent signal proportional to the amount of ATP 
present (the amount of ATP is directly proportional the number of viable cells). Before 
carrying out this experiment, generation of an ATP standard curve and determination of the 
cell seeding density was carried out. 
2.2.4.3.1 Generation of ATP standard curve 
ATP disodium stock solution 1 µM was prepared in growth medium. Serial dilutions of the 
stock solution ranging from 1 µM – 10pM were prepared. These were transferred (100 µl) 
into a 96-well black with clear bottom plate (Falcon®) and equal volume of CellTiter-Glo® 
reagent was added to serial dilutions before being placed on an orbital shaker for 2 min. 
Plates were incubated at room temperature for 10 min to stabilize the luminescent signal and 
was read using FLUOstar Omega (BMG LABTECH) plate reader. Data were analysed using 
GraphPad Prism (see figure 2.2).  
 
Figure 2.2: Standard curve for ATP quantitation 
 
2.2.4.3.2 CellTiter-Glo® Assay 
Appropriate cell seeding density was determined (see appendix A.1) to ensure the number 
of cells was within the linear range of the CellTiter-Glo® assay. HTR-8/SVneo cells were 
cultured in a 96-well black with clear bottom plate (Falcon®, UK) using 5 × 104 cells/well 
(100 µl). Cells were incubated overnight before treating with flavonoids, their metabolites 
alone or in combination for a further 24 h prior to HR-induced oxidative stress exposure. 
Afterwards, an equal volume of CellTiter-Glo® reagent (100 µl) was added to each 
experimental well.  
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Plates were mixed on an orbital shaker for 2 min (to induce cell lysis) and kept at room 
temperature for 10 min to stabilize the luminescent signal. Luminescence was recorded using 
FLUOstar Omega (BMG LABTECH) plate reader. Blank wells (culture medium containing 
treatment and CellTiter-Glo® reagent) represent background signals which were subtracted 
from experimental reading. 
2.2.5  Determination of flavonoids’ redox potential 
The effect of HR-induced oxidative stress, flavonoids, their metabolites alone or in 
combination on redox balancing was measured using GSH/GSSG-Glo™ and 
NADP/NADPH-Glo™ assays. 
2.2.5.1  Reagents preparation 
Total glutathione and oxidized glutathione lysis reagent were prepared according to the 
manufacturer’s instruction. Preparation of GSH and GSSG lysis reagents is summarised in 
table 2.3. 
Table 2.3: GSH and GSSG lysis reagent for adherent cells 
Total Glutathione lysis reagent Oxidized Glutathione lysis reagent 
Components Volume/reaction 
for 96 well plate 
(µl) 
Components Volume/reaction 
for 96 well plate 
(µl) 
Millipore water 39.0 Millipore water 38.5 
Passive lysis buffer 
(5X) 
10.0 Passive lysis buffer 
(5X) 
10 
Luciferin-NT 1.0 Luciferin-NT 1.0 
  NEM (25 mM) 0.5 
 
2.2.6 Determination of reduced and oxidized glutathione 
The effect of HR-induced oxidative stress, flavonoids, metabolites or in combinations on 
HTR-8/SVneo cells was assessed using GSH/GSSG-Glo™ assay (Promega, UK). This assay 
is a luminescence-based assay used in the detection and quantification of total glutathione 
(GSH + GSSG), oxidized glutathione (GSSG) and GSH/GSSG ratio in cultured cells. HTR-
8/SVneo cells were cultured in two 96-well black with clear bottom plate (Falcon®) using a 
cell density of 2 × 104 cells/well (100 µl). One plate was used to determine total glutathione 
and the other for oxidized glutathione. Both plates were incubated for 24 h before treating 
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with flavonoids, their metabolites alone or in combinations for further a 24 h prior to HR-
induced oxidative stress exposure.  
Culture medium was aspirated from both plates and replaced with 50 µl total glutathione 
lysis reagent (for the first plate) or 50 µl oxidized glutathione lysis reagent (the second plate) 
(see section 2.2.5.1 for reagent preparation). Both plates were kept on a plate shaker for 5 
min at room temperature. Afterwards, 50 µl of luciferin generation reagent was added to 
both plates before incubating at room temperature for another 30 min. Then 100 µl of 
luciferin detection reagent was added to both plates and luminescence was recorded after 15 
min using a FLUOstar Omega plate reader (BMG LABTECH, UK). No-cell control reflects 
the assay background signal. Calculating the GSH/GSSG ratio was carried out using 
manufacturer’s formula (see below). 
             
2.2.6.1  NADP/NADPH- Glo™ Assay 
NADP/NADPH-Glo™ Assay (Promega, UK) is a bioluminescent based assay for the 
detection of reduced and oxidized nicotinamide adenine dinucleotide phosphates (NADP+ 
and NADPH) as well as determining their ratio in biological samples. Both NADP and 
NADPH play an important role in the maintenance of reduction and oxidation (redox) 
reaction (Miller, et al. 2018).  
HTR-8/SV-neo cells were seeded at 2 × 104 cells/well in a 96- well black with clear bottom 
plate (Falcon®) for overnight before treating with flavonoids, their metabolites alone or in 
combinations for further 24 h prior to exposure to HR-induced oxidative stress. 
NADP/NADPH-Glo™ detection reagent was prepared according to the manufacturer’s 
guidelines. Equal volumes of NADP/NADPH™ detection reagent was added to samples 
(1:1), followed by gentle and brief shaking. The plate was kept at room temperature for 45 
mins. Luminescence was recorded using a FLUOstar Omega plate reader (BMG LABTECH, 
UK). 
2.2.7 Measurement of Intracellular ROS generation 
The effect of HR-induced oxidative stress, flavonoids, their metabolites alone or in 
combinations on intracellular hydrogen peroxide generation was measure using ROS-Glo™ 
H2O2 assay. 
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2.2.7.1  ROS-Glo™ H2O2 Assay 
Generation of hydrogen peroxide (H2O2) was measured in HTR-8/SVneo cells treated with 
flavonoids, their metabolites alone or in combination prior to HR-induced oxidative stress 
using ROS-Glo™ assay (Promega, UK). Cells were cultured at a density of 2 × 104 cells/well 
in a 96-well with black with clear bottom plate (Falcon®) as previously described in section 
2.2.6.1 ROS-Glo™ H2O2 detection solution was prepared according to the manufacturer’s 
guidelines. The addition of H2O2 substrate solution in all experiments was carried out in the 
last 6 h of the experiment. ROS-Glo™ H2O2 detection substrate was added to all 
experimental wells at a 1:1 with culture medium and kept at room temperature for 20 min 
before luminescence was measured using a FLUOstar Omega plate reader (BMG 
LABTECH). 
2.2.8 Caspase-Glo® 3/7 Assay 
Caspase-Glo® 3/7 assay (Promega, UK) is a homogenous, luminescent assay that measures 
caspase-3 and -7 activities in cultured cells. HTR-8/SVneo cells were cultured at a density 
of 2 × 104 cells/well in a 96-well black with clear bottom plate (Falcon®) as previously 
described in section 2.2.6.1 Caspase-Glo® 3/7 reagent was prepared according to 
manufacturer’s instruction and was added to experimental wells (1:1). Plate was gently 
mixed on a plate shaker for 30 secs and was kept at room temperature for 45 min. 
Luminescence was recorded using a FLUOstar Omega plate reader (BMG LABTECH). 
Blank reaction (Caspase-Glo® 3/7 and culture medium without cells) was used to measure 
background luminescence signal and was subtracted from all readings. 
2.2.9 Immunoblotting 
2.2.9.1 Cell lysate preparation for protein analysis 
Cells were cultured in T75 to about 70% confluency before treating with flavonoids, their 
metabolites alone or in combinations prior to exposure to HR-induced oxidative stress. Cells 
were harvested using 1X trypsin as described in section 2.2.1. Cell pellets were directly lysed 
with Pierce® RIPA buffer (ThermoScientific, UK) supplemented with Roche cOmplete™, 
Mini, EDTA-free Protease Inhibitor Cocktail (Sigma-Aldrich, UK) and phosphate inhibitor 
cocktail (Roche PhosSTOP™, Sigma-Aldrich, UK) according to manufacturer’s guidelines 
and allowed to incubate on ice for 1 h whilst maintaining agitation every 15 min. Afterwards, 
the samples were centrifuged at 27000 x g for 15 min at 4⁰C (Harrier 15/80 refrigerated 
centrifuge, Sanyo). Following this, supernatants were carefully transferred to 1.5 ml 
Eppendorf™ tubes and then stored at -80⁰C and pellets were discarded. 
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2.2.9.2 Determination of protein concentration by Bicinchoninic Acid (BCA) Assay 
Estimating the protein concentration in all samples from section 2.2.9.1 was carried using 
BCA (Sigma-Aldrich, UK). BCA assay mixture was prepared according to manufacturer’s 
guidelines by mixing 50 parts of reagent A (BCA) and 1 part of reagent of B (4% w/v Copper 
(II) sulphate solution). Bovine serum albumin (BSA) (Fisher Scientific, UK) in the 
concentration of 0.2, 0.4, 0.6, 0.8 and 1 mg/ml was used as protein standard to generate a 
standard curve (see figure 2.3). Cell lysates, BSA standards, and blank (RIPA buffer) were 
added to 96 well plate before adding the BCA mixture. The plate was incubated at 37⁰C for 
30 min. Absorbance was read at 570 nm using a FLUOstar Omega plate reader (BMG 
LABTECH) and the protein concentrations were calculated based on the standard curve. 
 
Figure 2.3: Protein standard curved produced with BCA method and known BSA 
concentrations. 
 
2.2.9.3 Protein separation by SDS-PAGE 
Since antibodies typically recognise a small portion of their target protein (epitope), 
denaturing (protein unfolding) the samples will enable the antibodies access to this portion. 
To denature the protein, 2X Laemmli buffer (4 % SDS, 20 % glycerol, 10 % 2-
mercaptoethanol, 0.004 % bromphenol blue and 0.125 M Tris HCl, pH approx. 6.8) (Sigma-
Aldrich, UK) was added to cell lysates and the mixture was boiled at 95⁰C for 5 min on a 
heating block. Gel preparation was performed using ProtoGel® 30% w/v acrylamide, 
ProtoGel® 4X resolving (Tris-base 18 % w/v and SDS 0.5 % w/v) and ProtoGel® stacking 
(Tris-base 6 % w/v and SDS 0.5 % w/v) buffers in accordance with manufacturer’s 
guidelines (National Diagnostics, UK). Equal amount of denatured proteins (30 µg) were 
loaded into 12.5 % w/v SDS-PAGE gel along with molecular weight maker; prism ultra-
protein ladder, 10-245 kDa (Abcam, UK).  
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Electrophoresis was performed at 50 volts for 15 min followed by 100 volts for 90 min in 
electrophoresis buffer. Coomassie Brilliant Blue (Bio-Rad Laboratories, Ltd, UK) was used 
to visualise proteins following SDS-PAGE to ensure proteins were electrophoresed 
uniformly and evenly (during voltage and duration optimization process). 
2.2.9.4 Transfer, antibody incubation, imaging and data analysis 
The separated proteins from the SDS-PAGE as described in section 2.2.9.3 were transferred 
onto 0.45 µm nitrocellulose membrane (Bio-Rad Laboratories, Ltd, UK) by wet-transfer (see 
table 2.1 for transfer buffer composition) method overnight in a cold room. Afterwards, the 
nitrocellulose membrane was stained with ponceau red (Sigma-Aldrich, UK) to visualise 
successful transfer before incubating the membrane in a blocking solution (3% w/v BSA or 
5% w/v non-fat milk in TBS-Tween 20) for 1 h at room temperature with gentle agitation 
(this process prevents non-specific background binding). After incubation with blocking 
solution, the nitrocellulose membrane was washed three times for five min with TBS-
Tween20 before incubation with the indicated primary antibody (see dilution in table 2.2) 
overnight on a shaker at 4⁰C. Following incubation, primary antibody was removed, and the 
membrane was washed with TBS-Tween20 three times for five min followed by further 
incubation with horseradish peroxidase (HRP) conjugated secondary antibody (see dilution 
in table 2.2) for 1 h at room temperature. After which, the membrane was washed with TBS-
Tween20 three times for five min to remove excess secondary antibody.  
Nitrocellulose membrane was developed using EZ-Chemiluminescence Detection Kit for 
HRP (Geneflow Ltd, UK). Imaging was performed using FujiFilm LAS 4000 and quantified 
using Li-Cor image studio™ lite (Li-Cor®, UK). GAPDH, β actin or β tubulin were used to 
check that all lanes in the gel have been loaded evenly (loading control) and were also used 
to normalise the target proteins during quantification.  
2.2.10 Invasion assay 
Invasion assay was used to assess the protective effect of flavonoids, their metabolites or in 
combinations in enabling HTR-8/SVneo cell invasion after HR-induced oxidative stress 
using Corning® BioCoat™ Tumour Invasion system. HTR-8/SVneo cells were treated with 
flavonoids, their metabolites alone or in combinations for 24 h prior to HR-induced oxidative 
stress. Cells were harvested as described in section 2.2.1 and the following protocol was 
carried out: 
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 Rehydration: Corning® BioCoat™ Tumour Invasion system was removed from -20⁰C 
and allowed to equilibrate at room temperature for 30 min. Then the apical chambers 
were filled with 75 µl of warm RPMI-1640 serum free medium and allowed to rehydrate 
for 2 h at 37⁰C in a 5% CO2 environment. After 2 h of rehydration, 50 µl of the RPMI-
1640 serum free medium was removed from all apical chamber without disturbing the 
layer of Matrigel matrix on the membrane. In contrast, the uncoated Corning® 
FluoroBlok™ 96 multiwell insert system (migration control) does not require 
rehydrating. 
 Pre-labelling of cells: Harvested cells were incubated with 5 µM CellTrace™ CFSE dye 
(Molecular Probes®, UK) for 45 min at 37⁰C and shielded from light. After which, 
RPMI-1640 growth medium was added (5 times the volume of CellTrace™ CFSE dye) 
to the cells and allowed incubate for at room temperature for 5 min to eliminate excess 
dye. After the incubation, cells were centrifuged and re-suspended in fresh warm RPMI-
1640 serum free medium. 
 Assay set-up: The addition of 25 µl of cell suspension (1.25 x 104 cell density) in RPMI-
1640 serum free medium to the apical chambers of the coated 96-multiwell plate 
(invasion plate) was carried out. Similarly, addition of 25 µl of cell suspension (1.25 x 
104 cell density) in RPMI-1640 serum free medium to the apical chambers of the 
uncoated 96-multiwell plate (migration plate). The basal chamber for both invasion and 
migration plates were filled with 200 µl of RPMI-1640 growth medium containing 5% 
v/v FBS serving as chemoattractant. Then both plates were allowed to incubate at 37⁰C 
in CO2 environment for 20-22 h (according to manufacturer’s guidelines). 
 Imaging: After 22 h incubation, membranes for both plates were carefully detached 
using tweezers and mounted on slides. Imaging of invaded/migrated cells were taken 
using EVOS FL microscope (ThermoFisher Scientific, UK). 
 Image analysis: The number of cells invaded/migrated were analysed using 
WimCounting (Wimasis Image Analysis, Germany). Data were presented as either 
number of cells invaded or invasion percentage using manufacturer’s formula (see 
below). See figure 2.4 for image summary of this assay. 
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Figure 2.4: Summary of the invasion assay protocol. 
 
2.2.11 Generation of spheroidal stem-like cells 
Spheroidal stem-like cells were generated to assess the effect of HR-induced oxidative stress 
on formation of spheroids and the effects of 24 h pre-treatment of cells with flavonoids, their 
metabolites alone or in combinations prior to HR-induced oxidative stress on the generation 
of spheroid. The process for this assay are highlighted in stages below; 
 Stage 1 (Bulking up of HTR-8/SVneo cells) 
HTR-8/SVneo cells were grown in a T75 flask usually at a density of 5 x 106cells/ml for up 
to 72 h. Once a confluency of 70-80% was achieved, cells were treated with or without the 
indicated flavonoids, their metabolites alone or in combinations for 24 h prior to exposure 
to HR-induced oxidative stress. Afterwards, cells were harvested and ready for stage 2. 
 Stage 2 (Spheroid formation) 
Harvested HTR-8/SVneo cells from stage 1 were sub-cultured in non-adherent ultra-low 
attachment T75 flask (Sigma-Aldrich, UK) in 20 ml spheroid formation medium that is made 
up with the following; RPMI-1640 serum free medium supplemented with 1% w/v L-
glutamine, 1% v/v penicillin/streptomycin, 5 µg/ml bFGF (Sigma-Aldrich, UK), 5 µg/ml 
EGF (Sigma-Aldrich, UK), 5 µg/ml insulin (Sigma-Aldrich, UK) and 0.4% (w/v) BSA 
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(Sigma-Aldrich, UK). Cells were incubated at 37⁰C in 5% CO2 and 95% air for 3-5 days 
monitoring the formation of spheroid under the microscope every 24 h. 
 Stage 3 (Cell sorting by gravity separation) 
Single cells were separated from spheroids by gravity separation. Cell mixtures consisting 
of both single and spheroid cells were transferred into Sterlin® tubes (Sarstedt, UK) and left 
at room temperature for 10 min allowing the separation of spheroids from single cells. This 
technique allows the spheroid cells to settle at the bottom of the tube while the single cells 
keep floating in the upper layer with the medium. Then the medium is discarded without 
disturbing the pellet of spheroids. Afterwards, the spheroids were centrifuged at 1000 x g for 
5 min.  
2.2.12 Soft-Agar Colony Formation Assay 
To quantify the effects of flavonoids, their metabolites alone or in combinations on the 
spheroid growth area, soft-agar colony formation assay was carried out. This assay is semi-
quantitative and measures the morphological transformation of in vitro cellular colonies. 
HTR-8/SVneo cells were cultured in T75 flask to about 80% confluency before being treated 
with or without flavonoids, their metabolites alone or in combinations prior to HR-induced 
oxidative stress (as described previously). Cells were harvested and counted before adjusting 
the cell density to 2.5 x 103 cell/well in a 6 well plate (Sarstedt, UK). Preparations of soft-
agar are as follows:  
 Preparation of Base Agar: Difco Agar noble (France) at 1% (w/v) was dissolved in 
Millipore water by microwave heating, then allowed to cool to 40⁰C in water bath. 
RPMI-1640 2X was prepared by adjusting the growth medium from 10% FBS (as 
previously described in section 2.2.1) to 20% FBS and was also kept in the water bath 
(40⁰C). After 45 min of equilibration of both base agar and 2X RPMI-1640 culture 
medium, equal volume (1:1) was mixed in a fresh Sterlin® 50 ml tube and 1 ml was 
transferred into a 6-well plate to form the base layer, carefully shaking the plate to ensure 
even distribution of the base agar. Plate was keep at room temperature for 5 min to allow 
solidification for the base agar. 
 Preparation of Top Agarose: Agarose (Sigma-Aldrich, UK) at 0.7% (w/v) was melted 
in Millipore water using microwave and allowed to cool in a 37⁰C water bath.  Cells 
concentration as described earlier in this section was made up in 2X RPMI medium. 
Equal volume of cell suspension (2.5 x 103 cell/well) and agarose (1:1) was mixed in a 
fresh Sterlin® 20ml tube and 1 ml was transferred in the same 6-well plate containing 
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the base layer. The plate was kept at humidified 37⁰C in CO2 environment for up to 20 
days. Cells were fed twice a week with RMPI-1640 culture medium and the spheroid 
colony formation was monitored every 5 days using a microscope. 
2.2.13 Cultrex® 96 well 3D spheroid Base Membrane Extract (BME) cell invasion 
assay 
This assay offers a standardized, three-dimensional cell structure for quantitating the degree 
to which invasive cells penetrate a barrier consisting of components resembling basement 
membrane in response to chemoattractant.  The procedure for this experiment was preformed 
according to manufacturer’s guidelines, see below for highlights; 
 Step 1/Day 0: HTR-8/SVneo cells were cultured in T75 flask to about 80% confluency 
before being treated with or without flavonoids, their metabolites alone prior to HR-
induced oxidative stress (as described previously). Cells were harvested and counted 
before adjusting the cell density to 3 x 103 cell/well (single cell suspension). The single 
cell suspension (50 µl) was prepared in 1X formation extracellular matrix per well and 
then transferred to the 3D 96-well plate. The plate was then centrifuged at 200 x g for 5 
min at room temperature and incubated in a humidified 37⁰C, 5% CO2 and 95% air 
environment for 72 h to promote the formation of spheroids. 
 Step 2/Day 3: After 72 h, the 3D plate was taken out from the incubator and placed on 
ice for 5 min to cool. Working on ice, invasion matrix (50 µl) was added to all wells and 
the plate was centrifuged at 300 x g at 4⁰C for 5 min to eliminate bubbles and position 
spheroids towards the middle of the well. The 3D 96-well plate was transferred to the 
incubator for 1 h to promote gel formation. After which, 100 µl of warm growth medium 
was added to each well and images were taken using a confocal microscope before 
returning the plate to the incubator for additional 72 h. 
 Step 3/Day 6: After 72 h, plate was taken out and images of spheroids were taken using 
a confocal microscope and analysed using Image-J software. Image data were analysed 
using GraphPad prism software. 
2.2.15 Statistical analysis 
Statistical analysis was performed using GraphPad prism 7.0 software. One-way ANOVA 
was used to compare three or more sets of data applying with Turkey’s/Dunnett’s multiple 
comparisons to further demonstrate the significant difference. Data are presented as mean + 
SEM (standard error of mean) and statistical significance was deemed to be represented as 
P <0.05.
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3.1 Introduction 
As previously described in chapter 1, oxidative stress can be defined as the imbalance in the 
generation and accumulation of reactive oxygen species (ROS) in cells/tissues, and the 
ability of antioxidants to detoxify them. This can occur as the result of increased production 
of ROS and/or decrease in effectiveness of antioxidant defence system (Myatt and Cui, 2004; 
Pizzino et al., 2017). Considerable evidence has linked oxidative stress to the 
pathophysiology of several diseases including cardiovascular diseases, neurological 
diseases, cancers, respiratory disease, rheumatoid arthritis as well as pregnancy related 
disorders (Lázár, 2012; Pizzino et al., 2017). In fact, pregnancy can be considered as a state 
of oxidative stress due to the increased placental mitochondrial activity and production of 
ROS as a low/moderate level of oxidative stress is essential for the normal development of 
foetal growth (Khera et al., 2013). Over-production of ROS during early gestation period 
has been associated with shallow trophoblast/placental invasion that leads to pregnancy 
complications such as intrauterine growth restriction (IUGR), prematurity, placenta percreta, 
placenta accreta, foetal/maternal death, miscarriage and preeclampsia (PE) (Khera et al., 
2013; Jauniaux et al., 2007). PE is a pregnancy-specific condition characterised by 
hypertension (≥160/100 mmHg) and proteinuria (>300 mg/day) usually after 20 weeks of 
gestation (early onset) and occasionally after 34 weeks (late onset). It is the world leading 
cause of maternal and foetal morbidity and mortality and complicates about 5 – 8% of all 
pregnancies (Bolnick et al., 2015). Additional consequences of PE include retardation of the 
foetal growth leading to seizure and coma (Cross et al., 2015; Wu et al., 2015; Petla et al., 
2013). Incidentally, it was first reported in the nineteenth century and its prevention has been 
a major issue for clinicians and researchers as the cause remains unknown (Fayyad and 
Harrington, 2005). Also, the only cure is to deliver the placenta and the foetus. In recent 
years, several antioxidant therapies such as vitamin C and E, polyphenols, aspirin, calcium, 
magnesium and zinc supplements, have been used early in gestation period to reduced 
oxidative stress and they have all proved to be controversial and mostly ineffective (Carty et 
al., 2008; Fayyad and Harrington, 2005).  
However, very little is known about the effects of dietary flavonoids as antioxidants during 
gestation. Flavonoids are a large group of polyphenolic compounds and phytochemicals that 
are present in fruit and vegetable rich diets (e.g. apples, red grapes, oranges and grapefruit 
juice, soybeans, green leafy spices).  In the last two decades, extensive body of evidences 
from in vitro research have revealed that flavonoids may be beneficial to health in vivo, due 
to their antioxidant properties (Day et al., 2000; R.J. Williams et al., 2004; Procházková et 
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al., 2011). However, the exact mechanism by which flavonoids carry out their beneficial 
effects remains a mystery. Their biological effects are attributed to be highly dependent upon 
their structural configurations, especially the availability of their hydroxyl group (Day et al., 
2000). As mentioned in chapter 1, the presence or absence of a hydroxyl functional group 
plays a crucial role in the classification of flavonoids (Erlund, 2004; Bentz, 2009). 
Interestingly, flavonoids can act as pro-oxidants under circumstances such as high 
concentrations, presence of O2 molecules, alkali pH and the presence of too many hydroxyl 
groups in the B-ring (Procházková et al., 2011; Eghbaliferiz and Iranshahi, 2016). Therefore, 
optimising the non-toxic concentrations was important for this study and selection of 
flavonoids belonging to different classes and subclasses. 
Table 3.1: Summaries of flavonoids/metabolites used in this study and their sources 
Flavonoids Metabolites Sources 
Quercetin Quercetin 3-O-β-glucuronide 
(Q3G) 
Apples, Onions, Tea, 
and Red wines 
Morin Q3G (No commercial available 
metabolites) 
Guavas, Osage oranges, 
Old fustics, Coffee, 
Seaweeds, Onions, and 
Apples. 
Naringin Naringenin Citrus fruits, Chinese 
herbs, and Tomatoes 
Hesperidin Hesperetin Citrus fruits, and 
Tomatoes 
Ideas adapted from (Gonzalez et al., 2015; Panche et al., 2016; Erlund et al., 2001). 
 
3.2 Aims 
 Optimisations of non-toxic concentrations of 
I. Flavonoids 
II. Their metabolites alone 
III. Flavonoid-metabolite combinations 
IV. Flavonoid combinations 
 Effects of different concentrations of O2 on HTR-8/SVneo cell viability 
I. Effects of 2% O2  
II. Effects of 0.5% O2 
III. Effects of hypoxia/reoxygenation 
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3.3 Results 
Four different flavonoids (quercetin, morin, naringin and hesperidin) were selected for this 
study based on the on the classification and sub-classification of flavonoids. Metabolites 
(Q3G, naringenin and hesperetin) for flavonoids were chosen based on availability except 
for morin which is not commercially available. In this section, the effects of different 
concentrations of flavonoids (1, 3, 10, 20 and 40 µM) or their metabolite alone or in 
combinations was assessed.  
3.3.1 Optimization of non-toxic concentration of flavonoids 
MTT and CellTox™ green cytotoxicity assays were used to assess the non-toxic 
concentrations for flavonoids and their metabolites after 24 and 48 h treatment on cell 
viability in HTR-8/SVneo cells. As shown in figure 3.1 (A-D), MTT assay showed that 24 
h treatment of HTR-8/SVneo cells with 1 and 3 µM concentrations of quercetin, morin, 
naringin and hesperidin were not toxic. However, unlike quercetin and naringin, morin and 
hesperidin did not show any indication of toxicity at 10 µM after 24 h treatment.  However, 
concentrations of 20 and 40 µM of all flavonoids triggered significant cell death on HTR-
8/SVneo cells after 24 h. Further validation was carried using CellTox™ green cytotoxicity 
assay to measure the changes in membrane integrity as a result of cell death (figure 3.1, E-
H). Data from CellTox™ green cytotoxicity assay was in agreement with MTT assays 
indicating that concentration 10, 20 and 40 µM of flavonoids were indeed toxic to HTR-
8/SVneo cells after 24 h treatment. 
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Figure 3.1: Effects of 24 h flavonoids treatment on HTR-8/SVneo cell viability. 
HTR-8/SVneo cells were treated with the indicated concentrations (1-40 µM) of quercetin, morin, naringin and hesperidin for 24 h. Following 
flavonoid treatment, cell viability was assessed by MTT reduction assay (A-D) and membrane integrity (cell death) via CellTox™ green 
cytotoxicity assay (E-H). Statistical analysis was carried out using one-way ANOVA (Dunnett’s multiple comparisons test against control). 
Data are expressed as the percentage of control cells and represent the mean ± SEM of nine (A-D) and three (E-H) independent experiments 
performed in quadruplicate. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001 versus control. 
 
Further experiment was carried out using MTT assay alone to determine the effects of the indicated flavonoids and concentrations on HTR-
8/SVneo after 48 h treatment. The MTT data as shown in figure 3.2 (A-D) showed that again 1 and 3 µM of all flavonoids were not toxic to 
HTR-8/SVneo cells. Again, concentrations of 10, 20 and 40 µM of all flavonoids showed more toxicity after 48 h treatment. 
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Figure 3.2: Effects of 48 h flavonoids treatment on HTR-8/SVneo cell. 
HTR-8/SVneo cells were treated with the indicated concentrations (1-40 µM) of quercetin, 
morin, naringin and hesperidin for 48 h. Following flavonoid exposure, cell viability was 
measured by MTT reduction assay (A-D). Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test against control). Data are expressed as the 
percentage of control cells and represent the mean ± SEM of six independent experiments 
performed in quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001 versus control. 
 
3.3.2 Optimization of non-toxic concentration of metabolites 
After optimising the non-toxic concentration for quercetin, morin, naringin and hesperidin 
for both 24 h and 48 h, it was essential to determine the working concentration for their 
metabolites (Q3G, naringenin and hesperetin) for both 24 h and 48 h treatment as the form 
in which they exist in plant and vegetable differs from their in vivo form. Flavonoids undergo 
extensive biotransformation in the liver and small intestine to produce their metabolite. 
Therefore, cell viability following 24 h and 48 h treatment of HTR-8/SVneo cells with Q3G, 
naringenin and hesperetin was determined using MTT and CellTox™ green cytotoxicity 
assay.
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Herein, 1 and 3 µM of these metabolites did not trigger any cell death after 24 h as seen in figure 3.3 (A-C) MTT assay and figure 3.3 (D-F) 
CellTox™ green. HTR-8/SVneo cells tolerated 10 µM of naringenin (figure 3.3B), although CellTox™ green assay showed traces of cell death 
(figure 3.3E). As seen figure 3.3 (A-C and D-F) both MTT and CellTox™ assays agreed that concentrations 10 µM and above were toxic after 
24 h treatment. 
 
Figure 3.3: Effects of 24 h metabolites treatment on HTR-8/SVneo cell viability. 
HTR-8/SVneo cells were treated with the indicated concentrations (1-40 µM) of Q3G, naringenin and hesperetin for 24 h. Following flavonoid 
treatment, cell viability was assessed by MTT reduction assay (A-C) and membrane integrity (cell death) via CellTox™ green cytotoxicity assay 
(D-F). Statistical analysis was carried out using one-way ANOVA (Dunnett’s multiple comparisons test against control). Data are expressed as 
the percentage of control cells and represent the mean ± SEM of nine (A-C) and three (D-F) independent experiments performed in quadruplicate. 
**P<0.01, ***P<0.001 and ****P<0.0001 versus control.
                   Chapter 3: Optimisation of non-toxic concentrations of flavonoids 
 
61 | P a g e  
 
Determination of prolonged exposure (48 h) of HTR-8/SVneo to the indicated 
concentrations of Q3G, naringenin and hesperetin was carried out using MTT assay alone. 
Unsurprisingly, similar results as that of 24 h exposure was seen following 48 h exposure 
(figure 3.4, A-C) 1 and 3 µM of all metabolites was tolerated by HTR-8/SVneo. In contrast, 
concentrations of 10, 20 and 40 µM induced toxic effects as seen by the MTT reduction. 
 
Figure 3.4: Effects of 48 h metabolites treatment on HTR-8/SVneo cell viability. 
HTR-8/SVneo cells were treated with the indicated concentrations (1-40 µM) of Q3G, 
naringenin and hesperetin for 48 h. Following flavonoid treatment, cell viability was 
assessed by MTT reduction assay (A-C). Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test against control). Data are expressed as the 
percentage of control cells and represent the mean ± SEM of six independent experiments 
performed in quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001 versus control. 
 
3.3.4 Determination of working concentration for flavonoid-metabolite 
combinations. 
Flavonoids are proposed to exist in glyosidic or aglycone form (parent compound), upon 
metabolism they exist as glucuronide and sulphate conjugates (metabolites) in the 
bloodstream. Most researches on flavonoids focus on studying either their aglycone form or 
glucuronide/sulphate form but not together. Therefore, it was important to assess the effect 
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of the combinations of flavonoid-metabolites to mimic the in vivo environment. Therefore, 
flavonoids at 3 µM was combined with their metabolites at 1 µM (quercetin/Q3G; 
morin/Q3G; naringin/naringenin and hesperidin/hesperetin). Cells viability on 24 h 
treatment of flavonoid-metabolite combinations on HTR-8/SVneo cells was assessed using 
MTT and CellTiter-Glo® luminescent cell viability assays. As shown in fig 3.5 (A), the MTT 
assay data showed no indication of toxicity and this data was further validated using 
CellTiter-Glo® viability assay, which monitors intracellular ATP levels (figure 3.5, B). 
 
Figure 3.5: Effects of 24 h treatment with flavonoid-metabolite combinations on 
HTR-8/SVneo cell viability. 
HTR-8/SVneo cells were treated with the indicated flavonoids (3 µM) and their respective 
metabolites (1 µM) for 24 h. Following the combinations of flavonoid-metabolite treatment, 
cell viability was measured by MTT reduction assay (A) and Cell proliferation via CellTiter-
Glo® Luminescent assay (B). Statistical analysis was carried out using one-way ANOVA 
(Dunnett’s multiple comparisons test against control). Data are expressed as the percentage 
of control cells and represent the mean ± SEM of six (A) and three (B) independent 
experiments performed in quadruplicate.   
 
The effect of prolonged (48 h) exposure of flavonoid-metabolite was carried out to check for 
toxicity using MTT and CellTiter-Glo® luminescent cell viability assays. Again, the data 
from figure 3.6 (A and B) showed that there was no sign of toxicity.  
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Figure 3.6: Effects of 48 h treatment with flavonoid-metabolite combinations on 
HTR-8/SVneo cell viability. 
HTR-8/SVneo cells were treated with the indicated flavonoids (3 µM) and their respective 
metabolites (1 µM) for 48 h. Following the combinations of flavonoid-metabolite treatment, 
cell viability was assessed by MTT reduction assay (A) and Cell proliferation via CellTiter-
Glo® Luminescent assay (B). Statistical analysis was carried out using one-way ANOVA 
(Dunnett’s multiple comparisons test against control). Data are expressed as the percentage 
of control cells and represent the mean ± SEM of six (A) and three (B) independent 
experiments performed in quadruplicate.  
 
3.3.5 Determination of working concentration for flavonoids combination 
Another important aspect of this project was to examine the effect of combining two 
different flavonoids. This is because flavonoids in fruits and other natural sources are mostly 
distributed as combined forms. Since quercetin is the most abundant flavonoid in fruits (and 
the fact that it is the most studied), it was used as a reference for other flavonoids. 
Combination of flavonoids (quercetin + morin; quercetin + naringin and quercetin + 
hesperdin) at 3 µM was carried to check for synergistic, addictive or antagonistic effects. 
The effects of flavonoids combination on HTR-8/SVneo cells after 24 and 48 h was 
examined using MTT and CellTiter-Glo® luminescent cell viability assays. The data shown 
in figure 3.7 (A) showed that there was no cytotoxic effect after 24 h treatment. MTT assay 
data was validated using CellTiter-Glo® luminescent cell viability assay (figure 3.7, B), 
which also showed that there were no cytotoxic effects. Furthermore, the effect of flavonoids 
combinations on HTR-8/SVneo cells after 48 h showed that there was no indication of 
toxicity as shown in figure 3.8A (MTT assay) and figure 3.8B (CellTiter-Glo® assay). 
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Figure 3.7: Effects of 24 h treatment with flavonoids combination on HTR-8/SVneo 
cell viability. 
HTR-8/SVneo cells were treated with the indicated flavonoids at 3 µM (individually) for 24 
h. The combinations are indicated as + for presence (and – for absence). Following the 
combination of flavonoids treatment, cell viability was measured by MTT reduction assay 
(A) and Cell proliferation via CellTiter-Glo® Luminescent assay (B). Statistical analysis 
was carried out using one-way ANOVA (Dunnett’s multiple comparisons test against 
control). Data are expressed as the percentage of control cells and represent the mean ± SEM 
of six (A) and three (B) independent experiments performed in quadruplicate.  
 
 
 
Figure 3.8: Effects of 48 h treatment with flavonoid-metabolite combinations on 
HTR-8/SVneo cell viability. 
HTR-8/SVneo cells were treated with the indicated flavonoids at 3 µM (individually) for 48 
h. The combinations are indicated as + for presence (and – for absence). Following the 
combination of flavonoids treatment, cell viability was assessed by MTT reduction assay 
(A) and Cell proliferation via CellTiter-Glo® Luminescent assay (B). Statistical analysis 
was carried out using one-way ANOVA (Dunnett’s multiple comparisons test against 
control). Data are expressed as the percentage of control cells and represent the mean ± SEM 
of six (A) and three (B) independent experiments performed in quadruplicate.  
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3.3.6 Establishing an oxidative stress model 
To induce oxidative stress, cells were exposured to either 2 or 0.5% oxygen (O2) in glucose 
and serum free medium for up to 24 h. The effect of reduced oxygen (hypoxia) was assessed 
using the MTT assay. Firstly, to determine the optimal duration of hypoxia to cause cell 
death or induce oxidative stress, HTR-8/SVneo cells were exposured to 2% O2 for up to 24 
h. The data from the MTT assay showed that HTR-8/SVneo cells were proliferating under 
hypoxic, glucose free and serum free condition for up to 24 h (see figure 3.9, A). Since 2% 
O2 was ineffective in inducing oxidative stress as shown by MTT assay, reducing the O2 
concentration to 0.5% (under glucose- and serum- free medium condition) was considered 
and again cell viability was measured using MTT assay. As shown in figure 3.9 (B) 0.5% 
O2 did not induced oxidative stress or cause cell death in HTR-8/SVneo cells. Therefore, 
hypoxia alone (2 or 0.5% O2) coupled with glucose- and serum- free medium was not 
sufficient to cause cell death or induced oxidative stress in the human first trimester 
trophoblast cell line HTR-8/SVneo. 
  
Figure 3.9: The effects of hypoxia alone on survival of HTR-8/SVneo cells. 
HTR-8/SVneo cells were exposed to different concentrationss of oxygen (O2) for up to 24 h 
in glucose and serum free medium. HTR-8/SVneo cell viability was assessed using MTT 
reduction assay. (A) the effect of 2% O2 on HTR-8/SVneo survival and (B) the effects of 
0.5% O2 on HTR-8/SVneo survival. Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test against control). Data are expressed as the 
percentage of normoxic control cells and data represent the mean ± SEM of at least six 
independent experiments performed in quadruplicate. *P<0.05, ***P<0.001 and 
****P<0.0001. 
Oxidative stress model was achieved by the exposure of HTR-8/SVneo cells to 2 h hypoxia 
(0.5% O2) followed by 6 h re-oxygenation in a humidified incubator (37ºC, 5% CO2, 95% 
air). Both hypoxic and re-oxygenation conditions were carried out using glucose- and serum- 
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free medium. Cell viability was determined using MTT and CellTox™ green cytotoxicity 
assays. 
As seen in figure 3.10 (A), the MTT assay showed that upon re-oxygenation (4 and 6 h), 
there was in a significant reduction in cell viability (figure 3.10A). However, re-oxygenation 
after 2 h did not show significant reduction from the normoxic control but when compared 
to hypoxia alone, there was a significant reduction (figure 3.10, A). The data from CellTox™ 
green confirmed that cell death started from 2 h of re-oxygenation (figure 3.10, B). This 
assay also confirmed that hypoxia alone did not induced cell death as seen figure 3.10 (B or 
D). Summary of MTT and CellTox™ green assays can be found in figure 3.10 (C and D 
respectively). Therefore, oxidative stress model will be represented as hypoxia/re-
oxygenation (HR)-induced oxidative stress for the rest of the research. 
  
Figure 3.10: The effects of hypoxia alone or hypoxia/re-oxygenation on HTR-8/SVneo 
cell survival.  
HTR-8/SVneo cells were exposed to hypoxia (0.5% O2) for 2 h followed by re-oxygenation 
for up to 6 h in glucose- and serum- free medium. HTR-8/SVneo cell viability was assessed 
by MTT reduction assay (A and C) and membrane integrity (cell death) via celltox™ green 
cytotoxicity assay (B and D). Statistical analysis was carried out using one-way ANOVA 
(Tukey’s multiple comparisons test). Data are expressed as the percentage of normoxic 
control cells and data represent the mean ± SEM of six (A, C) and three (B,D) independent 
experiments performed in quadruplicate .**P<0.01, ***P<0.001 and ****P<0.0001, (a) 
versus normoxia control and (b) versus hypoxia alone. 
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Although 2 h hypoxia followed by 6 h re-oxygenation was an established model for oxidative 
stress, further experiment was carried out to assess the effect of 4 h hypoxia followed by up 
to 6 h re-oxygenation. Cell viability assay was measured using MTT assay.  
Data shown in figure 3.11 indicate that 4 h hypoxia followed by up to 6 h re-oxygenation 
did not cause any significant cell death to HTR-8/SVneo cells. Therefore 4 h hypoxia and 6 
h re-oxygenation was not suitable for this study. 
 
Figure 3.11: The effects of 4 h hypoxia followed by up to 6 h reoxygenation on 
survival of HTR-8/SVneo cells.  
HTR-8/SVneo cells were exposed to hypoxia (0.5% O2) for 4 h followed by re-oxygenation 
for 6 h in glucose and serum free medium. HTR-8/SVneo cell viability was assessed by MTT 
reduction assay (A). Statistical analysis was carried out using one-way ANOVA (Tukey’s 
multiple comparisons test). Data are expressed as the percentage of normoxic control cells 
and data represent the mean ± SEM of six independent experiments performed in 
quadruplicate. ***P<0.001 versus normoxia control. 
3.3.7 Morphological alteration of HTR-8/SVneo during hypoxia/re-oxygenation 
Light microscopy was used to track morphology alteration in HTR-8/SVneo cell during HR-
induced oxidative stress. As observed in figure 3.12 (A-C), there were no changes in cell 
morphology between normoxic control and hypoxia alone (2 h). Comparing normoxic 
control (A) or hypoxia alone (B) to hypoxia/re-oxygenation (C), there were changes in cell 
morphology. Hypoxia/re-oxygenation cells had so many cells with altered morphological 
structure, clusters of cells and confluency was reduced. 
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Figure 3.12: Morphological alteration of HTR-8/SVneo cells in response hypoxia/re-
oxygenation. 
HTR-8/SVneo cells were exposed to hypoxia (0.5% O2) for 2 h followed by 6 h re-
oxygenation in glucose and serum free medium. Images were taking using Motic AE2000 
inverted microscope and GT vision GXCAM-5 camera with objective magnification 10X 
(Scale bar = 100 µm). (A) shows the morphology of HTR-8/SVneo cells before exposure to 
hypoxia or hypoxia/re-oxygenation, (B) shows the morphology of HTR-8/SVneo cells after 
2 h of hypoxia alone and (C) shows the morphology of HTR-8/SVneo cells after 2 h hypoxia 
followed by 6 h re-oxygenation. Red bold arrow indicates the formation of cell clusters, 
which was only seen in hypoxia/re-oxygenated cells and occasionally in cell exposed to 
hypoxia. Purple bold arrow shows that there are more spacing between cells and black bold 
arrow shows the roundish single cells and elongated structures.   
 
3.4 Result Summary 
It was demonstrated that flavonoids or their metabolites can have cytotoxic effects when 
cells are exposed to higher concentrations (10, 20 and 40 µM) at 24 h and 48 h. However, at 
low concentrations (1 or 3 µM), flavonoids, metabolites or their combinations used herein, 
did not trigger cell death after 24 h or 48 h treatment. Hypoxia at 2 or 0.5% O2 was not 
adequate to induce oxidative stress or cause cell death. Hypoxia (2 h) followed by re-
oxygenation for up to 6 h induced significant cell death. In contrast, hypoxia (4 h) followed 
by re-oxygenation for up to 6 h did not cause significant cell death. Light microscopy 
confirmed changes in HTR-8/SVneo cells during 2 h hypoxia followed by 6 h re-
oxygenation. 
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3.5  Discussion 
The aim of this chapter was to optimise the non-toxic concentrations of flavonoids, (their 
metabolites alone or in combinations) on HTR-8/SVneo cell viability as well establishing an 
oxidative stress model for further research (see Chapters 4 to 6).  
3.5.1 Selection and optimisation of flavonoids/concentrations 
This study began with the determination of non-toxic concentrations of flavonoids, their 
metabolites alone or in combination (flavonoid-metabolite or flavonoids). The study started 
with the selection of flavonoids, which was based on the structural configurations; presence 
and absence of a hydroxyl group in C-3 position of the C-ring (3-hydroxy and 3-
desoxyflavonoids respectively). Quercetin belong to the 3-hydroxyflavonoid class and 
flavonol subclass, it is the most common and studied flavonoid (over 3000 citations on 
PubMed). In this study, quercetin served as a reference as it is the most abundant in fruits 
and vegetables as well as the most studied. Since morin is an isomer of quercetin, it was 
essential to investigate if both flavonoids have similar antioxidant properties and if the 
structural arrangement would be a factor. Naringin and hesperidin are classified as the 3-
desoxyflavonoid class and flavanones subclass, they have not gained much interest like that 
of flavonols. Herein, it was aimed to determine if the presence of hydroxyl group could 
influence the antioxidant or pro-oxidant properties of flavonoids.  
After the selection of flavonoids, the next step was to optimise the non-toxic concentration 
for further studies. Since there were no previous studies conducted on this subject using a 
human first trimester trophoblast cell line (HTR-8/SVneo), a range of concentrations (1 – 40 
µM) were selected based on other studies carried out using non-trophoblast cells (PeiMing 
et al., 2012; Yamamoto et al., 2013; Daubney et al., 2015). This present study has shown 
flavonoids (quercetin, morin, naringin and hesperidin) at high concentrations (10, 20 and 40 
µM) induced cytotoxic effects in HTR-8/SVneo cells as shown from the MTT and CellTox™ 
assays. In a study conducted by Boesch-Saadatmandi et al. (2011), concentration of 
flavonoid (quercetin) above 25 µM decreased cell viability in a mouse macrophage 
(RAW264.7) cell line. In addition, quercetin at 10 µM and above was found to induce 
cytotoxicity in a leukaemia cell line (Nalm6) after 48 h treatment (Srivastava et al., 2013). 
Since flavonoids exist in plants as mainly glycosidic forms and occasionally as aglycones, 
most research has focused on studying the antioxidant properties of flavonoids in the 
glycosidic forms (Erlund, 2004). However, the compounds found in the plasma and urine 
after ingesting flavonoids are different and these compounds are known as metabolites.  
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Flavonoids are absorbed by the gastrointestinal tracts of humans and are intensively 
metabolised (first past metabolism, both intestinal and hepatic) resulting in methylated 
derivatives and conjugates (glucuronides and sulphates). Interestingly, many flavonoid 
glycosidic forms have not been detected in plasma even if the retention time is similar to 
their glucuronides (Erlund, 2004; Bentz, 2009; Boesch-Saadatmandi et al., 2011). Therefore, 
studying the effect on their metabolites on HTR-8/SVneo cells was important. Until recently, 
flavonoid metabolites were rarely used because data about them were scare and their 
commercial availability were limited due to chemical standards. Herein, flavonoid 
metabolites (Q3G, naringenin and hesperetin), triggered cell death from concentrations 10 
µM and above in HTR-8/SVneo cells after 24 and 48 h as seen in the MTT and CellTox™ 
assays.  
To mimic the in vivo environment, combination of flavonoids (3 µM) and their metabolites 
(1 µM) (quercetin + Q3G, morin + Q3G, naringin + naringenin and hesperidin + hesperetin) 
were carried out as well as combinations of flavonoids at 3 µM (quercetin + morin, quercetin 
+ naringin and quercetin + hesperidin). As mentioned earlier in this section, daily intake of 
flavonoids cannot be estimated as they are widely distributed in several fruits and vegetables, 
and since the craving of fruits cannot be controlled during gestation, there is a tendency that 
two or more flavonoids will be consumed. Also, these combinations were carried out using 
non-toxic concentrations from individual flavonoids or metabolites. There was no indication 
that these combinations were toxic to the cells as shown in the MTT and CellTiter-Glo® 
assays. 
3.5.1  Oxidative stress model 
Oxygen (O2) is often referred to as the Janus gas because it is necessary for healthy living 
and potentially damaging to the cells (as well toxic) at high or very low 
concentrations/partial pressure (or radicalised). In this study, the toxic effect of O2 on HTR-
8/SVneo cells was investigated by exposing the cells to a hypoxic environment. Initially, 
HTR-8/SVneo cells were subjected to 2% and 0.5% O2 respectively for up to 24 h and cell 
viability was monitored by MTT assay. The data from this experiment showed that the 
human first trimester trophoblast cell line tolerated and adapted to the hypoxic environment. 
In fact, there are bodies of evidence that shows that trophoblast cells are acclimatised to a 
low O2 environment (Sagrillo-Fagundes et al., 2018; Hung and Burton, 2006; Armant et al., 
2006). In fact, initial trophoblast cells development occurs in a low oxygen environment 
estimated to be around an ambient pO2 of ~18 mmHg (or 2%) (Armant, et al. 2006).  
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This low oxygen environment is beneficiary to trophoblast cells in promoting proliferation, 
invasion and angiogenesis in the placenta. This adaptation to changes in O2 concentrations 
by the placenta is brought about by the modulation of hypoxia inducible factor 1α and by 
increasing antioxidant defences system (Burton and Jauniaux 2011, Tuuli, Longtine and 
Nelson 2011). This led to the conclusion that hypoxia alone was not enough to induce 
oxidative cell death in HTR-8/SVneo cells. This conclusion was in agreement with studies 
by Kilburn et al. (2000) and Armant et al (2006), where they found that HTR-8/SVneo cells 
increased in proliferation and were resistant to hypoxia-induced apoptosis upon exposure to 
2% O2 for up to 24 h. Therefore, the oxidative stress model used in this study was established 
by 2 h hypoxia (either 2 or 0.5% O2) followed by 6 h re-oxygenation, which was a minor 
modification from the protocol employed by Armant et al (2006) and Leach et al (2008). 
Cell viability was assessed using MTT and CellTox™ green cytotoxicity assays. Increasing 
hypoxia to 4 h and reoxygenation for up to 6 h did not reveal any significant MTT reduction. 
Therefore, 2 h hypoxia followed by 6 h reoxygenation was a suitable model for oxidative 
stress in HTR-8/SVneo cells. 
3.6 Conclusions 
The collective data from MTT, CellTox™ green cytotoxicity and CellTiter-Glo® assays 
suggest that 1 and 3 µM of flavonoids (quercetin, morin, naringin and hesperidin) and their 
metabolites (Q3G, naringenin and hesperetin) are not toxic to HTR-8/SVneo cells. These 
data also suggest that concentrations above 10 µM of flavonoids or metabolites trigger 
cytotoxic effects which could suggest pro-oxidant properties of flavonoids and their 
metabolites. Combinations of flavonoids and their metabolites, or flavonoids at low 
concentrations were tolerated by HTR-8/SVneo cells. It can also be concluded that hypoxia 
alone either at 2% or 0.5% was not enough to induce oxidative cell death and that H/R is a 
better model of oxidative stress for this study.
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4.0 Introduction  
As described in chapter 1, during oxidative stress there is increased production of reactive 
oxygen species (ROS). This deleterious effect can negatively affect numerous cellular 
processes. ROS are free radicals generated from biotransformation of molecular oxygen, 
which relies on either enzymatic (such as respiratory chain, phagocytosis and cytochrome 
P450 system) or non-enzymatic (O2 reacting with organic compound) reactions 
(Banjarnahor and Artanti, 2014; Pizzino et al., 2017). Free radicals can be defined as species 
containing one more unpaired electrons and are considered to be very unstable and extremely 
reactive and their stability is associated with their acquisition of extra election from nucleic 
acids, lipids, carbohydrates or proteins (Banjarnahor and Artanti, 2014).  Superoxide anion 
(O2-), hydrogen peroxide (H2O2) and hydroxyl (OH•) are the three major types of ROS that 
are of physiological significance. Superoxide anion radical is produced from the leakage of 
electrons from the electron transport chain (Aouache et al., 2018). The mitochondria are the 
main site for the production of superoxide anion and its mediated by nicotine adenine 
dinucleotide phosphate [NAD(P)H] oxidase, or xanthine oxidase (Birben et al., 2012). 
Detoxification of superoxide by superoxide dismutase leads to the production of hydrogen 
peroxide (Burton and Jauniaux, 2011). Hydrogen peroxide is less reactive than superoxide 
and it is not a free radical. Hydroxyl ion is the most reactive of all three major ROS and it is 
generated by the reaction of superoxide with hydrogen peroxide in the presence of reaction 
catalyst such as ferrous (Fe2+) or cuprous (Cu+) ions (Lázár, 2012; Pizzino et al., 2017).  
ROS have been linked to the pathophysiology of over 100 diseases and involved several 
organ systems such as human reproductive tract; ovaries, fallopian tube, placenta or even 
embryos (Agarwal and Gupta, 2005). In placenta, hypoxia followed by re-oxygenation is a 
very common source of ROS during gestational period resulting in oxidative stress and 
eventually incomplete remodelling of the maternal spiral arteries during placentation (Leach 
et al., 2008; Wu et al., 2016). Placental oxidative stress can be adversely destructive such as 
shallow invasion of the trophoblast cells (see chapter 6), DNA damage, apoptosis (see 
chapter 5), endothelial dysfunction and immune disturbance (Wu et al., 2016). These adverse 
effects lead to spontaneous abortion (30-50% of conceptions), pre-eclampsia (8-10%) and 
intrauterine growth restriction (3-10%) (Wu et al., 2016). One major indicator of oxidative 
stress is the ratio between reduced and oxidised glutathione (GSH/GSSG).  
This ratio is often used to explain reduction and oxidation (redox) regulation and other 
cellular/biological processes (Flohé, 2013). Reduced glutathione (GSH) is an essential 
intracellular, small-molecular (tripeptide) antioxidant and detoxification agent.  
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GSH is the main intracellular redox buffer that protects the cells/tissue against ROS and its 
generated by-products. It acts as an independent antioxidant or combination with other 
enzymes such as glutathione peroxidase. GSH is converted to a disulphide/oxidised form 
represented as oxidised glutathione (GSSG) (Massarsky et al., 2017). Within cells, GSH 
constitute > 98% of total glutathione while GSSG usually constitute < 2%. This ratio is 
tightly regulated, and it is an essential mechanism for cell survival (proliferation, 
differentiation and apoptosis). During severe oxidative stress, there is a drastic shift in the 
GSH/GSSG ratio that results in the reduction of GSH and increment of GSSG levels 
resulting in GSH/GSSH redox imbalance (Giustarini et al., 2015; Li et al., 2016). Altered 
GSH/GSSG ratio plays a major role in the development of human diseases such as diabetes 
mellitus, cancer, cardiovascular diseases and pre-eclampsia (Giustarini et al., 2015). GSSG 
reduction to GSH is achieved by glutathione disulphide reductase in a reaction using 
nicotinamide adenine dinucleotide phosphate (NADPH) as a cofactor. NADP/NADPH ratio 
is a redox couple of one of nicotinamide adenine dinucleotide system in cells that is 
responsible for several biological processes including maintenance of redox balance (Miller 
et al., 2018). This ratio determines the intracellular redox state that influences the 
thermodynamic effects of several reactions in vivo (Miller et al., 2018). NADP (oxidised 
form) is reduced to NADPH which is ten-fold more in abundance. In addition, NADPH is 
predominantly utilised by the cells for reduction reactions such as anabolic or antioxidant 
(converting GSSG to GSH) activities whereas NADP synthesis is dependent on NAD 
availability and it functions as a co-enzyme in cellular electron transport reactions (Agledal 
et al., 2010). NADP/NADPH ratio is maintained at a very low level and disruption in ratio 
eventually results in increased ROS leading to oxidative stress (Miller et al., 2018).  
Interestingly, there are numerous enzymatic and non-enzymatic antioxidant defence systems 
against ROS and oxidative cell damage, which includes glutathione, Vitamin C & E and 
flavonoids. However, the antioxidative effects of flavonoids are yet to be investigated during 
early pregnancy. Therefore, investigating the non-toxic concentrations of flavonoids, their 
metabolites alone or combinations (from Chapter 3) will be used to determine their 
cytoprotective effects and potential intracellular mechanisms in this chapter. 
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4.1 Aims 
• To assess the effects of pre-treatment of HTR-8/SVneo with the indicated flavonoids, 
their metabolites alone or in combinations prior to HR-induced oxidative stress on; 
i. Cell Viability 
ii. GSH and GSSG levels 
iii. NADP/NADPH ratio 
iv. Hydrogen peroxide (H2O2) levels 
                                                 Chapter 4: Antioxidative mechanisms of flavonoids 
 
76 | P a g e  
 
4.2 Results 
4.2.1 Cytoprotective effects of flavonoids on HR-induced oxidative stress 
The cytoprotective effects of flavonoids, their metabolites alone or in combinations on HTR-
8/SVneo cells exposed to HR-induced oxidative stress was assessed using MTT and 
CellTiter-Glo® assays. As seen in chapter 3, HR-induced oxidative stress significantly 
increased cell death and increased MTT reduction as demonstrated by CellTox™ green and 
MTT assays respectively. Therefore, pre-treating HTR-8/SVneo cells with the non-toxic 
concentrations (1 and 3 µM) of the indicated flavonoids for 24 h prior to exposure to H/R 
insult was carried out. The data from MTT assay as shown in figure 4.1 (A-D) suggested 
that cells pre-treated with flavonoids (quercetin, morin, naringin and hesperidin) were 
associated with significant protection against HR-induced inhibition of MTT reduction.  
 
Figure 4.1: Effect of 24 h flavonoid treatment on the viability of HTR-8/SVneo cells 
subjected to HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with either 1 or 3 µM of quercetin, morin, naringin and 
hesperidin for 24 h prior to HR-induced oxidative stress exposure. Cell viability was 
measured by MTT reduction assay (A-D). Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparisons test). Data are expressed as the percentage of 
control cells and represent the mean ± SEM of six independent experiments performed in 
quadruplicate. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus control, (b) 
versus H/R alone. 
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Comparing to untreated cells (H/R), pre-treating with 1 and 3 µM flavonoids has a significant 
protective effect against oxidative stress. However, there was no significant difference 
between flavonoid treated cells and control cells. 
Comparable results were achieved by monitoring cell viability based on ATP quantitation 
during this flavonoid-mediated cytoprotection using CellTiter-Glo® assay (figure 4.2, A-D). 
The data showed that 24 h pre-treated cells with 3 µM showed significantly increased ATP 
levels compared to H/R cells indicating flavonoid mediated proliferation. Again, comparison 
between 24 h pre-treated cells and control showed no significant changes in ATP level.  
 
Figure 4.2: Effect of 24 h treatment with flavonoids on HTR-8/SVneo cells viability 
based on ATP detection in response to HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with 3 µM of quercetin, morin, naringin and hesperidin 
for 24 h prior to HR-induced oxidative stress exposure. Cell viability was measured by 
CellTiter-Glo® Luminescent assay (A-D). Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparisons test). Data are expressed as relative luminescence 
unit and represent the mean ± SEM of three independent experiments performed in 
quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001, versus control. 
 
 
Since 24 h pre-treated HTR-8/SVneo cells showed significant protection against HR-
induced oxidative stress, the effect of 48 h pre-treatment was assessed by MTT assay alone. 
Although, the usual maximum plasma peak recovery for flavonoids never exceed 24 h, 
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flavonoids have been recovered from the bloodstream after 48 h in some studies. The data 
from figure 4.3 (A-D) showed that the indicated flavonoids at both 1 and 3 µM showed 
significant protection against HR-induced MTT reduction. The MTT assay data from figure 
4.1 (A-D) and figure 4.3 (A-D) suggest that flavonoids’ cytoprotective is not only restricted 
to 24 h pre-treatment but also 48 h. 
 
Figure 4.3: Effect of 48 h treatment with flavonoids on the viability of HTR-8/SVneo 
cells subjected to HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with either 1 or 3 µM of quercetin, morin, naringin and 
hesperidin for 48 h prior to HR-induced oxidative stress exposure. Cell viability was 
measured by MTT reduction assay (A-D). Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparisons test). Data are expressed as the percentage of 
control cells and represent the mean ± SEM of six independent experiments performed in 
quadruplicate. .*P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus control, (b) 
versus H/R alone. 
 
 
As previously described in chapter 1, after the absorption of flavonoids, their metabolites 
were found in bloodstream, urine and faeces. Therefore, assessing the effects of these 
metabolites is necessary. Similar to parent compounds, 24 h pre-treatment with 1 and 3 µM 
of respective metabolites (namely Q3G, naringenin and hesperetin) exhibited significant 
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protection against MTT reduction as shown in figure 4.4 (A-C). Further validation was 
carried out using CellTiter- Glo® assay. The results as seen in figure 4.5 (A-C) were in 
agreement with the MTT assay data, indicting that their metabolites were significantly 
protective against HR-induced oxidative stress. 
 
Figure 4.4: Effect of 24 h treatment with metabolites on the viability of HTR-8/SVneo 
cells subjected to HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with either 1 or 3 µM of Q3G, naringenin and 
hesperetin for 24 h prior to HR-induced oxidative stress exposure. Cell viability was 
measured by MTT reduction assay (A-C). Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparisons test). Data are expressed as percentage of control 
cells and represent the mean ± SEM of six independent experiments performed in 
quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus control, (b) versus H/R 
alone. 
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Figure 4.5: Effect of 24 h treatment with flavonoid metabolites on HTR-8/SVneo cells 
viability based on ATP detection subjected to HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with 1 µM of Q3G, naringenin and hesperetin for 24 h 
prior to exposure to HR-induced oxidative stress. Cell viability was measured by CellTiter-
Glo® Luminescent assay (A-C). Statistical analysis was carried out using one-way ANOVA 
(Tukey’s multiple comparisons test). Data are expressed as relative luminescence units and 
represent the mean ± SEM of three independent experiments performed in quadruplicate. 
*P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus H/R alone, (b) versus 
control. 
 
As explained earlier, it was important to mimic the in vivo environment by combining the 
parent compounds (flavonoids) and their respective metabolites. The effect on flavonoid-
metabolite combinations as explained in section 3.2.4 (quercetin/Q3G, morin/Q3G, 
naringin/naringenin and hesperidin/hesperetin) with 24 h pre-treatment prior to H/R insult 
was investigated. The MTT assay data as seen in figure 4.6 (A-D) shows that flavonoid-
metabolite combinations exhibited significant protection against HR-induced MTT 
reduction.  
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Figure 4.6: Effect of 24 h treatment with flavonoid-metabolite combinations on the 
viability of HTR-8/SVneo cells subjected to HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with 3 µM of flavonoid and 1 µM metabolite for 24 h 
prior to HR-induced oxidative stress exposure. Cell viability was measured by MTT 
reduction assay (A-D). Statistical analysis was carried out using one-way ANOVA (Tukey’s 
multiple comparisons test). Data are expressed as percentage of control cells and represent 
the mean ± SEM of six independent experiments performed in quadruplicate. *P<0.05, 
**P<0.01, ***P<0.001 and ****P<0.0001, (a) versus H/R alone, (b) versus control. 
 
Similar results were obtained from the CellTiter-Glo® assay (figure 4.7, A-D). Again, the 
protective effects of flavonoid-metabolites combinations were seen, but unlike the MTT 
assay there was no significance difference between morin/Q3G, naringin/naringenin and 
hesperidin/hesperetin pre-treated cell compared to control. 
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Figure 4.7: Effect of 24 h treatment with flavonoid-metabolite combinations on HTR-
8/SVneo cells viability based on ATP detection subjected to HR-induced 
oxidative stress. 
HTR-8/SVneo cells were pre-treated with 3 µM of flavonoid and 1 µM metabolite for 24 h 
prior to HR-induced oxidative stress exposure. Cell viability was measured by CellTiter-
Glo® Luminescent assay (A-D). Statistical analysis was carried out using one-way ANOVA 
(Tukey’s multiple comparisons test). Data are expressed as relative luminescence units and 
represent the mean ± SEM of three independent experiments performed in quadruplicate. 
*P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus H/R alone, (b) versus 
control. 
 
Since the daily intake of flavonoids cannot be precise and the craving of flavonoid rich fruits 
and vegetables cannot be controlled during early gestation, it was important to investigate 
the synergistic, addictive or antagonistic effect of combining two or more flavonoids. 
Therefore, the effects of 24 h pre-treatment with flavonoids combination as described in 
section 3.2.4 (quercetin/morin, quercetin/naringin and quercetin/hesepredin) was 
investigated by MTT and CellTire-Glo® assays. As shown in figure 4.8 (A-C), the MTT 
assay data showed that combination of flavonoids exhibited significant protection against 
MTT reduction induced by HR-induced oxidative.  
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Figure 4.8: Effect of 24 h treatment with flavonoids combination on the viability of 
HTR-8/SVneo cells subjected to HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with the combination of flavonoids at 3 µM 
(individually) for 24 h prior to HR-induced oxidative stress exposure. Cell viability was 
measured by MTT reduction assay. Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparisons test). Data are expressed as the percentage of 
control cells and represent the mean ± SEM of six independent experiments performed in 
quadruplicate. ***P<0.001 and ****P<0.0001, versus H/R alone. 
 
As before, to validate the data from the MTT assay (figure 4.8), CellTiter-Glo® assay was 
performed. Comparable results were achieved as seen in figure 4.9 (A-C). Apart from the 
protective effects of combined flavonoids, the viability assay also indicated that 24 h pre-
treated cells had significant reduction in viability when compared to controls unlike that of 
MTT assay. Both assays agreed upon comparison between pre-treated cells and untreated 
H/R cells. 
  
                                                 Chapter 4: Antioxidative mechanisms of flavonoids 
 
84 | P a g e  
 
 
Figure 4.9: Effect of 24 h treatment with flavonoids combination on HTR-8/SVneo cells 
viability based on ATP detection subjected to HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with the combination of flavonoids at 3 µM 
(individually) for 24 h prior to HR-induced oxidative stress exposure. Cell viability was 
measured by CellTiter-Glo® Luminescent assay. Statistical analysis was carried out using 
one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as the relative 
luminescence unit and represent the mean ± SEM of three independent experiments 
performed in quadruplicate. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus 
H/R alone, (b) versus control. 
4.2.1.1 Effects of lower concentrations of flavonoids/metabolites on HR-induced 
oxidative stress 
Since 1 and 3 μM of flavonoids/metabolites were protective against HR-induced oxidative 
stress in HTR-8/SVneo cell line, further investigation was carried out to assess the effects of 
flavonoids/metabolites below 1 μM. As seen in figure 4.10 (A-D), 24 h pre-treatment with 
the selected flavonoids (quercetin, morin, naringin or hesperidin) did not protect HTR-
8/SVneo against HR-induced oxidative at either 0.3 or 0.5 μΜ. Similarly, 24 h pre-treatment 
with their respective metabolites (Q3G, naringenin and hesperetin) failed to protect HTR-
8/SVneo from HR-induced oxidative stress as shown in figure 4.11 (A-C).  
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Figure 4.10: Effect of 24 h treatment with concentrations below 1 μM of flavonoids on 
the viability of HTR-8/SVneo cells subjected to HR-induced oxidative 
stress. 
HTR-8/SVneo cells were pre-treated with either 0.3 or 0.5 µM of quercetin, morin, naringin 
and hesperidin for 24 h prior to HR-induced oxidative stress exposure. Cell viability was 
measured by MTT reduction assay (A-D). Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparisons test). Data are expressed as the percentage of 
control cells and represent the mean ± SEM of three independent experiments performed in 
quadruplicate. .*P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus control, (b) 
versus H/R alone. 
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Figure 4.11: Effect of 24 h treatment with concentrations below 1 μM of metabolites 
on the viability of HTR-8/SVneo cells subjected to HR-induced oxidative 
stress. 
HTR-8/SVneo cells were pre-treated with either 0.3 or 0.5 µM of Q3G, naringenin and 
hesperetin for 24 h prior to HR-induced oxidative stress exposure. Cell viability was 
measured by MTT reduction assay (A-C). Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparisons test). Data are expressed as the percentage of 
control cells and represent the mean ± SEM of six independent experiments performed in 
quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus control, (b) versus H/R 
alone. 
 
4.2.2 Effect of flavonoids on redox state 
The effects of 24 h pre-treatment with flavonoids, their metabolites alone or in combination 
prior to HR-induced oxidative stress on redox state was assessed using GSH/GSSG-Glo™ 
and NADP/NADPH-Glo™ assays. 
4.2.2.1 Effect of flavonoids on glutathione (GSH/GSSG) levels 
This sub-section aimed to assess the effect of 24 h pre-treatment of HTR-8/SVneo cells with 
flavonoids on total (GSH+GSSG), reduced (GSH) and oxidised (GSSG) glutathione in 
response to HR-induced oxidative stress. As seen in figure 4.10 (A-D), 24 h pre-treatment 
with flavonoids (quercetin, morin, naringin or hesperidin) or H/R insult did not affect the 
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total glutathione level. However, the data from GSH (figure 4.10, E-H) indicated that levels 
of GSH were significantly depleted in H/R untreated cells while cells pre-treated with the 
indicated flavonoids significantly increased GSH levels when compared to both control and 
H/R cells. Again, there was a significant increase in the level of GSSG during HR-induced 
oxidative stress, yet cells pre-treated with indicated flavonoids significantly reduce the 
generation of GSSG. These data indicate that flavonoids were associated with the elevation 
of GSH and depletion of GSSG levels, restoring the imbalance produced by HR-induced 
oxidative stress. Comparable results were obtained from their respective metabolites (Q3G, 
naringenin or hesperetin; figure 4.11A-C). There was no change in the total glutathione; pre-
treatment with the indicated metabolites significantly elevated GSH (figure 4.11, D-F) and 
significantly decreased GSSG levels (figure 4.11, G-I). Not surprisingly, pre-treatment with 
combinations of flavonoids and their respective metabolites (quercetin/Q3G, morin/Q3G, 
naringin/naringenin or hesperidin/hesperetin) did not significantly increase the total 
glutathione (figure 4.12A-D). However, these combinations significantly increased the GSH 
level (see figure 4.12, E-H) and significantly depleted GSSG level as shown in figure 4.12 
(I-L). Surprisingly, the combination of flavonoids (quercetin/morin, quercetin/naringin or 
quercetin/hesperidin) significantly increased the total glutathione level as seen in figure 4.13 
(A, B) with the exception of the quercetin/hesperidin combination as shown in figure 4.13 
(C).  
Furthermore, flavonoid combination pre-treatment significantly elevated GSH as indicated 
in figure 4.13 (D-F) and significantly reduced the GSSG level (figure 4.13, G-I). The data 
obtained in this section indicates that cells pre-treated with either flavonoids, their 
metabolites alone or in combinations significantly restore GSH/GSSG ratio. 
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Figure 4.12: Effects of flavonoids on glutathione in response to HR-induced oxidative 
stress. 
HTR-8/SVneo cells were pre-treated with the indicated flavonoids at 3 µM for 24 h prior to 
exposure to HR-induced oxidative stress. Total, reduced and oxidised glutathione was 
measured using GSH/GSSG-Glo™ assay. (A) represent the effect of flavonoids on total 
glutathione, (B) represent the effects of flavonoids on reduced glutathione, and (C) represent 
the effect of flavonoids on oxidised glutathione. Statistical analysis was carried out using 
one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as the relative 
luminescence units (RFU) and represent the mean ± SEM of at least three independent 
experiments performed in quadruplicate. *P<0.05, **P<0.01, ***P<0.001 and 
****P<0.0001, (a) versus control and (b) versus HR. 
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Figure 4.13: Effects of flavonoid metabolites on glutathione after HR-induced 
oxidative stress. 
HTR-8/SVneo cells were pre-treated with the indicated flavonoid metabolites at 1 µM for 
24 h prior to exposure to HR-induced oxidative stress. Total, reduced and oxidised 
glutathione was assessed using GSH/GSSG-Glo™ assay. (A) represent the effect of 
metabolites on total glutathione, (B) represent the effects of metabolites on reduced 
glutathione, and (C) represent the effect of metabolites on oxidised glutathione. Statistical 
analysis was carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data 
are expressed as the relative luminescence units (RFU) and represent the mean ± SEM of at 
least three independent experiments performed in quadruplicate. *P<0.05, **P<0.01, 
***P<0.001 and ****P<0.0001, (a) versus control and (b) versus HR. 
 
                                                 Chapter 4: Antioxidative mechanisms of flavonoids 
 
90 | P a g e  
 
  
Figure 4.14: Effects of flavonoid-metabolite combinations on glutathione after HR-
induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with the indicated flavonoids (3 µM) and their 
metabolites (1 µM) combinations for 24 h prior to exposure to HR-induced oxidative stress. 
Total, reduced and oxidised glutathione was determined using GSH/GSSG-Glo™ assay. (A) 
represent the effect of flavonoid-metabolite combinations on total glutathione, (B) represent 
the effects of flavonoid-metabolite combinations on reduced glutathione, and (C) represent 
the effect of flavonoid-metabolite combinations on oxidised glutathione. Statistical analysis 
was carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data are 
expressed as relative luminescence units (RFU) and represent the mean ± SEM of at least 
three independent experiments performed in quadruplicate. **P<0.01 and ****P<0.0001, 
(a) versus control and (b) versus HR. 
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Figure 4.15: Effects of flavonoid combinations on glutathione after HR-induced 
oxidative stress. 
HTR-8/SVneo cells were pre-treated with the indicated combinations of flavonoids (3 µM 
each) for 24 h prior to exposure to HR-induced oxidative stress. Total, reduced and oxidised 
glutathione was assessed using GSH/GSSG-Glo™ assay. (A) represent the effect of 
combined flavonoids on total glutathione, (B) represent the effects of combined flavonoids 
on reduced glutathione, and (C) represent the effect of combined flavonoids on oxidised 
glutathione. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple 
comparisons test). Data are expressed as relative luminescence units (RFU) and represent 
the mean ± SEM of at least three independent experiments performed in quadruplicate. 
*P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus control and (b) versus HR.
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4.2.2.2 Effect of flavonoids on the nicotinamide adenine dinucleotide system 
The effects of 24 h flavonoid pre-treatment prior to H/R insult on the nicotinamide adenine 
dinucleotide system was investigated by measuring NADP/NADPH ratio. As explained 
previously, the intracellular concentrations of NADP and NADPH are kept low levels as 
they are very important molecules responsible for major biological processes including the 
maintenance of redox balance. Most importantly, the mechanisms for redox balancing and 
subcellular ratio of NADP/NADPH has been proposed to be crucial in influencing the 
physiology of cells and their survival. The NADP/NADPH ratio data seen in figure 4.14 (A-
D) indicated H/R control cells show high levels of the NADP/NADPH ratio which is an 
indication of oxidative stress. 24 h pre-treatment with flavonoids (quercetin, morin, naringin 
or hesperidin) significantly restored the balance in NADP and NADPH. 
 
Figure 4.16: Effects of flavonoids on the redox state of HTR-8/SVneo cells after HR-
induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with the indicated flavonoids at 3 µM for 24 h before 
exposure to HR-induced oxidative stress. Redox state was assessed using NADP/NADPH-
Glo™ assay (A-D). Statistical analysis was carried out using one-way ANOVA (Dunnett’s 
multiple comparisons test against HR). Data are expressed as the relative luminescence units 
and represent the mean ± SEM of three independent experiments performed in quadruplicate. 
***P<0.001 and ****P<0.0001. 
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Comparable data were obtained from their respective metabolites alone (Q3G, naringenin or 
hesperetin), as shown in figure 4.15 (A-C) there was significant reduction in the 
NADP/NADPH ratio when compared to H/R cells. 
                     
Figure 4.17: Effects of flavonoid metabolites on the redox state of HTR-8/SVneo cells 
after HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with the indicated flavonoid metabolites at 1 µM for 
24 h before exposure to HR-induced oxidative stress. Redox state was assessed using 
NADP/NADPH-Glo™ assay (A-C). Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test against HR). Data are expressed as relative 
luminescence units and represent the mean ± SEM of three independent experiments 
performed in quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001. 
 
In addition, the effects of 24 h pre-treatment with flavonoid/metabolite combinations 
(quercetin/Q3G, morin/Q3G, naringin/naringenin or hesperidin/hesperetin) on 
NADP/NADPH was investigated. The data from figure 4.16 (A-D) shows that these 
combinations significantly restored the ratio balance of the nicotinamide adenine 
dinucleotide system. Similar results were also achieved in the investigation of 24 h pre-
treatment with flavonoid combinations (quercetin/morin, quecetin/naringin or 
quercetin/hesperidin) as seen in figure 4.17 (A-C). 
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Figure 4.18: Effects of flavonoid-metabolite combinations on the redox state of HTR-
8/SVneo cells after HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with the indicated combinations flavonoid (3 µM) and 
flavonoid metabolite (1 µM) for 24 h before exposure to HR-induced oxidative stress. Redox 
state was assessed using NADP/NADPH-Glo™ assay (A-D). Statistical analysis was carried 
out using one-way ANOVA (Dunnett’s multiple comparisons test against HR). Data are 
expressed as relative luminescence units and represent the mean ± SEM of three independent 
experiments performed in quadruplicate. ***P<0.001 and ****P<0.0001. 
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Figure 4.19: Effects of flavonoid combinations on the redox state of HTR-8/SVneo cells 
after HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with the indicated combinations of flavonoids at 3 µM 
for 24 h before exposure to HR-induced oxidative stress. Redox state was assessed using 
NADP/NADPH-Glo™ assay (A-C). Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test against HR). Data are expressed as relative 
luminescence units and represent the mean ± SEM of three independent experiments 
performed in quadruplicate. ***P<0.001 and ****P<0.0001. 
 
4.2.3 Scavenging effect of flavonoids on ROS 
In this section the role of flavonoids, their metabolites alone or in combinations in 
scavenging of ROS (hydrogen peroxide) was investigated. The effects of 24 h pre-treatment 
was assessed using ROS-Glo™ H2O2. As expected, exposure to H/R insult significantly 
increased the generation of hydrogen peroxide as seen in figures 4.18-21 (H/R untreated 
cells). The data from figure 4.18 (A-D) indicated that flavonoids (quercetin, morin, naringin 
or hesperidin) exhibited significant scavenging effects on hydrogen peroxide (generated by 
HR-induced oxidative stress) was significantly reduced.  
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Figure 4.20: Scavenging effects of flavonoids on intracellular ROS during HR-induced 
oxidative stress in HTR-8/SVneo cells. 
HTR-8/SVneo cells were pre-treated with the indicated flavonoids (3 µM) for 24 h before 
exposure to HR-induced oxidative stress. Intracellular ROS was assessed using ROS-Glo 
H2O2 assay (A-D). Statistical analysis was carried out using one-way ANOVA (Dunnett’s 
multiple comparisons test against HR). Data are expressed as relative luminescence units 
and represent the mean ± SEM of three independent experiments performed in quadruplicate. 
**P<0.01, and ****P<0.0001. 
 
Investigating the effects of 24 h pre-treatment with their metabolites alone, again there was 
significant reduction in HR-induced hydrogen peroxide generation as shown in figure 4.19 
(A-C). Comparable results were obtained from the combination of flavonoid-
metabolite/flavonoids as seen in figure 4.20 (A-D) and figure 4.21 (A-C) respectively. 
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Figure 4.21: Scavenging effects of metabolites on intracellular ROS during HR-
induced oxidative stress in HTR-8/SVneo cells. 
HTR-8/SVneo cells were pre-treated with the indicated flavonoid metabolites at 1 µM for 
24 h before exposure to HR-induced oxidative stress. Intracellular ROS was assessed using 
ROS-Glo H2O2 assay (A-C). Statistical analysis was carried out using one-way ANOVA 
(Dunnett’s multiple comparisons test against HR). Data are expressed as relative 
luminescence units and represent the mean ± SEM of three independent experiments 
performed in quadruplicate. **P<0.01 and ****P<0.0001. 
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Figure 4.22: Scavenging effects of flavonoid-metabolite combinations on intracellular 
ROS during HR-induced oxidative stress in HTR-8/SVneo cells. 
HTR-8/SVneo cells were pre-treated with the indicated combinations of flavonoid (3 µM) 
and flavonoid metabolite (1µM) for 24 h before exposure to HR-induced oxidative stress. 
Intracellular ROS was assessed using ROS-Glo H2O2 assay (A-D). Statistical analysis was 
carried out using one-way ANOVA (Dunnett’s multiple comparisons test against HR). Data 
are expressed as relative luminescence units and represent the mean ± SEM of three 
independent experiments performed in quadruplicate. ***P<0.001 and ****P<0.0001. 
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Figure 4.23: Scavenging effects of flavonoid combinations on intracellular ROS during 
HR-induced oxidative stress in HTR-8/SVneo cells. 
HTR-8/SVneo cells were pre-treated with the indicated combinations of flavonoid (3 µM) 
for 24 h before exposure to HR-induced oxidative stress. Intracellular ROS was assessed 
using ROS-Glo H2O2 assay (A-D). Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test against HR). Data are expressed as relative 
luminescence units and represent the mean ± SEM of three independent experiments 
performed in quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001. 
 
4.3 Result Summary 
Flavonoid (quercetin, morin, naringin or hesperidin) pre-treatment for 24 and 48 h exhibited 
cytoprotective effects against HR-induced oxidative stress in HTR-8/SVneo cells. This 
cytoprotective effect was also observed with their metabolites alone (Q3G, naringenin or 
hesperetin) and their combinations (flavonoid/metabolites or flavonoid/flavonoid). Initial 
data from the MTT reduction assay confirmed that both 1 and 3 µM of the indicated 
flavonoids or metabolites, alone showed significant cytoprotection against MTT reduction 
from HR-induced oxidative cell death. On the contrary, concentrations 0.3 and 0.5 μM of 
flavonoids/metabolites alone failed to show cytoprotective effects against HR-induced 
oxidative stress in HTR-8/SVneo cells. Investigating the intracellular mechanism of the 
cytoprotective effects of these flavonoids, pre-treated cells (24 h) showed restorative effects 
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in redox balancing during HR-induce oxidative stress by significantly elevating the levels of 
GSH, depleting GSSG levels and maintaining the ratio balance in the nicotinamide adenine 
dinucleotide system (NADP/NADPH). Unexpectedly, combination of flavonoids such as 
quercetin/morin and quercetin/ naringin significantly increased the total glutathione 
(GSH+GSSG) level during HR-induced oxidative stress despite the finding that there was 
no change in total glutathione level between control and H/R cells. Finally, there was 
significant ROS (H2O2) scavenging effects exhibited by 24 h pre-treated cells with 
flavonoids/metabolites. 
4.4 Discussion 
The aim of this section was to assess the cytoprotective effects of the indicated flavonoids, 
their metabolites alone or in combinations (flavonoids-metabolites or flavonoids) as well as 
their intracellular pathways such as redox balance (GSH/GSSG, NADP/NADPH) and 
scavenging of ROS (H2O2) on HR-induced oxidative stress in first trimester trophoblast cell 
line (HTR-8/SVneo).  
4.4.1 Cytoprotective effects of flavonoids against H/R 
To the author’s knowledge, this is the first study to investigate the cytoprotective effects of 
flavonoids on HTR-8/SVneo cells during HR-induced oxidative stress. The data obtained 
from MTT assays showed that HTR-8/SVneo cells pre-treated with flavonoids for 24 h prior 
to H/R insult showed significant cytoprotection against MTT reduction. Both 1 and 3 µM of 
flavonoids and metabolites alone, induced cytoprotective effects but more consistent 
protection was observed in 3 µM for flavonoids and 1 µM for metabolites (Q3G, naringenin 
or hesperetin) pre-treated cells as seen from the MTT assay. These protective effects seen 
from both flavonoids and their metabolites alone was further validated with using CellTiter-
Glo® viability assay, which assesses cellular proliferation/viability based on ATP 
quantitation and was in agreement. Furthermore, cells pre-treated with flavonoids alone for 
48 h also showed protective effects against HR-induced oxidative stress as seen by the MTT 
reduction. However, 24 h pre-treatment was used for this study as the absorption, 
metabolism and excretion of flavonoids as well as the peak plasma levels are achieved in the 
first 24 h (Lotito and Frei, 2006; Thilakarathna and Vasantha Rupasinghe, 2013). Assessing 
the effects of 24 h pre-treatment with flavonoid-metabolite/flavonoid combinations, there 
was also a significant protection against H/R insult as seen from the MTT reduction and 
CellTiter-Glo® assays. This protective effect of flavonoids, their metabolites or in 
combination against H/R can be associated with their anti-oxidative properties. Since this is 
the first study on the effects of flavonoids on a human first trimester trophoblast cell line, 
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comparable data or studies are not available. However, there are numerous studies of 
flavonoids on non-trophoblast origin, for instance, quercetin and it’s metabolite (Q3G) were 
associated with protection against H2O2-induced oxidative stress in mitotic and 
differentiated H9c2 cardiomyoblasts as well as neuronal PC12 cells (Daubney et al., 2015; 
Ho and Chang, 2004a). In another study conducted by Lee et al. (2017) morin exhibited 
cytoprotective effects in lung fibroblast cells (V79-4) following H2O2-induced oxidative 
DNA damage and cell death. In addition, naringin attenuated the effect of H2O2-induced 
cytotoxicity in mouse leukemic (P388) and lung fibroblast (V79) cells (Bacanli et al., 2015; 
Kanno et al., 2003). Furthermore, in a study conducted by Chen et al. (2010), hesperidin was 
found to be cytoprotective against tert-butyl hydroperoxide in human hepatocyte L02 cells. 
The data from this current study is in agreement with the above studies that flavonoids are 
protective against oxidative stress. Another unique feature of this current study is that fact 
that cytoprotection was achieved using low concentrations that are within physiological 
range and within the daily recommended intake. In contrast to other studies (stated above), 
higher concentrations (20-500 µM) of flavonoids are used that cannot be achieved 
physiologically by the daily intake of fruits and vegetables. Also, the daily average intake of 
flavonoids cannot be estimated due to their extensive distribution in plants and varieties. 
Considering these factors, the dietary daily intake of flavonoids has been proposed to range 
from 100 to 1000 mg/day (Yao et al., 2004; Mullie et al., 2007).  
Investigating the effects of flavonoid-metabolite combinations (quercetin/Q3G, morin/Q3G, 
naringin/naringenin or hesperidin/hesperetin), the data from MTT and CellTiter-Glo® assays 
showed that, there is significant protection against inhibition of MTT reduction and 
significant increase in ATP levels in pre-treated cells when compared with H/R cells. 
Although synergistic or addictive effects could not be confirmed, the data clearly indicated 
that these combinations were not antagonist. Again, this is the first study to report the 
combination of flavonoid-metabolite combination in HTR-8/SVneo cells prior to H/R insult. 
Therefore, comparable results were not available both from trophoblast or non-trophoblast 
origins due to limited studies. Furthermore, the combinations of flavonoids 
(quercetin/morin, quercetin/naringin or quercetin/hesperidin) also showed significant 
protective against HR-induced oxidative stress as demonstrated by MTT and CellTiter-Glo® 
assays. Combinations of flavonoids were found to have more reducing power when 
compared to single flavonoid during oxidative stress using the pancreatic ductal 
ademonocarcinoma cell line (BxPc-3) and PaCaDD-183, and primary cells (Appari et al., 
2014).  
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4.4.2 Regulation of redox balance 
To investigate the effects of 24 h pre-treatment with flavonoids, their metabolites alone or 
in combinations on the redox state of HTR-8/SVneo cells during HR-induced oxidative 
stress, GSH/GSSG-Glo™ and NADP/NADPH-Glo® assays were carried out. 
GSH/GSSG-Glo™ assay was used to assess the intracellular levels of total (GSH+GSSG), 
reduced (GSH) and oxidised (GSSG) glutathione in HTR-8/SVneo cells during H/R insult. 
As glutathione plays a vital role in the cellular defence system, maintaining the cellular 
GSH/GSSG ratio is important as depletion of GSH or elevation of GSSG levels increases 
cellular vulnerability to oxidative stress-induced cell death (Cavia-Saiz et al., 2010). Data 
obtained from this report indicated that 24 h pre-treated cells (except for quercetin/morin 
and quercetin/naringin), did not significantly increase or decrease the level of total 
glutathione. Comparisons between the control and H/R cells did not show any significant 
difference in total glutathione. This may suggest that the total glutathione is not a factor 
during the oxidative stress and more emphasis should be focused on GSH and GSSG, alone 
as well as their ratio. Investigating GSH, the data from GSH/GSSG-Glo™ assay showed that 
H/R significantly depleted the level of GSH when compared to control cells. Interestingly, 
cells pre-treated with flavonoid (24 h) prior to H/R showed elevated levels of GSH. 
Comparing pre-treated to control cells, flavonoids (morin and hesperidin) and metabolites 
(Q3G, naringenin and hesperetin) showed significant elevation of GSH levels. Although 
other flavonoids or combinations did not significantly increase GSH levels when compared 
to control but was significantly increased when compared to H/R cells. This data may 
suggest that flavonoid-mediated cytoprotection can be linked to their ability to elevate GSH 
levels.  In a study carried out by Myhrstad et al. (2002), flavonoids significantly increased 
cellular GSH by approximately 50% in COS-1 fibroblast-like cells. In addition, quercetin 
was found to significantly elevate GSH in the human laryngeal carcinoma cell line HEp2 
cells (Myers et al., 2013). Comparable results were also obtained from in vivo studies 
concluding that flavonoids significantly increase the level of GSH as a protective mechanism 
against oxidative stress (Subash and Subramanian, 2009; Golechha et al., 2011; Pari et al., 
2015; Chandra Jagetia, 2015). 
Elevated levels of GSSG is an indicator of oxidative stress as it only constitutes less than 1% 
of total glutathione as previously described in section 4.0. The data from GSH/GSSG-Glo™ 
assay showed that there was a significant increase in GSSG level in H/R untreated cells when 
compared to controls. Pre-treated cells before exposure to HR-induced oxidative stress 
significantly decreased the intracellular GSSG levels. This indicates that these flavonoids, 
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their metabolite alone or their combinations restore the redox state by increasing GSH and 
decreasing GSSG level. GSSG has been proposed to significantly increase in cells when 
exposed to oxidative stress or electrophilic chemicals. This elevation leads to an imbalance 
in the GSH/GSSG ratio, loss of GSH as well as severe nuclear protein modifications such as 
insolubilization, oxidation and cross-linking (Ballatori et al., 2009). Although comparable 
data from both trophoblast and non-trophoblast in vitro studies are limited, these flavonoids 
were found to significantly increase GSH and deplete GSSG levels in mouse macrophage 
RAW264.7 cell line following oxidative stress caused by PCV2 (viral) infection (Chen et 
al., 2017). In addition, comparable data was also obtained from an in vivo study conducted 
by Wu et al. (2016), in their study, they discovered that PCV2  infection in mice induced 
oxidative stress by significantly reducing GSH and remarkably elevating GSSG level, and 
the introduction of flavonoids (post treatment) reversed the changes seen in GSH and GSSH 
level as well as restoring the ratio. 
The nicotinamide adenine dinucleotide system (NADP/NADPH) is crucial to cellular 
oxidative stress defence system and reductive synthesis (Pollak et al., 2007). Physiological 
redox balance is important for the development of the foetus and embryogenesis; 
overproduction of free radicals has detrimental effects on placentation and embryogenesis 
leading to disturbed metabolism and impaired intracellular milieu  (Agarwal and Gupta, 
2005). The data from this section showed that H/R insult significantly increased the 
NADP/NADPH ratio when compared to control cells. However, 24 h pre-treatment either 
flavonoids, their metabolite alone or in combination revealed that there was significant 
decrease in NADP/NADPH ratio when compared to H/R untreated cells. Cells pre-treated 
for 24 h prior to HR-induced oxidative stress reduced the NADP/NADPH ratio to almost 
baseline level (control cells). This decrease once again shows that flavonoids are capable of 
maintaining redox via mechanisms other than GSH/GSSG balancing in HTR-8/SVneo cells 
As explained before, there are limited studies about the effects of flavonoids on 
NADP/NADPH ratio during oxidative stress in both trophoblast and non-trophoblast cells; 
however, there are considerable evidence linking NADP/NADPH ratio to increases in 
oxidative stress (Itsumi et al., 2015; Blacker and Duchen, 2016; Corpas and Barroso, 2014). 
This current study has shown that flavonoids regulate oxidative stress caused by H/R insult 
by elevating GSH and decreasing GSSG as well as restoring the balance in NADP/NADPH 
ratio in HTR-8/SVneo cells, thereby maintaining the redox state.  
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4.4.3 ROS scavenging activity of flavonoids 
To further investigate the antioxidant properties of flavonoids, their metabolites alone or in 
combinations prior to HR-induced oxidative stress on HTR-8/SVneo cells, their ability to 
scavenge free radical such as H2O2 was assessed using the ROS-Glo™ H2O2 assay. The data 
obtained from this assay indicated that flavonoids, their metabolites or combinations 
significantly scavenged H2O2 activity generated by HR-induced oxidative stress. H2O2 is 
generated from the dismutation of superoxide and it is an indicator of oxidative stress ( 
Agarwal and Gupta, 2005). Increase in free radicals (especially H2O2) can have detrimental 
effects on the development of the placenta, remodelling of the maternal spiral arteries, the 
foetus, as well at the mother and it is known to mediate cell death via apoptosis. Thereby 
leading to health implications such as pre-eclampsia as a result of shallow invasion during 
early gestation period (Dennery, 2010). The anti-oxidative properties of flavonoids have 
been linked to their ability to scavenge free radicals which was shown in this present study. 
The mechanisms behind flavonoid anti-oxidant properties remain unclear although studies 
have speculated their ability to donate hydrogen molecules is not the only mechanism 
(Williams et al., 2004). Another study suggested that the B ring hydroxyl group 
configuration (at position 3) plays an important role in the ability of flavonoids to scavenge 
ROS (Procházková et al., 2011). Other mechanisms that have been suggested include their 
ability to interact with various antioxidant enzymes such as inducing phase II detoxifying 
enzymes (glutathione S-transferase) and regulation of protective gene expression 
(Procházková et al., 2011). Herein, the data from this section, revealed that flavonoids can 
interact with other antioxidants as seen in the GSH and GSSG levels. In addition, flavonoids 
have been suggested to inhibit oxidase enzymes (e.g. xanthine oxidase) responsible for the 
production of superoxide leading to reduction in oxidative injures or cell death. 
(Procházková et al., 2011). In a study conducted by Chuenkitiyanon, Pengsuparp and 
Jianmongkol (2010), they concluded that quercetin was protective against H2O2-induced 
tight junction disruption and hyperpermeability in the umbilical vein endothelial cell line 
(ECV304). In addition, morin was found to attenuate H2O2-induced apoptosis in the hamster 
lung fibroblast cell line V79-4 (Lee et al., 2017). In an in vivo study, naringin and its 
metabolite, naringenin were found to significantly scavenge free radicals (superoxide and 
hydroxyl) in male Wistar rats livers induced with xanthine oxidase (enzymatic) and nitro 
blue tetrazolium (non-enzymatic) oxidative stress (Cavia-Saiz et al., 2010). Flavonoids are 
known not only to influence the propagation reaction of free radicals but also their generation 
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by halting the enzymes involved in the production or by metal chelating activity 
(Procházková et al., 2011; Cavia-Saiz et al., 2010). 
4.5 Conclusions 
The data from this chapter showed that flavonoids, their metabolites alone or in combination 
exhibited cytoprotective effects against HR-induced oxidative stress by increasing cell 
viability and proliferation. Further investigations on their cytoprotective intracellular 
mechanisms revealed that their protective effects are brought about by maintaining balance 
in the redox state; such as elevating GSH and depleting GSSG level thereby restoring the 
GSH/GSSG ratio as well as their ability to balance the nicotinamide adenine dinucleotide 
system (NADP/NADPH ratio). The data also suggest that flavonoids, their metabolites alone 
or in combinations are potent scavengers of free radicals such H2O2 which is one of the 
major free radicals associated with increased ROS and oxidative stress. 
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5.0 Introduction 
As discussed in chapter 4, cells pre-treated for 24 h with flavonoids, their metabolites or in 
combinations prior to HR insult showed that they are associated with cytoprotection by 
increasing viability and proliferation, elevating GSH and depleting GSSG levels, scavenging 
of ROS (H2O2) and restoring the balance in NADP/NADPH ratio. Herein, the focus of this 
chapter is to determine their effects on apoptosis and their involvement in the activation or 
inhibition of protein kinases such as protein kinase B (PKB), extracellular signal-regulated 
kinases (ERK1/2), p38 mitogen-activated protein kinase (p38 MAPK) and stress-activated 
protein kinase/c-Jun N-terminal kinases (SAPK/JNK).  
Overproduction of free radicals leading to oxidative stress has been linked to cell death by 
apoptosis. Apoptosis (or programmed cell death) is a natural occurrence of cell death, which 
is important for the normal development, functioning and maintenance of homeostasis for 
all multicellular organisms (Kannan and Jain, 2000; Sinha et al., 2013). Changes in the redox 
state in favour of oxidation leads to the activation of cysteine proteases and caspases. 
Depending on sequences of activation during apoptosis, caspases can be classified into two 
groups, which are the initiator caspases (-2, -8, -9 and -10) and the effector/executioner 
caspases (-3, -6 and -7) (Sinha et al., 2013; Tan et al., 2016). There are three main 
mechanisms that result in the activation of caspases; first, receptor-ligand binding also 
known as the extrinsic pathway (via activation of caspase -8); second, intracellular stresses 
leading to a mitochondria-dependent mechanism also known as the intrinsic pathway (via 
activation of caspase-9) and finally, the involvement of the endoplasmic reticulum and 
activation of caspase-12 (Sinha et al., 2013). Only the first and second mechanisms lead to 
the activation of the effector/executioner caspases (Sinha et al., 2013). Summarising the first 
two mechanisms, receptor-ligand binding mechanism involves cell death receptors that are 
members of the tumour necrosis factor receptor super family and also involves transmitting 
of death signals from the surface to the inside of the cells (Sinha et al., 2013). This pathway 
utilises ligands such as FasL/R, TNF-α/TNFR1, which activate caspase-8 at the death-
inducing signal complex resulting in two different mechanisms depending on the extent of 
activation. Normal activation of caspase-8 activates caspase-3 directly and low caspase-8 
activation induces the activation of caspase-3 indirectly by involving the mitochondria 
(Barnhart et al., 2003). The intrinsic /mitochondria-mediated pathway involves and plays a 
crucial role in the integration and circulation of death signals initiated from inside the cells 
such as oxidative stress and DNA damage. Mitochondria is the origin of excessive ROS 
production; and, in pathological states, become the target of oxidative stress assault resulting 
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in mitochondrial swelling, superoxide formation and cytochrome c leakage (Wu et al., 
2016). The main regulatory mechanism in this pathway is the release of cytochrome c into 
the cytoplasm, which triggers a rapid apoptotic response by activating cysteine proteases, 
caspase -9 and -3  (Sinha et al., 2013; Kralova et al., 2008). 
Oxidative stress activates multiple signalling pathways that decide the fate of the cell i.e. 
either to die or survive. Among the signalling pathways are the mitogen-activated protein 
kinase (MAPK) cascades that transmit extracellular signals regulating survival, 
proliferation, cell cycle arrest, death, differentiation, migration, invasion, etc (Kralova et al., 
2008; Wada and Penninger, 2004; Sui et al., 2014). To date, 14 members of the MAPK 
family have been established, including ERK (1/2), JNK (1/2/3) and p38 MAPK (Yao et al., 
2017). ERK activation is important for survival (anti-apoptotic), whereas p38 MAPK and 
JNK/SAPK activation are responsible and involved in apoptosis (pro-apoptotic). Different 
external stimuli such as oxidative stress and overproduction of free radicals can activate one 
or more MAPK pathways, subsequently activating a series of signal transductions and 
regulation to induce different physiological responses (Wada and Penninger, 2004; Yao et 
al., 2017). Upon phosphorylation at the serine/threonine sites, MAPKs can further mediate 
the activation of downstream kinases in the cytoplasm or translocated into the nucleus 
through the nuclear pore to enhance transcription of genes that can either be a positive or 
negative outcome to the entire signalling cascades (Yao et al., 2017; Wada and Penninger, 
2004). 
Another signalling pathway is that is crucial to this study is the protein kinase B or AKT 
(PKB/AKT) pathway. This pathway is a serine/threonine protein kinase that is regulated  via 
the phosphoinositide 3-kinase (PI3k) pathway and it comprises of three isoforms (AKT1/2/3) 
that play unique or vague roles (Fayard et al., 2010; Nicholson and Anderson, 2002). Like 
other signalling pathways, PKB is activated by stress stimuli but its activation mechanism is 
not fully understood. However, PKB/AKT phosphorylates and mediates the function of 
several cellular proteins responsible for glucose metabolism and transport, apoptosis, 
migration and proliferation (Fayard et al., 2010; Burghardt et al., 2018). Dysfunction in this 
pathway has been linked to numerous diseases including cancer, diabetes mellitus as well as 
pregnancy complications like preeclampsia (Burghardt et al., 2018; Ferreira et al., 2011)  
The regulation of apoptosis by either PKB or MAPKs is very complex and still under debate. 
In this chapter, investigating the effects of flavonoids, their metabolites alone or combination 
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prior to H/R insult on caspase-3 and -7 activation, MAPKs and protein kinase B activation 
was important to further understand flavonoid-mediated cytoprotection. 
5.1 Results 
In this chapter, the pro-apoptotic effects of H/R-induced oxidative stress and anti-apoptotic 
effects of 24 h pre-treatment with the indicated flavonoids, their metabolites alone or in 
combinations was investigated using Caspase-Glo® 3/7 assay and MAPK activation status 
via western blot.  
5.1.1 The modulation of flavonoids on caspase 3/7 
The data from the Caspase-Glo® assay as shown in figure 5.1 (A-D) indicates that H/R insult 
activates caspase -3 and -7. Furthermore 24 h pre-treatment with flavonoids (quercetin, 
morin, naringin or hesperidin) prior to H/R insult significantly reduced the H/R-induced 
activity of caspase -3/-7 in HTR-8/SVneo cells suggesting that flavonoids pre-treatment 
attenuates the activation of caspases.  
 
Figure 5.1: Modulation by flavonoids of caspase 3/7 activation in response to HR-
induced oxidative stress. 
HTR-8/SVneo cells were treated with the indicated flavonoids at 3 µM for 24 h prior to HR-
induced oxidative stress. Caspase 3/7 activation was measured using Caspase-Glo® Assay 
(A-D). Statistical analysis was carried out using one-way ANOVA (Dunnett’s multiple 
comparisons test against HR). Data are expressed as relative luminescence units and 
represent the mean ± SEM of at least three independent experiments. *P<0.05, ***P<0.001 
and ****P<0.0001 versus HR. 
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Comparable data were achieved from their respective metabolites (Q3G, naringenin or 
hesperetin). As seen in figure 5.2 (A-C), there was a significant reduction in the caspase -3/-
7 activity from cells pre-treated with Q3G, naringenin or hesperetin (24 h) prior to H/R 
insult.  
 
Figure 5.2: Effect of flavonoid metabolites on caspase 3/7 activation in response HR-
induced oxidative stress. 
HTR-8/SVneo cells were treated with the indicated metabolites at 1 µM for 24 h prior to 
HR-induced oxidative stress. Caspase 3/7 activation was measured using Caspase-Glo® 
Assay (A-C). Statistical analysis was carried out using one-way ANOVA (Dunnett’s 
multiple comparisons test against HR). Data are expressed as relative luminescence units 
and represent the mean ± SEM of at least three independent experiments. *P<0.05, 
**P<0.01, ***P<0.001 and ****P<0.0001 versus HR. 
 
 
Further investigation was carried out to study the effects of flavonoid-metabolite and 
flavonoid combinations on apoptosis (caspase 3/7). As seen in figure 5.3 (A-D) and 5.4 (A-
C), there was a significant reduction in H/R-induced caspase (3/7) activity in cells pre-treated 
with either flavonoid-metabolite (quercetin/Q3G, morin/Q3G, naringin/naringenin or 
hesperidin/hesperetin) or flavonoid combinations (quercetin/morin, quercetin/naringin or 
quercetin/hesperidin).  
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Figure 5.3: Effect of flavonoid-metabolite combinations on caspase 3/7 activation in 
response HR-induced oxidative stress. 
HTR-8/SVneo cells were treated with the indicated flavonoids at 3 µM and metabolites at 1 
µM for 24 h prior to HR-induced oxidative stress. Caspase 3/7 activation was measured 
using Caspase-Glo® Assay (A-D). Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test against HR). Data are expressed as relative 
luminescence units and represent the mean ± SEM of at least three independent experiments. 
**P<0.01, ***P<0.001 and ****P<0.0001 versus HR. 
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Figure 5.4: Effect of flavonoid combinations on caspase 3/7 activation in response HR-
induced oxidative stress. 
HTR-8/SVneo cells were treated with the indicated combination of flavonoids at 3 µM 
(individually) for 24 h prior to HR-induced oxidative stress. Caspase 3/7 activation was 
measured using Caspase-Glo® Assay (A-C). Statistical analysis was carried out using one-
way ANOVA (Dunnett’s multiple comparisons test against HR). Data are expressed as 
relative luminescence units and represent the mean ± SEM of at least three independent 
experiments. ***P<0.001 and ****P<0.0001 versus HR. 
 
5.1.2 Involvement of protein kinases in flavonoid-mediated cytoprotection 
As previously observed in chapter 4, 24 h pre-treatment with 3 µM of flavonoids and 1 µM 
of metabolites or in combinations was able to induce significant cytoprotection in HTR-
8/SVneo against HR-induced oxidative stress. Here the intracellular mechanism of the 
cytoprotective effect was investigated using western blot analysis to assess involvement of 
total and phosphorylated protein kinases associated with cell survival and death; PKB/AKT, 
ERK1/2, SAPK/JNK and p38 MAPK were investigated. As seen in figures 5.4-8, H/R insult 
consistently induced significant activation of PKB, ERK1/2, SAPK/JNK and p38 MAPK in 
HTR-8/SVneo cells. Furthermore, the data from figure 5.5-5.8 (A-D) showed that 24 h pre-
treatment with quercetin, morin, naringin and hesperidin inhibited HR-induced activation of 
PKB, ERK/1/2, p38 MAPK and JNK.  
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Figure 5.5: Effect of quercetin on HR-induced protein kinase activation 
HTR-8/SVneo cells were treated with the 3 µM quercetin for 24 h prior to HR-induced 
oxidative stress. Cells were then lysed and western blotting was performed using specific 
antibodies (phosphorylated and total). (A) effects of quercetin on HR-induced activation of 
PKB, (B) effects of quercetin on HR-induced activation of ERK1/2, (C) effects of quercetin 
on HR-induced activation of P38 MAPK and (D) effects of quercetin on HR-induced 
activation of SAPK/JNK.  Statistical analysis was carried out using one-way ANOVA 
(Dunnett’s multiple comparisons test). Data are expressed as percentage of control and 
represent the mean ± SEM of at least three independent experiments. **P<0.01 and 
****P<0.0001 versus control untreated. 
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Figure 5.6: Effect of morin on HR-induced protein kinase activation. 
HTR-8/SVneo cells were treated with or without 3 µM of morin for 24 h prior to HR-induced 
oxidative stress exposure. Cells were then lysed and western blotting was performed using 
specific antibodies (phosphorylated and total). (A) effects of morin on HR-induced 
activation of PKB, (B) effects of morin on HR-induced activation of ERK1/2, (C) effects of 
morin on HR-induced activation of P38 MAPK and (D) effects of morin on HR-induced 
activation of SAPK/JNK. Statistical analysis was carried out using one-way ANOVA 
(Dunnett’s multiple comparisons test). Data are expressed as percentage of control and 
represent the mean ± SEM of at least three independent experiments. ***P<0.001 and 
****P<0.0001 versus control untreated. 
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Figure 5.7: Effect of naringin on HR-induced protein kinase activation. 
HTR-8/SVneo cells were treated with or without 3 µM of naringin for 24 h prior to HR-
induced oxidative stress exposure. Cells were then lysed and western blotting was performed 
using specific antibodies (phosphorylated and total). (A) effects of naringin on HR-induced 
activation of PKB, (B) effects of naringin on HR-induced activation of ERK1/2, (C) effects 
of naringin on HR-induced activation of P38 MAPK and (D) effects of naringin on HR-
induced activation of SAPK/JNK. Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test). Data are expressed as percentage of control 
and represent the mean ± SEM of at least three independent experiments. *P<0.05, 
***P<0.001 and ****P<0.0001 versus control untreated. 
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Figure 5.8: Effect of hesperidin on HR-induced protein kinase activation. 
HTR-8/SVneo cells were treated with or without 3 µM of hesperidin for 24 h prior to HR-
induced oxidative stress exposure. Cells were then lysed and western blotting was performed 
using specific antibodies (phosphorylated and total). (A) effects of naringin on HR-induced 
activation of PKB, (B) effects of naringin on HR-induced activation of ERK1/2, (C) effects 
of naringin on HR-induced activation of p38 MAPK and (D) effects of naringin on HR-
induced activation of SAPK/JNK. Statistical analysis was carried out using one-way 
ANOVA (Dunnett’s multiple comparisons test). Data are expressed as percentage of control 
and represent the mean ± SEM of at least three independent experiments. ***P<0.001 and 
****P<0.0001 versus control untreated. 
 
Similar sets of data were obtained from their respective metabolites, as seen in figures 5.9 - 
5.11 (A-D respectively). Cells pre-treated with Q3G, naringenin and hesperetin fully 
inhibited HR-induced PKB, ERK1/2, p38 MAPK and JNK activation. Comparing the pre-
treated (Q3G, naringenin and hesperetin) with untreated control showed that there was not 
significant difference in protein kinase activation as shown in figure 5.9 – 11. 
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Figure 5.9: Effect of Q3G on HR-induced protein kinase activation. 
HTR-8/SVneo cells were treated with or without 1 µM of Q3G for 24 h prior to HR-induced 
oxidative stress exposure. Cells were then lysed and western blotting was performed using 
specific antibodies (phosphorylated and total). (A) effects of Q3G on HR-induced activation 
of PKB, (B) effects of Q3G on HR-induced activation of ERK1/2, (C) effects of Q3G on 
HR-induced activation of p38 MAPK and (D) effects of Q3G on HR-induced activation of 
SAPK/JNK. Statistical analysis was carried out using one-way ANOVA (Dunnett’s multiple 
comparisons test). Data are expressed as percentage of control and represent the mean ± 
SEM of at least three independent experiments. ***P<0.001 and ****P<0.0001 versus 
control untreated. 
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Figure 5.10: Effect of naringenin on HR-induced protein kinase activation. 
HTR-8/SVneo cells were treated with or without 1 µM of naringenin for 24 h prior to HR-
induced oxidative stress exposure. Cells were then lysed and western blotting was performed 
using specific antibodies (phosphorylated and total). (A) effects of naringenin on HR-
induced activation of PKB, (B) effects of naringenin on HR-induced activation of ERK1/2, 
(C) effects of naringenin on HR-induced activation of p38 MAPK and (D) effects of 
naringenin on HR-induced activation of SAPK/JNK. Statistical analysis was carried out 
using one-way ANOVA (Dunnett’s multiple comparisons test). Data are expressed as 
percentage of control and represent the mean ± SEM of at least three independent 
experiments. ***P<0.001 and ****P<0.0001 versus control untreated. 
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Figure 5.11: Effect of hesperetin on HR-induced protein kinase activation. 
HTR-8/SVneo cells were treated with or without 1 µM of hesperetin for 24 h prior to HR-
induced oxidative stress exposure. Cells were then lysed and western blotting was performed 
using specific antibodies (phosphorylated and total). (A) effects of hesperetin on HR-
induced activation of PKB, (B) effects of hesperetin on HR-induced activation of ERK1/2, 
(C) effects of hesperetin on HR-induced activation of p38 MAPK and (D) effects of 
hesperetin on HR-induced activation of SAPK/JNK. Statistical analysis was carried out 
using one-way ANOVA (Dunnett’s multiple comparisons test). Data are expressed as 
percentage of control and represent the mean ± SEM of at least three independent 
experiments. ***P<0.001 and ****P<0.0001 versus control untreated. 
 
Further investigation was carried out to monitor the effect of pre-treatment with either 
flavonoid combinations or flavonoid-metabolite combinations on HR-induced protein kinase 
activation. As seen from the data in figure 5.12 – 5.18 (A-D respectively), flavonoid-
metabolite combinations (quercetin/Q3G, morin/Q3G, naringin/naringenin or 
hesperidin/hesperetin) or flavonoid combinations (quercetin/morin, quercetin/naringin or 
quercetin/hesperidin) significantly inhibited HR-induced protein kinase activation. 
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Figure 5.12: Effects of quercetin and Q3G combination on HR-induced protein kinase 
activation. 
HTR-8/SVneo cells were treated with or without 3 µM quercetin and 1 µM Q3G 
combination for 24 h prior to HR-induced oxidative stress exposure. Cells were then lysed 
and western blotting was performed using specific antibodies (phosphorylated and total). 
(A) effects of quercetin and Q3G combination on HR-induced activation of PKB, (B) effects 
of quercetin and Q3G combination on HR-induced activation of ERK1/2, (C) effects of 
quercetin and Q3G combination on HR-induced activation of p38 MAPK and (D) effects of 
quercetin and Q3G combination on HR-induced activation of SAPK/JNK. Statistical 
analysis was carried out using one-way ANOVA (Dunnett’s multiple comparisons test). 
Data are expressed as percentage of control and represent the mean ± SEM of at least three 
independent experiments. ****P<0.0001 versus control untreated. 
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Figure 5.13: Effects of morin and Q3G combination on HR-induced protein kinase 
activation. 
HTR-8/SVneo cells were treated with or without 3 µM morin and 1 µM Q3G combination 
for 24 h prior to HR-induced oxidative stress exposure. Cells were then lysed and western 
blotting was performed using specific antibodies (phosphorylated and total). (A) effects of 
morin and Q3G combination on HR-induced activation of PKB, (B) effects of morin and 
Q3G combination on HR-induced activation of ERK1/2, (C) effects of morin and Q3G 
combination on HR-induced activation of p38 MAPK and (D) effects of morin and Q3G 
combination on HR-induced activation of SAPK/JNK. Statistical analysis was carried out 
using one-way ANOVA (Dunnett’s multiple comparisons test). Data are expressed as 
percentage of control and represent the mean ± SEM of at least three independent 
experiments. ****P<0.0001 versus control untreated.  
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Figure 5.14: Effects of naringin and naringenin combination on HR-induced protein 
kinase activation. 
HTR-8/SVneo cells were treated with or without 3 µM naringin and 1 µM naringenin 
combination for 24 h prior to HR-induced oxidative stress exposure. Cells were then lysed 
and western blotting was performed using specific antibodies (phosphorylated and total). 
(A) effects of naringin and naringenin combination on HR-induced activation of PKB, (B) 
effects of naringin and naringenin combination on HR-induced activation of ERK1/2, (C) 
effects of naringin and naringenin combination on HR-induced activation of p38 MAPK and 
(D) effects of naringin and naringenin combination on HR-induced activation of SAPK/JNK. 
Statistical analysis was carried out using one-way ANOVA (Dunnett’s multiple comparisons 
test). Data are expressed as percentage of control and represent the mean ± SEM of at least 
three independent experiments. ***P<0.001 and ****P<0.0001 versus control untreated. 
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Figure 5.15: Effects of hesperidin and hesperetin combination on HR-induced protein 
kinase activation. 
HTR-8/SVneo cells were treated with or without 3 µM hesperidin and 1 µM hesperetin 
combination for 24 h prior to HR-induced oxidative stress exposure. Cells were then lysed 
and western blotting was performed using specific antibodies (phosphorylated and total). 
(A) effects of hesperidin and hesperetin combination on HR-induced activation of PKB, (B) 
effects of hesperidin and hesperetin combination on HR-induced activation of ERK1/2, (C) 
effects of hesperidin and hesperetin combination on HR-induced activation of p38 MAPK 
and (D) effects of hesperidin and hesperetin combination on HR-induced activation of 
SAPK/JNK. Statistical analysis was carried out using one-way ANOVA (Dunnett’s multiple 
comparisons test). Data are expressed as percentage of control and represent the mean ± 
SEM of at least three independent experiments. *P<0.05, **P<0.01, ***P<0.001 and 
****P<0.0001 versus control untreated.  
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Figure 5.16: Effect of quercetin and morin combination on HR-induced protein kinase 
activation. 
HTR-8/SVneo cells were treated with or without 3 µM of quercetin and 3 µM of morin 
combination for 24 h prior to HR-induced oxidative stress exposure. Cells were then lysed 
and western blotting was performed using specific antibodies (phosphorylated and total). 
(A) effects of quercetin and morin combination on HR-induced activation of PKB, (B) 
effects of quercetin and morin combination on HR-induced activation of ERK1/2, (C) effects 
of quercetin and morin combination on HR-induced activation of p38 MAPK and (D) effects 
of quercetin and morin combination on HR-induced activation of SAPK/JNK. Statistical 
analysis was carried out using one-way ANOVA (Dunnett’s multiple comparisons test). 
Data are expressed as percentage of control and represent the mean ± SEM of at least three 
independent experiments. ****P<0.0001 versus control untreated. 
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Figure 5.17: Effect of quercetin and naringin combination on HR-induced protein 
kinase activation. 
HTR-8/SVneo cells were treated with or without 3 µM of quercetin and 3 µM of naringin 
combination for 24 h prior to HR-induced oxidative stress exposure. Cells were then lysed 
and western blotting was performed using specific antibodies (phosphorylated and total). 
(A) effects of quercetin and naringin combination on HR-induced activation of PKB, (B) 
effects of quercetin and naringin combination on HR-induced activation of ERK1/2, (C) 
effects of quercetin and naringin combination on HR-induced activation of p38 MAPK and 
(D) effects of quercetin and naringin combination on HR-induced activation of SAPK/JNK. 
Statistical analysis was carried out using one-way ANOVA (Dunnett’s multiple comparisons 
test). Data are expressed as percentage of control and represent the mean ± SEM of at least 
three independent experiments. ***P<0.001 and ****P<0.0001 versus control untreated. 
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Figure 5.18: Effect of quercetin and hesperidin combination on HR-induced protein 
kinase activation. 
HTR-8/SVneo cells were treated with or without 3 µM of quercetin and 3 µM of hesperidin 
combined for 24 h prior to HR-induced oxidative stress exposure. Cells were then lysed and 
western blotting was performed using specific antibodies (phosphorylated and total). (A) 
effects of quercetin and hesperidin combination on HR-induced activation of PKB, (B) 
effects of quercetin and hesperidin combination on HR-induced activation of ERK1/2, (C) 
effects of quercetin and hesperidin combination on HR-induced activation of P38 MAPK 
and (D) effects of quercetin and hesperidin combination on HR-induced activation of 
SAPK/JNK. Statistical analysis was carried out using one-way ANOVA (Dunnett’s multiple 
comparisons test). Data are expressed as percentage of control and represent the mean ± 
SEM of at least three independent experiments. *P<0.05, ***P<0.001 and ****P<0.0001 
versus control untreated. 
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5.2 Results Summary 
The flavonoids quercetin, morin, naringin and hesperidin significantly reduced caspase -3/-
7 activity during HR-induced oxidative stress. The data also revealed that H/R insult induces 
apoptosis as seen from the caspase 3/7 assay. Similarly, their respective metabolites (Q3G, 
naringenin, hesperetin), and their combinations (flavonoid-metabolite/flavonoids) 
significantly reduced the activity of caspase -3/-7. In addition, flavonoid-
metabolite/flavonoids combinations showed very significant reductions in caspase -3/-7 
activity compared to single flavonoid treatment. The cytoprotective effects of pre-treatment 
with flavonoids, their metabolites or combinations is likely to be associated with an 
inhibitory effect on HR-induced protein kinase activation as shown in figure 5.5 – 5.18 (A-
D), which may suggest that this is a potential cytoprotective mechanism. 
5.3 Discussion  
The aim of this chapter was to investigate the effect of 24 h pre-treated cells on HR-induced 
oxidative stress apoptosis (caspase 3/7) and total/phosphorylated protein kinases 
(PKT/AKT, ERK1/2, SAPK/JNK and p38 MAPK) in HTR-8/SVneo as a potential 
mechanism for flavonoid-mediated cytoprotection. 
5.3.1 Flavonoid modulation of apoptosis 
The data from Caspase-Glo® 3/7 assays revealed that HR-induced oxidative significantly 
increased the activity of executioner caspases (3/7) in HTR-8/SVneo cells. These data are in 
agreement with several studies that showed that oxidative stress induces apoptosis; for 
example, in non-trophoblast cell origin such as H2O2-induced caspase activation in human 
epithelial RPE cell in vitro, human melanoma M14 cell line (Kook et al., 2008; Clément et 
al., 1998). With Respect to trophoblast cell origin, H/R- and H2O2-induced oxidative stress 
significantly activated caspases in HTR-8/SVneo, BEWO, JEG-3 cells (the latter two are 
originated from choriocarcinoma) (Kilburn, 2000; Hung et al., 2002; Leach et al., 2008; 
Aouache et al., 2018). Pre-treatment (24 h) with either flavonoids, their metabolites or 
combinations significantly reduced HR-induced caspase 3/7 activation in HTR-8/SVneo 
cells. Although the effects of flavonoids or their metabolites on trophoblast cells have not 
been explored before, studies have revealed that they are potent inhibitors of caspase during 
oxidative stress in non-trophoblast cells. For example; quercetin significantly reduced the 
activation of caspase -3 in RPE cells exposed to H2O2-induced oxidative stress (Kook et al., 
2008). Morin was found to attenuate H2O2-induced apoptosis in hamster lung V79-4 
fibroblasts cells and significantly reduce caspase -3 activity in rat primary cells exposed to  
high glucose-induced oxidative stress which mimics diabetes mellitus (Lee et al., 2017; 
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Kapoor and Kakkar, 2012). Furthermore, naringin was found to significantly attenuate 
apoptosis in mouse leukaemia P388 cells from H2O2-induced cell death as well as 
significantly reducing caspase -3 activity in human neuroblastoma SH-SY5Y cells following  
rotenone-induced cell death (Kim et al., 2009; Kanno et al., 2003). Hesperidin significantly 
downregulated the expression of caspase -3 in human keratinocyte (HaCaT) cell line during 
ultraviolet B-induced cell apoptosis (Hewage et al., 2016). Hesperidin was also found to 
effectively ameliorate RPE (ARPE-19) cell line from high glucose-induced damages by 
reducing the activity of caspase 3/9 (Liu et al., 2018). In addition, their respective 
metabolites have also been found to reduce apoptosis during oxidative stress by 
downregulating the expression of executioner caspases such as -3, -7 and -9 (Kapoor et al., 
2013; Han et al., 2008; Bai et al., 2017). Apoptosis is important in the maintenance of tissue 
homeostasis by equilibrating the balance between cell survival and death, and therefore must 
be tightly regulated. During gestation, unregulated apoptosis resulting from increased 
oxidative stress leads to trophoblast death. Trophoblast death leads to poor placentation and 
shallow trophoblast invasion, resulting in incomplete maternal spiral arteries remodelling, 
which eventually results in pregnancy complications such as spontaneous pregnancy loss, 
intrauterine growth restriction (IUGR), gestational diabetes mellitus, and preeclampsia 
(Aouache et al., 2018). 
5.3.2 Effect of flavonoids on HR-induced phosphorylation of protein kinases 
Protein kinase activation is a key decider of cell fate by either mediating cell survival or 
death. Herein, the data obtained indicated that HR-induced oxidative stress activated all four 
phosphorylated protein kinases. These findings agreed with others that reported oxidative 
stress-induced phosphorylation of protein kinase activation in vitro. It has also been reported 
that H2O2 induced phosphorylation of protein kinase (PKB, ERK1/2, SAPK/JNK and p38 
MAPK) in cardiomyocyte (H9c2) cells and epithelial tight junction (ECV304) cells 
(Daubney et al., 2015; Chuenkitiyanon et al., 2010). In this present study, the introduction 
(24 h pre-treatment) of flavonoids, their metabolites alone or in combinations significantly 
inhibited HR-induced protein kinase activation (PKB, ERK1/2, SAPK/JNK and p38 
MAPK). Pre-treatment of cells (24 h) with flavonoids/metabolites alone or combination had 
no effects on the levels of phosphorylated forms of PKB, ERK1/2, SAPK/JNK and p38 
MAPK in the absence of H/R. However, pre-treatment (24 h) prior to HR-induced oxidative 
stress significantly inhibited the HR-induced phosphorylation of PKB, ERK1/2, SAPK/JNK 
and p38 MAPK. Herein, the data indicated that pre-treated cells showed significant anti-
apoptotic (SAPK/JNK and p38 MAPK inhibition) effect against HR-induce oxidative stress. 
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In other studies, naringin was concluded to significantly inhibit SAPK/JNK and p38 MAPK 
activation against rotenone-induce apoptosis in human SH-SY5Y cells (Kim et al., 2009).  
Morin was found to significantly inhibit the phosphorylation of p38 MAPK against t-BHP 
induced ROS generation in YPEN-1 cells (Kim et al., 2010). In addition, quercetin 
successfully inhibited the activation of phosphorylated p38 MAPK in ECV304 cells against 
H2O2-induce protein kinase activation whilst hesperidin significantly inhibited the 
activation of phosphorylated p38 MAPK and JNK against high glucose-induced protein 
kinase activation in retinal ganglion (RGC-5) cells (Chuenkitiyanon et al., 2010; Chen et al., 
2010). It is known that the anti-oxidative properties of flavonoids are capable of preventing 
MAPK activation under oxidative state as seen in these previous studies. This present study 
supports the protective role of flavonoids, their metabolites alone or combinations in HTR-
8/SVneo cells exposed to H/R insult via the inhibition of phosphorylation of p38 MAPK and 
SAPK/JNK activation.  
Exploring the role of pro-survival/anti-apoptotic protein kinases (ERK1/2 and PKB), 
flavonoids, their metabolites or combinations also inhibited their activation against HR-
induced activation. ERK1/2 and PKB activation is generally considered to be pro-survival 
but under certain circumstances, they can have pro-apoptotic functions (Lu and Xu, 2006; 
Song et al., 2008). Traditionally, the ERK1/2 signalling cascade consists of Ras-Raf family 
members followed by MEK1/2 activation. PKB activation is mediated via PI3K as described 
earlier (Lu and Xu, 2006; Lee et al., 2003; Martindale and Holbrook, 2002). The activation 
of ERK1/2 have been suggested to inhibit apoptosis in response to several stimuli, however, 
their activation in response to cellular DNA damage fosters apoptosis by increasing the 
activity of some pro-apoptotic signalling molecules such as BAX, cytochrome c release, 
caspase 3 activation, and p53 transcriptional factors (Lu and Xu, 2006).  
Activation of PKB in an important mediator of cell survival in response to growth factor 
withdrawal, disturbance in cell cycle and extracellular matrix detachment but there have 
been controversies over the role of their activation under other conditions of stress 
(Martindale and Holbrook, 2002). Other studies have shown oxidative stress-mediated 
activation of  ERK1/2 and PKB whilst the introduction of flavonoids or their metabolites 
significantly inhibited this activation to promote cell survival (Kim et al., 2010). This 
inhibition during oxidative stress is likely to be induced through a pathway independent of 
MEK1 and PI3K inhibition. However, how these protein kinases promote apoptosis is still 
unclear. The intricate balance between cell survival and cell death pathways is an important 
determinant of cell fate, 24 h pre-treatment with flavonoids, their metabolites or in 
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combination have shown to balance HTR-8/SVneo cell fate during HR-induced oxidative 
stress. 
5.4 Conclusions 
To conclude this chapter, 24 h pre-treatment with either flavonoids, their metabolites alone 
or in combination significantly reduced HR-induced apoptosis in HTR-8/SVneo cells by 
reducing the activation of caspases (3/7) resulting in trophoblast cell survival and potentially 
preventing poor placentation. This cytoprotective effect of 24 h pre-treatment of cells with 
flavonoids were also associated with their ability to significantly inhibit the HR-induced 
protein kinase phosphorylation (PKB, ERK, JNK and p38 MAPK), thereby deciding cell 
fate (pro-survival). 
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6.0 Introduction 
As previously described in chapter 1, immediately after implantation, the trophoblast cell 
layers of the blastocysts proliferate into the two pathways, namely; extravillous (highly 
invasive/less migratory) and villous (non-invasive/migratory) trophoblast cells (Gude et al., 
2004). It is the former extra-villous trophoblast cells that invade the maternal spiral arteries 
and are responsible for the physiological conversion of these arteries into a high flow system. 
This is the key to a successful human pregnancy (Burton et al., 2009; Burton et al., 2010).  
Proper implantation and placental development/function are crucial to the well-being of the 
mother and foetus during gestation. However, defects in these processes (maternal-foetal 
interface) especially the poor invasion leading to insufficient spiral artery remodelling can 
lead to foetal growth restriction, preeclampsia, foetal/maternal death, maternal/foetal 
immune disturbance, and miscarriage (Pereira et al., 2015; Yu qi Li et al., 2017). Thus, 
insufficient invasion and incomplete spiral artery remodelling have been associated with 
placental oxidative stress that results from overproduction of free radicals (ROS) as a result 
of a prolonged hypoxic environment, hypoxia/reoxygenation. This prolonged hypoxic insult 
is usually aggravated in conditions such as maternal obesity and smoking (Whitley and 
Cartwright, 2010; Yu qi Li et al., 2017; Pereira et al., 2015). Therefore, investigating the 
anti-oxidative effects of dietary flavonoids, their respective metabolites or combinations 
during trophoblast cell (HTR-8/SVneo cells as an in vitro model of extravillous trophoblast) 
invasion under H/R insult is crucial to this study. 
Another unique feature of the placenta is that it comprises of cytotrophoblast stem cells, 
which are attached to the basement membrane of the trophoblast cells. These cytotrophoblast 
stem cell populations are responsible for the promotion of self-renewal processes, which are 
proposed to play a vital role in the generation of intraembryonic lineage (Ferretti et al., 2007; 
Red-Horse et al., 2004). Apart from their self-renewal function, cytotrophoblast stem cells 
also play an important role during trophoblast invasion, differentiation as well as maturation 
of the maternal-foetal interface (Red-Horse et al., 2004). Although there are a limited 
number of reports assessing the generation and function of cytotrophoblast stem cells during 
oxidative stress. High levels of free radicals from ROS generation impair stem cell function 
by mediating the activation of signalling pathways that inhibit self-renewal, exhaustion of 
stem-cell population, pre-mature aging as well as defective DNA repair machinery (Schieber 
and Chandel, 2014; Cieślar-Pobuda et al., 2017).  
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6.1 Aims 
The aims of this chapter are to assess the effect of 24 h pre-treatment of HTR-8/SVneo cells 
with flavonoids, their respective metabolites alone or in combinations prior to HR-induced 
oxidative stress on the ability of transformed first trimester trophoblast cell line HTR-
8/SVneo to: 
a) invade through Basement Membrane Extract (BME) (in vitro 2D invasion) and  
b) generate spheroidal stem-like cells under normoxic and hypoxic conditions.   
Experiments also compared the ability of these self-assembling spheroidal stem-like cells to 
invade a 3-D invasion under normoxia and hypoxia conditions and to identify whether the 
flavonoids are capable of assisting invasion under severe hypoxia. Finally, using proteomic 
analysis the potential intracellular proteins/molecules that were involved in flavonoid-
mediated cytoprotection during invasion were identified. 
6.3 Results 
In vitro invasion assay was carried out first using 2D Matrigel, followed by the optimisation 
and generation of spheroids from either flavonoid-treated or untreated HTR-8/SVneo cells 
after H/R insult. The invasive capacity of the spheroids was generated subsequently assessed 
using 3D spheroid BME. 
6.3.1 Effects of flavonoids on 2D in vitro cell invasion 
2-D invasion assay was carried out using Corning® BioCoat™ Tumour Invasion system as 
previously described in section 2.10. This investigation was performed to monitor the effects 
of HR-induced oxidative stress on HTR-8/SVneo cells with or without 24 h pre-treatment 
with the indicated flavonoids (quercetin, morin, naringin or hesperidin), their respective 
metabolites alone (Q3G, naringenin or hesperetin) or their combinations 
(flavonoid/flavonoid and metabolite/flavonoid). The number of cells invaded and migrated 
were analysed by using WimCounting (Wimasis®) and represented as either percentage 
invasion (number of cells invaded/number of cells migrated x 100) or number of cells 
invaded using GraphPad Prism statistical software. 
The data from figure 6.1 to 6.4 showed that H/R insult significantly reduced the invasive 
capacity of HTR-8/SVneo. Interestingly, it did not affect the migratory capacity of HTR-
8/SVneo cells (data given in appendix A.2 – 5). However, cells pre-treated (24 h) with either 
quercetin, morin, naringin or hesperidin prior to HR-induced oxidative stress significantly 
increased the invasiveness of HTR-8/SVneo cells when compared to H/R as shown in figure 
6.1 (A-C). Comparing the migration control plate, there was no significant difference 
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between H/R and pre-treated (flavonoids) cells (see appendix A.2). This data indicates that 
HR-induced oxidative stress does not have any significant effect on migration but 
significantly decreases the invasion of HTR-8/SVneo cells. Furthermore, flavonoids do not 
enhance migration but significantly promote invasion. Similar results were achieved with or 
without migration control (B and C). 
In the case of their respective metabolites (Q3G, naringenin and hesperetin), comparable 
results were achieved from those of flavonoids. As shown in figures 6.2, pre-treatment with 
the indicated metabolites alone prior to H/R insult significantly increased the invasion of 
HTR-8/SVneo cells. Interestingly there was a significant decrease in the migration of cells 
pre-treated with naringenin and hesperetin but not Q3G when compared to H/R untreated 
cells (see appendix A.3). Further comparison of cell migration of metabolites pre-treated cell 
with control did not indicate any significant decrease in migration (see appendix A.3). Again, 
similar trends were observed in both number of cells invaded and percentage invasion with 
or without migration control (Figure 6.2B and C). 
Further investigation of the effects of the combinations of flavonoids and their respective 
metabolites (quercetin/Q3G, morin/Q3G, naringin/naringenin and hesperidin/hesperetin) 
prior to H/R insult revealed a significant increase in HTR-8/SVneo cell invasion as seen in 
figures 6.3 (A-C). Again, there was a significant decrease in the migration of cells pre-treated 
cells when compared with untreated H/R cells but not with control cells (refer to appendix 
A.4). Due to the reduced migration exhibited by the flavonoid-metabolite combination pre-
treated cells, the percentage invasion was significantly increased when compared to control 
and H/R cells (see figures 6.3C). 
In addition, 24 h pre-treatment with the combination of flavonoids (quercetin/morin, 
quercetin/naringin and quercetin/hesperidin) was also investigated. From the data shown in 
figures 6.4 (A-C), 24 h pre-treatment with these combinations significantly increased HTR-
8/SVneo cell invasion and significantly reduced cell migration. Again, the data seen in 
figures 6.4C shows a significant increase in percentage invasion when compared to H/R 
untreated and control cells as a result of reduced migration from pre-treated cells (see 
appendix A.5 for migration data). 
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Figure 6.1: Effect of flavonoids on HTR-8/SVneo cell invasion after HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with 3 µM quercetin, Morin, naringin or hesperidin for 24 h prior to HR-induced oxidative stress. Cell invasion was assessed 
using Corning® BioCoat™ tumour invasion system. (A) Representative images of cell invasion after 24 h. Images were taken from the bottom coated membrane 
using EVOS FL with objective magnification 20X (Scale bar = 200 µm. (B) Quantitative analysis of the number of cells invaded using WimCounting and 
GraphPad Prism software. (C) The percentage of invasion (number of cells invaded/number of cells migrated x 100) using WimCounting and GraphPad Prism. 
Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as number of cells invaded (B) and percentage 
of control (C) and represent the mean ± SEM of at least three independent experiments. ***P<0.001 and ****P<0.0001 (a) versus control and (b) versus HR. 
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Figure 6.2: Effect of metabolites on HTR-8/SVneo cell invasion after HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with 1 µM Q3G, naringenin or hesperetin for 24 h before exposure to HR-induced oxidative stress. Cell invasion was 
assessed using Corning® BioCoat™ tumour invasion system. (A) Representative image of cell invasion after 24 h. Image were taken from the bottom coated 
membrane using EVOS FL with objective magnification 20X (Scale bar = 200 µM). (B) Quantitative analysis of the number of cells invaded using WimCounting 
and GraphPad Prism software. (C) The percentage of invasion (number of cells invaded/number of cells migrated x 100) using WimCounting and GraphPad 
Prism. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as number of cells invaded (B) and 
percentage of control (C) and represent the mean ± SEM of at least three independent experiments. ****P<0.0001 (a) versus control and (b) versus HR. 
                                                             Chapter 6: The effects of flavonoids on trophoblast invasion under oxidative stress 
 
137 | P a g e  
 
                     
Figure 6.3: Combined effect of flavonoids and their respective metabolites on HTR-8/SVneo cell invasion after HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with flavonoid at 3 µM and 1 µM of metabolite combination for 24 h before exposure to HR-induced oxidative stress. Cell 
invasion was assessed using Corning® BioCoat™ tumour invasion system. (A) Representative image of cell invasion after 24 h. Image were taken from the bottom 
coated membrane using EVOS FL with objective magnification 20X (Scale bar = 200 µM). (B) Quantitative analysis of the number of cells invaded using 
WimCounting and GraphPad Prism software. (C) The percentage of invasion (number of cells invaded/number of cells migrated x 100) using WimCounting and 
Graphpad. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as number of cells invaded (B) 
and percentage of control (C) and represent the mean ± SEM of at least three independent experiments. *P<0.05 and ****P<0.0001, (a) versus control and (b) 
versus HR. 
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Figure 6.4: Effect of flavonoid combinations on HTR-8/SVneo cell invasion after HR-induced oxidative stress. 
HTR-8/SVneo cells were pre-treated with flavonoids (3 µM) for 24 h prior to HR-induced oxidative stress exposure. Cell invasion was assessed using Corning® 
BioCoat™ tumour invasion system. (A) Representative image of cell invasion after 24 h. Image were taken from the bottom coated membrane using EVOS FL 
with objective magnification 20X (Scale bar = 200 µM). (B) Quantitative analysis of the number of cells invaded using WimCounting and GraphPad Prism 
software. (C) The percentage of invasion (number of cells invaded/number of cells migrated x 100) using WimCounting and Graphpad. Statistical analysis was 
carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as number of cells invaded (B) and percentage of control (C), and 
represent the mean ± SEM of at least three independent experiments. **P<0.01 and ****P<0.0001, (a) versus control and (b) versus HR.
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6.3.2 Effects of flavonoids on spheroid formation 
As previously described in the introduction of this chapter, high levels of ROS impair stem 
cell function. It has also been established that HTR-8/SVneo cells have the ability to generate 
spheroidal stem cells under normal conditions (Balahmar et al., 2018). Herein, the effects of 
H/R insult on the ability of HTR-8/SVneo cells to generate spheroidal stem cells with or 
without the treatment of flavonoids, their metabolites or in combinations was investigated. 
The data from figure 6.15 (A, B) showed that 24 h pre-treatment with quercetin prior to HR-
induced oxidative stress enhances the generation of spheroidal stem cells. Also, H/R on 
untreated cells showed impairment of spheroid formation. Similar results were obtained after 
24 h pre-treatment with Q3G, quercetin/Q3G and quercetin/morin (see appendix A.6 – 8). 
 
Figure 6.5: The effect of quercetin on HR-induced oxidative stress on the generation 
of spheroidal stem cells in HTR-8/SVneo cells. 
HTR-8/SVneo cells were treated with or without quercetin (3 µM) prior to HR-induced 
oxidative stress exposure. Images were taken using Nikon Eclipse TS100 microscopy 
attached with Nikon DS-Fi2 camera. Objective magnification (A) 4X and (B) 10X. 
 
This experiment was carried out in a T75 ultra low attachment flask (Corning®, UK) and 
quantification was not possible. Therefore, soft-agar colony formation assay (3-D invasion) 
was carried out to quantify the size and growth area of the spheroids.  Again, quercetin, Q3G, 
quercetin/Q3G and quercetin/morin were used as representative treatments for this study. 
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The data shown in figures 6.6 (A, B) indicates that HTR-8/SVneo cells pre-treated with 
flavonoid prior to H/R insult were able to successfully generate spheroidal stem cells when 
compared to H/R untreated cells. Pre-treated cells produced almost the same size and growth 
area of spheroids as seen in the control and there was not a significant difference between 
pre-treated cells and contreol. However, there was significant decrease in the size and growth 
area of H/R untreated spheroid cells when compared to both control and pre-treated cells. 
These data suggest that flavonoids help to protect and restore trophoblast stem cell integrity. 
Investigating their invasive capacity is very important to study as shallow invasion can lead 
to pregnancy complications as described previously.
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Figure 6.6: The effect of selected flavonoids on the formation of spheroidal stem cells after HR-induced oxidative stress. 
HTR-8/SVeno cells were pre-treated with or without flavonoids for 24 h prior to HR-induced oxidative stress exposure. Cells were cultured in cultured in T75 to 
about 80-90% confluency, cells were harvested by trypsinization, counted and a single cell suspension of 5 x 103 cells/well (6 well plate) was seeded in the 1% 
agar and 0.7% agarose mixture as described in section 2.12. (A) Representative image taken after 15 days using Nikon Eclipse TS100 microscopy attached with 
Nikon DS-Fi2 camera with objective magnification 20X. (B) Quantitative analysis of growth area of the spheroids using WimColony and GraphPad Prism 
software. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as area of cell growth (µm) and 
represent the mean ± SEM of at least three independent experiments. ***P<0.001 and ****P<0.0001, (a) versus control and (b) versus HR. 
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6.3.3 Effects of flavonoids on spheroidal stem cell invasion (3D invasion) 
In this section, the invasiveness of spheroids generated from HTR-8/SVneo cells with or 
without pre-treatment with flavonoids/metabolites prior to HR-induced oxidative stress was 
investigated. The duration of this experiment was increased to 72 h due to some limitations 
encountered and discussed in Chapter 7. It was observed that not only does H/R insult affect 
the formation of spheroids but also significantly inhibited their invasiveness as shown in 
figures 6.7. As expected, cells pre-treated with flavonoids (quercetin, morin, naringin and 
hesperidin) prior to H/R insult significantly enhanced the invasive capacity of HTR-8/SVneo 
cells (figures 6.7). Comparing pre-treated cells to control there was no significant difference 
in the invasiveness of spheroidal stem cells. Comparable results were observed with their 
respective metabolites (Q3G, naringenin and hesperetin). The data shown in figures 6.8 
indicate that pre-treatment with metabolites alone significantly increased the invasion of 
HTR-8/SVneo cells when compared to H/R untreated. Again, there was no significant 
difference in metabolite pre-treated cells and control cells.
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Figure 6.7: Flavonoids enhances spheroid invasion after HR-induced oxidative stress in HTR-8/SVneo cells. 
HTR-8/SVneo cells were pre-treated with or without the quercetin, morin, naringin or hesperidin (3 µM) for 24 h before exposure to HR-induced oxidative stress. 
Single cell suspension was seeded at 3 x 103 cells/well in a 96 well 3D spheroid BME invasion plate (A) representative image taken at 0 h, just after adding the 
spheroid invasion matrix. Image was taken using confocal microscopy with objective magnification 10X. (B) Quantitative analysis of invasion area of the 
spheroids using ImageJ and GraphPad Prism software. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data are 
expressed as area of cell invasion (µM) and represent the mean ± SEM of at least three independent experiments. *P<0.05, **P<0.01, and ***P<0.001 (a) versus 
control and (b) versus HR. 
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Figure 6.8: Metabolites enhances spheroid invasion after HR-induced oxidative stress in HTR-8/SVneo cells. 
HTR-8/SVneo cells were pre-treated with or without the Q3G, naringenin or hesperetin (1 µM) for 24 h before exposure to HR-induced oxidative stress. Single 
cell suspension was seeded at 3 x 103 cells/well in a 96 well 3D spheroid BME invasion plate (A) representative image taken at 0 h, just after adding the spheroid 
invasion matrix. Image was taken using confocal microscopy with objective magnification 10X. (B) Quantitative analysis of invasion area of the spheroids using 
ImageJ and GraphPad Prism software. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as 
area of cell invasion (µM) and represent the mean ± SEM of at least three independent experiments. *P<0.05, and **P<0.01, (a) versus control and (b) versus 
HR.
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6.4 Result Summary 
HR-induced oxidative stress significantly reduces the invasiveness of HTR-8/SVneo cells as seen in the 2D 
invasion assay. However, pre-treatment with flavonoids, their metabolites or combinations 24 h prior to H/R 
insult significantly increased the invasive capability of this cell line. Further investigations indicated that H/R 
has the potential to significantly inhibit the formation of spheroidal stem-like cells from HTR-8SVneo parent 
cells. Cells pre-treated with flavonoids prior to H/R insult showed statistically significant increase in formation 
size and growth area when compared to H/R untreated cells. The invasive potential of these spheroids was 
investigated using 3D invasion techniques.  Finally, these studies revealed that not only does H/R insult 
significantly inhibit the formation of spheroids, it also significantly reduces their invasiveness. In contrast, 
flavonoid pre-treatment significantly increased the invasiveness of these spheroids.  
6.5 Discussion 
The aim of this chapter was to investigate the effects of 24 h pre-treatment with selected flavonoids, their 
metabolites alone or in combinations prior to HR-induced oxidative stress on HTR-8/SVneo invasion (2D), 
spheroid formation and invasiveness (3D) as well as identifying potential regulatory proteins via mass 
spectrometry. 
6.5.1 Effect of flavonoids on single cell invasion (2D) 
The effects of H/R insult and 24 h flavonoid pre-treated cells were compared using the Corning® BioCoat™ 
tumour invasion system. This system consists of fluoroBlok™ 96-well plates with 8 µm pores that are either 
coated (for invasion) and uncoated (for migration control) with matrigel matrix. The migration control was 
necessary as it is possible for trophoblast cells to be highly migratory but less invasive (Kilburn, 2000). The 
data seen in this chapter from the 2D invasion experiments showed that HR-induced oxidative stress 
significantly reduced the invasiveness of HTR-8/SVneo cells but did not affect their migratory capacity. This 
result was in agreement with other studies using H/R insult to assess the invasiveness of HTR-8/SVneo cells 
(Kilburn, 2000; Leach et al., 2008; Yang et al., 2014; Balahmar et al., 2018). This present study is the first 
report to show that pre-treatment with flavonoids, their metabolites alone or in combinations prior to HR-
induced oxidative stress can significantly increase the number of cells invaded as well as the percentage 
invasion of HTR-8/SVneo cells. The mechanism for the increased invasion can be attributed to flavonoids 
ability to increase proliferation and viability, increase GSH and reduced GSSG, restoring NADP/NADPH 
ratio, scavenging of H2O2, inhibiting caspases (3/7) and the inhibition of oxidative stress-induced activation 
of protein kinases during H/R insult as seen in previous chapters (3, 4 and 5).  Interestingly, there was no 
significant difference in the migration of control and H/R untreated cells. Further investigations revealed that 
flavonoids (quercetin, morin, naringin or hesperidin) or flavonoid metabolite (Q3G) alone did not significantly 
change the migratory potentials of this cell line. Surprisingly, naringenin and hesperetin (metabolites) and 
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combinations of flavonoid-metabolites/flavonoids significantly reduced the migration of HTR-8/SVneo cells 
during H/R insult. This could indicate that the indicated metabolites and combination of flavonoid/flavonoid-
metabolite increase HTR-8/SVneo cell differentiation to the invasive phenotype as the contrary is observed 
during hypoxia or H/R insult  (Kilburn, 2000). 
6.5.2 Effects of flavonoids on spheroid formation and invasion (3D) 
Since the continual proliferation, migration and invasion of trophoblast stem cells is critical during pre- or 
post-implantation for the maintenance of pregnancy, it was important to investigate how HR-induced 
oxidative stress and flavonoid pre-treatment affect trophoblast stem cell function. To achieve these aims, first 
the effect of H/R insult and flavonoid pre-treatment on the formation of spheroids was assessed. Secondly, 
further investigation into the invasiveness of these spheroids was performed. 
Spheroid formation, size and growth area was assessed using soft-agar colonies and results indicated that H/R 
insult significantly reduced the spheroidal growth area when compared to control. However, pre-treatment (24 
h) with flavonoids prior to HR-induced oxidative stress significantly increased the spheroidal growth area 
when compared to H/R untreated spheroids and there was no significant difference when compared to control. 
These data were in agreement with other studies confirming that oxidative stress significantly impairs the 
functions of stem cells by inhibiting their capacity for self-renewal and their ability to differentiate into 
multiple cell types (Tower, 2012; Cieślar-Pobuda et al., 2017). According to Tower (2012), prevention of 
oxidative stress in stem cells is important as unregulated ROS can play a lead role in the pathogenesis of 
disease. In another study conducted by Guo et al. (2010), H2O2-induced oxidative stress in mouse embryonic 
stem cells significantly reduced cell viability and proliferation, increased apoptosis, reduced number of 
spheroidal colonies, senescence and inhibited self-renewal. Hyperosmolar stress on trophoblast stem cells has 
been found to be implicated in the impairment of implantation and slow development of the placenta leading 
to reduced cell accumulation, increased apoptosis and cell cycle arrest (Liu et al., 2009). Since there are no 
studies investigating the effects of flavonoids on trophoblast stem cells, therefore comparisons were made 
with non-trophoblast stem cell origins.  
A flavonoid compound was proposed to promote mouse neuronal embryonic stem cells via the modulation of 
mitochondrial energy metabolism by peroxisome proliferator-activated receptors (Mei et al., 2016). In another 
study by Srivastava, Bankar and Roy (2013), quercetin was shown to increase proliferation and differentiation 
of mesenchymal osteoblast stem cells. Other studies have shown that antioxidants not only increase the 
proliferation and mitochondrial integrity of human mesenchymal stems but they also enhance their therapeutic 
potentials (Sara Shaban et al., 2017; Chia Jung Li et al., 2017). 
Dysfunctional trophoblast stem cell differentiation as a result of trophoblast stem cell lineage imbalance has 
been associated with gestational complications such as embryonic failure during implantation (Xie et al., 
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2014). This leads to the investigation of spheroid invasion with or without flavonoid pre-treatment prior to 
HR-induced oxidative stress. This was achieved using a 3D spheroid BME cell invasion system that provides 
an easy, quick and quantitative process for the comparison of spheroid morphological patterns and invasion 
speed. The data from this chapter revealed that not only does HR-induced oxidative stress significantly reduce 
the formation of spheroids, but they also inhibit their invasiveness. Furthermore, the data explained herein 
have shown that 24 h pre-treatment with flavonoids or their metabolites alone significantly increased spheroid 
invasion. As described previously, the differentiation of cytotrophoblasts to invasive extravillous trophoblasts 
is essential for successful remodelling of the maternal uterine spiral arteries (Harun et al., 2006). Again, this 
present study is the first study to investigate the effects of flavonoids or their metabolites on HTR-8/SVneo 
cell spheroid formation and invasion during HR-induced oxidative stress. It was established within this 
laboratory, by Balahmar et al. (2018) that HTR-8/SVneo cells have the ability to produce spheroids and these 
spheroids also possess stem cells markers such as OCT4, SOX2, NANOG1, CDX2 and NOTCH1. Limited 
studies have made it difficult to find comparable data. 
6.6 Conclusions 
According to the data from this chapter, it is clear that HR-induced oxidative stress reduces HTR-8/SVneo 
cell invasion and 24 h pre-treatment with the indicated flavonoids, their metabolites alone or in combinations 
significantly enhances trophoblast cells invasion although the mechanism behind flavonoid-enhanced 
trophoblast invasion is not fully understood. These data also revealed 24 h pre-treated cells increase the 
formation and growth area of spheroids and their invasiveness.
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7.0 Discussion 
The main aim of this study was to investigate the antioxidant effects of flavonoids on HR-
induced oxidative stress on human first trimester extravillous trophoblast cell line HTR-
8/SVneo.  This aim was achieved by (a) optimising the non-toxic concentrations of selected 
flavonoids (and their respective metabolites), (b) establishing a suitable oxidative stress 
model for HTR-8/SVneo cells to study the effects of flavonoids/metabolites and in 
combinations on the viability HTR-8/SVneo cells, and (c) investigating the potential 
mechanisms associated with flavonoid-mediated cytoprotection (role of cell survival and 
pro-apoptotic protein kinases and anti-apoptotic pathways) , and (d) establishing the link of 
flavonoid-induced cytoprotection specifically on early trophoblast invasion and spheroid 
formation with or without HR induced oxidative stress. 
7.1 Optimising the non-toxic concentration of flavonoids 
The present study started with the selection of first trimester trophoblast cell lines and 
flavonoids. Selection of flavonoids for this study was based on their chemical configurations. 
Flavonoids such as quercetin and its isomer, morin belong to the subclass of flavonol whilst 
naringin and hesperidin belong to the subclass of flavanones (Panche et al., 2016). The 
beneficiary effects of flavonoids has been linked to their structural arrangements such as the 
presence or absence of some functional groups (hydroxyl or methyl) in certain positions 
(Panche et al., 2016; Erlund, 2004; Yao et al., 2004). It was also important to select 
flavonoids of different subclasses to validate their combined effects. Especially the fact that 
craving of fruits and vegetables during early gestational period are not specific to a particular 
form or source of flavonoids (Belzer et al., 2010).  
In addition, recent evidence revealed that the bioactive active forms of flavonoids observed 
in vivo (methyl, sulphate or glucuronide) differs from those found in fruits and vegetable 
(aglycones or glycosides) (Panche et al., 2016; Robert J. Williams et al., 2004). This 
confirms that flavonoids undergoes biotransformation after ingestion to produces secondary 
compounds known as metabolites (Erlund, 2004). Therefore, it was important for this study 
to investigative the effects of their respective metabolites (namely Q3G, naringenin and 
hesperetin). Furthermore, the effects of combination of flavonoids and their metabolites for 
the purpose of mimicking in vivo environment and assessing synergistic, addictive or 
antagonistic effects were studied. In addition, the combination of flavonoids was 
investigated as the daily intake of flavonoids, in developed countries, estimated is between 
23 – 38 mg (Erlund, 2004; Heim et al., 2002). However, during gestation, the estimated daily 
intake is expected to double as food cravings increases. In survey conducted by 
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Wijewardene, Fonseka and Goonaratne (1994), 40% of pregnant women craved for un-
ripened fruits while 30% craved for ripened fruits. In another study by Bayley et al. (2002), 
fruits and fruits juices were among the cravings of 50% of pregnant women. However, the 
relationship between food craving during gestation and dietary intake remains unresolved 
(Belzer et al., 2010). Hence, investigating the effects of combined flavonoids is crucial for 
identifying their combined effects on placental and foetal health. 
Studies have linked the beneficial effects flavonoids/metabolites to their antioxidant 
properties, which resulted in cardioprotection, anti-cancer, anti-inflammatory, and 
neuroprotection (Daubney et al., 2015; Panche et al., 2016; Mei et al., 2016). However, 
flavonoids can also have deleterious (prooxidant) effects under certain circumstances such 
as high concentrations, presence of O2 molecules and involvement of free transition metal 
ion in oxidation processes resulting in the promotion of apoptosis, formation of H2O2 via 
bactericidal activities (Eghbaliferiz and Iranshahi, 2016; Procházková and Wilhelmová, 
2011). It was imperative to establish an optimal concentration range suitable for trophoblast 
cells as this is the first study using trophoblast cell line. To achieve this goal, a concentration 
range of 1- 40 µM was selected from previous data from non-trophoblast cell lines (Daubney 
et al., 2015; Yamamoto et al., 2013; PeiMing et al., 2012). Thus, optimising the non-toxic 
concentration of flavonoids and their metabolites was carried out using MTT and CellTox™ 
green cytotoxicity assays. The results suggested concentrations from 10 µM of the indicated 
flavonoids and their metabolites alone, triggered a robust MTT reduction and increase cell 
death in both HTR-8/SVneo (and TEV-1 in preliminary studies; refer to Appendix A.9 and 
A.10) cell lines. However, concentrations 1 and 3 µM were well tolerated by both cell lines 
(as there was no inhibition of MTT reduction or cell death after 24 and 48 h treatment). 
Hence, concentration 3 µM for flavonoids and 1 µM for metabolites were used for further 
experiments.  
7.2 Establishing oxidative stress model 
Placentation/implantation process in human and its complications (such as PE) are unique, 
hence no other in vivo animal models can provide a true representation of early gestational 
period. Several experimental studies have been carried out using primary cultures and cell 
lines (Staun-Ram and Shalev, 2005). To investigate the cytoprotective effects of the non-
toxic concentrations of flavonoids on trophoblast cell line, an oxidative stress model was 
established. During placentation, the trophoblast cells are able to survive in low oxygen 
(Tuuli et al., 2011). In fact until the maternal spiral arteries conversions are complete (10 – 
12 weeks of gestation), the oxygen tension in the maternal-foetal environment is estimated 
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to be < 20 mm Hg or < 2% (Tuuli et al., 2011). In this current study, the viability HTR-
8/SVneo cells (together with TEV-1 and Sw71) increased at 0.5% and 2% oxygen for up to 
24 h as demonstrated by the MTT assay. This data can be supported by the fact that 
trophoblast development and implantation occur in a hypoxic environment. Since these cells 
are originated from first trimester extra villous early trophoblast cells, they are 
physiologically tolerant to low oxygen concentrations and therefore may be resistant to 
hypoxia-induced cytotoxicity/apoptosis (Armant et al., 2006). Rapid trophoblast growth 
during early gestation has been attributed to their response to low oxygen in the foeto-
maternal interface (Armant et al., 2006). Autocrine signalling, altered trophoblast growth 
factors, transcription factors, integrins, glycolytic enzymes and stress-related protein 
expression have all be linked as a possible mechanisms for trophoblast survival and evasion 
of apoptosis during low oxygen tension in the first trimester (Armant et al., 2006). Successful 
remodelling of the maternal spiral arteries is one of the key events leading to a successful 
pregnancy, incomplete remodelling can results variation of maternal circulation to the 
intervillous space causing an inconsistency in placental perfusion (Hung et al., 2001) (See 
chapter 1). This inconsistency and variation in maternal blood flow to the intervillous space 
provides the basis for hypoxia reoxygenation (ischemic-reperfusion type of injury) (Hung et 
al., 2001). Hypoxia reoxygenation (H/R) insult in early pregnancy leads to the generation of 
cytotoxic ROS (and thereby oxidative stress) and increased apoptosis resulting in further 
reduction/shallow trophoblast invasion  (Hung and Burton, 2006; Hung et al., 2002; Hung 
et al., 2001; Leach et al., 2008). Hence in this current study, oxidative stress was achieved 
by hypoxia followed by reoxygenation which triggered a statistical significant inhibition of 
MTT reduction and increased cell death as observed in HTR-8/SVneo cells, (also in TEV-1 
and SW71 cell lines – as shown in preliminary studies (see appendix A.11). There are 
evidence proposing that H/R occurrence and the events associated with it, are responsible 
for pregnancy complications such as preeclampsia, IUGR and miscarriages (Hung and 
Burton, 2006; Leach et al., 2008; Aouache et al., 2018).  
7.3 Antioxidative effects of flavonoids 
As previously mentioned in section 7.2, the occurrence of H/R insult during first trimester 
leads to the overproduction of ROS and decrease trophoblast cell viability leading to 
increased apoptosis and insufficient EVT invasion (Aouache et al., 2018). These chains of 
events arising from increased oxidative stress have been linked with pregnancy 
complications such as preeclampsia. Currently, there is no known therapeutic intervention 
to reverse, stabilize or prevent preeclampsia apart from termination or delivery (Bolnick et 
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al., 2015). Although, antioxidant therapy such as vitamin C and E alone or in combination 
has been used to combat the overproduction of ROS observed in early pregnancy, hoping to 
reverse or prevent preeclampsia (Kiondo et al., 2014; Fu et al., 2018; Rumbold and 
Crowther, 2005; Basaran et al., 2010). These clinical trials concluded that supplementation 
with vitamin C and E alone or in combination did not reduce the risk or onset of preeclampsia 
and thus are not be used to treat PE. However, the antioxidant power of flavonoids have been 
proposed to be higher than that of vitamin C and E (Lotito and Frei, 2006). In a study 
conducted by Ho and Chang (2004) on the protective effects of quercetin and vitamin C on 
neuronal cells against H2O2-induced neurodegeneration, they observed that the vitamin C 
had lower protection when compared to quercetin (flavonoid). Another study by Eberhardt, 
Lee and Liu (2000), also concluded that quercetin have a higher antioxidative activity than 
that of vitamin C. In this present study, it was observed that pre-treated HTR-8/SVneo cells 
were protected from HR-induced oxidative stress based on cell viability as demonstrated by 
MTT and CellTiter®-Glo assays. Similar data were observed in the TEV-1 cell line (see 
appendix A.12), suggesting that cytoprotective effects of flavonoids is not cell line specific. 
Due to time constraints, it was not possible to obtain data using alternative cell lines such as 
TEV-1 and SW71 cells. It would be appropriate to repeat this investigation using these cell 
lines to corroborate these data (See chapter 4,5 and 6).  
The cytoprotective effects of flavonoids in non-trophoblast cells have been well documented 
(Daubney et al., 2015; Shokoohinia et al., 2015; Liu et al., 2018). However, these previous 
studies used concentrations (20-500 µM) that cannot be physiologically achieved by daily 
intake of fruits and vegetables. In fact, the plasma peak concentration of quercetin after 
ingesting quercetin rich fruits/vegetables (e.g. onions) was found to be 2.1 µg/mL-1 (which 
roughly equals to 4.53 µM) suggesting that the concentrations used in this present study can 
be physiologically achieved from daily consumption of fruits and vegetables  (Graefe et al., 
2001).  
The possible mechanisms behind flavonoid antioxidant properties has been linked to their 
ability to interact/activate other antioxidant enzymes, inhibit oxidases and scavenge free 
radicals (Procházková and Wilhelmová, 2011). In this present study, it was observed that 
flavonoids, their metabolites alone (or in combinations) significantly restored GSG/GSSG 
(elevated GSG and depleted GSSG) and NADP/NADPH ratio, hence restoring the redox 
balance. The activation/interaction with other antioxidant enzymes is bought about by 
inducing phase II detoxifying enzymes such as glutathione S-transferase, and NAD(P)H-
quinone (Panche et al., 2016; Procházková et al., 2011; Banjarnahor and Artanti, 2014). 
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Again, flavonoids’ structural configurations such as flavonoids having a hydroxyl function 
group at C-3 have been found to be the most effective inducer of phase II detoxifying 
enzymes (Banjarnahor and Artanti, 2014; Procházková et al., 2011). This current study 
showed that H/R insult significantly decreased GSH, thereby preventing its major function, 
which is to deactivate ROS and detoxify cytotoxicity during placentation and implantation 
(Knapen et al., 1999; Knapen et al., 1998). Decreased levels of GSH have been observed in 
preeclamptic cases (Krishna et al., 2017; Vaughan and Walsh, 2002). In a study conducted 
by Jin et al. (2017) on the proteomics analysis of pre-eclamptic placentae, it was observed 
that glutathione metabolism disorder (decreased GSH and increase GSSG) in placenta 
tissues  contributes to the pathogenesis of preeclampsia. The ability of flavonoids to inhibit 
oxidases such NADPH oxidase, which has been demonstrated by their ability to restore 
NADP/NADPH ratio was observed in this present study (see chapter 4). Quercetin and other 
flavonoids have been found to be protective due to their ability to regulate protective gene 
electrophile responsive element (EpRE). During oxidative stress, they activate EpRE-
mediated responses, which have been correlated with their redox restoration properties 
(Procházková et al., 2011).  The data from chapter 4 may suggest that consumption of 
flavonoid rich fruit and vegetables during early trophoblast development can be beneficial 
against trophoblast oxidative stress. 
It has also been well document that flavonoid-mediated cytoprotective is attributed to their 
free radical scavenging ability. Flavonoids’ involvement in ROS scavenging is brought 
about by the arrangement and total number of function groups  such as the B ring hydroxyl 
groups, which are the most major determinant to ROS scavenging (Procházková et al., 2011; 
Banjarnahor and Artanti, 2014). Flavonoids ability to directly scavenge H2O2 can also be 
achieved with their ability to freely donate hydrogen atom described in chapter 1. 
Overproduction of ROS is one of the hallmarks of H/R occurrence during early placentation 
as previously described in section 7.2. In this current study, it was demonstrated that cells 
pre-treated with flavonoids, metabolites alone or in combinations significantly reduced the 
generation of ROS (H2O2) in HTR-8/SVneo cells during H/R insult, confirming that 
flavonoids are potent scavengers of free radicals and may be beneficiary to trophoblast 
survival during early pregnancy.  
7.4 Effects of flavonoids on HR-induce apoptosis and protein kinase(s) activation 
Apoptosis is one of the major consequence of oxidative stress. As shown by previous studies, 
caspase-3 and caspase-7 are the executioner caspases during apoptosis (Tan et al., 2016). 
This current study confirmed that HR-induced oxidative stress is a mediator of apoptotic cell 
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death in HTR-8/SVneo cells via the activation of caspase 3/7 pathways as seen in chapter 5. 
Pre-treatment (24 h) with selected flavonoids, their metabolites alone or in combinations 
significantly inhibited HR-induced caspase 3/7 elevation (as seen in chapter 5). This current 
study was in agreement with previous studies from non-trophoblast origin, indicating that 
pre-treatment with flavonoids/metabolites prior to exposure to oxidative stress significantly 
inhibited apoptosis by halting the activation/elevation of caspase 3/7 (Tan et al., 2016; Nadia 
Z Shaban et al., 2017; Bournival et al., 2009). The ability of flavonoids to inhibit HR-
induced caspase 3/7 elevation in HTR-8/SVneo cells may be attributed to their ability to 
scavenge H2O2, elevate GSH and deplete GSSG levels, restore NADP/NADPH ratio which 
if left unregulated would activate the stimuli that leads to caspase(s) activation. Another 
possible mechanism in which flavonoids inhibit caspase activities during oxidative stress is 
by the restoration of mitochondrial  membrane depolarisation (caused by oxidative stress), 
hence preventing the release of cytochrome c resulting in the downstream activation 
caspases (Hewage et al., 2016; Liu et al., 2018). In addition, flavonoids were found 
significantly inhibit apoptosis by increase the expression of Bcl-2 both at the mRNA and 
protein level, thereby inhibiting the activation of caspase-3 (Han et al., 2008). During 
trophoblast development, increased apoptosis can result in slow development of the placenta, 
and reduced trophoblast invasion resulting in pregnancy complications (Aouache et al., 
2018). The data obtained from chapter 5, suggests that the intake of flavonoids rich food 
during early stages of pregnancy may help improve trophoblast survival during oxidative 
stress. 
This current study further investigated the signalling pathways (protein kinases) activated 
by oxidative stress. Among the pathways investigated are the members of the MAP kinase 
family (ERK1/2, JNK and p38 MAPK) and protein kinase B/AKT. These kinases involved 
in  cell survival (ERK1/2 and PKB) and cell death (p38 MAPK and JNK) (Liu et al., 2018). 
Previous studies indicated that oxidative stress significantly activated protein kinases in 
various cell lines and the introduction of flavonoids significantly inhibited the activation of 
protein kinases (Kim et al., 2009; Daubney et al., 2015; Liu et al., 2018). In this currently 
study, HR-induced oxidative significantly activated ERK1/2, SAPK/JNK, p38 MAPK and 
PKB phosphorylation, however, pre-treatment of HTR-8/SVneo cells significantly inhibited 
HR-mediated activation of these kinases. Flavonoids have been suggested to exert 
modulatory effects in cells via the stimulatory or inhibitory actions on protein kinases by 
changing the phosphorylation state of target molecules (R.J. Williams et al., 2004). In this 
present study flavonoids/metabolites or combinations was involved in the inhibition of pro-
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apoptotic SAPK/JNK and p38 MAPK phosphorylation pathways as seen in chapter 5. The 
inhibition of phosphorylated SAPK/JNK and p38 MAPK pathways, particularly to ROS-
mediated activation, is important for protecting HTR-8/SVneo cells from cellular death. 
During trophoblast development, ROS-mediated activation of phosphorylated SAPK/JNK 
and p38 MAPK results in premature differentiation of trophoblast cells, thereby affecting 
trophoblast maintenance, invasion, migration, proliferation and incomplete remodelling of 
maternal spiral arteries (Pfeffer and Pearton, 2012). The inhibition of HR-mediated 
activation of phosphorylated ERK1/2 by flavonoids/metabolites (or in combination) was 
also seen (see chapter 5). ERK1/2 activation is generally considered to be anti-apoptotic and 
plays a very important role in cell survival; but under certain conditions like severe hypoxia 
and hypoxia reoxygenation, ERK1/2 activation can have pro-apoptotic effects (Lu and Xu, 
2006). The mechanism in which flavonoids inhibit ROS-mediated ERK1/2 phosphorylation 
is not fully understood but has been suggested to be through a pathway independent of 
MEK1 inhibition (Kim et al., 2010). 
Further, the effects of flavonoids/metabolites (or their combinations) on HR-mediated PKB 
phosphorylation was also investigated. As demonstrated in chapter 5, pre-treated HTR-
8/SVneo cells significantly inhibited H/R-induced phosphorylation of PKB, although the 
exact mechanism is not fully understood, flavonoids are believed to inhibit HR-mediated 
PKB phosphorylation via a pathway independent of PI3K inhibition. PKB phosphorylation 
during oxidative has be hypothesize to participate in either pathogenic or protective 
mechanisms (Uranga et al., 2013). In this present study, PKB phosphorylation during HR-
induced oxidative triggered apoptosis and hence was not protective to HTR-8/SVneo cell.  
ROS-mediated activation of protein kinase phosphorylation has been proposed to induce 
apoptosis, inhibit proliferation, migration, differentiation and invasion of trophoblast cells, 
hence resulting the gestational complications (Aouache et al., 2018). Inhibition of ROS-
mediated protein kinase phosphorylation by the indicated flavonoids, their metabolites alone 
or in combinations suggest another mechanism in flavonoids protects HTR-8/SVneo cells. 
7.5 Effects of flavonoids on HTR-8/SVneo invasion and spheroid formation 
A critical component of the healthy placental development involves events like cell invasion, 
vasculogenesis and angiogenesis, which is crucial for the development of the foeto-placental 
communications and the survival of the foetus (Yu qi Li et al., 2017). Insufficient trophoblast 
invasion as a result of H/R insult may lead to angiogenic abnormalities and poor 
vascularization in placenta resulting in IUGR, PE, foetal/maternal death and miscarriage (Yu 
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qi Li et al., 2017; Pereira et al., 2015). In this current study, the effects of flavonoids on 
trophoblast invasion prior to HR-induced oxidative stress using HTR-8/SVneo cells was 
investigated. The invasive capacity of HTR-8/SVneo was assessed using Corning® 
FluorBlok™ 96-multiwell insert plate. This system provides cultured cells with an 
environment that allows the assessment of their invasive potential in vitro. The data from 
this present study was in agreement with previous studies confirming that HR-induced 
oxidative stress significantly reduced the invasive capability of HTR-8/SVneo cell line 
(Kilburn, 2000; Hung et al., 2002; Hung and Burton, 2006; Leach et al., 2008). However, 
pre-treatment with the flavonoids prior to HR-induced oxidative stress significantly 
enhanced HTR-8/SVneo invasive capacity. In fact flavonoid treatment resulted in 
comparable invasive patterns of normal (without HR) controls. This suggests that flavonoids 
may enhance the mechanisms involved in implantation, hence ensuring successful uterine 
spiral remodelling. Since this is the first study on flavonoid-enhanced invasion in trophoblast 
cell line, the exact mechanism(s) that is/are influenced by flavonoids is/are not yet known. 
However, flavonoids may interact with key trophoblast regulators such as Notch signalling, 
WNT signalling, hypoxia inducible factor (HIF) family, vascular endothelial growth factor 
(VEGF) family, transforming growth factor beta (TGF-β) superfamily, and HCF/c-Met 
pathways to ensure proper invasion and maternal spiral artery remodelling (Ji et al., 2013) 
(see section 7.7 for details). In addition to these key regulators, flavonoid-enhanced invasion 
can also be attributed to their antioxidative effects observed in this present study. 
To investigate the effects of flavonoids on stem-like cells after oxidative stress, 3-D 
spheroidal invasion model was used. Previous work carried out within this laboratory 
showed that HTR-8/SVneo cells have the ability to form spheroids under normoxic 
conditions and these spheroids have stem cells properties (Balahmar et al., 2018). As 
previously described in chapter 1, during early trophoblast development, the cytotrophoblast 
stem cells differentiate into the synctiotrophoblasts, and the latter giving rise to the invasive 
EVTs that are responsible for uterine spiral artery remodelling. To establish the effects 
flavonoid on spheroid formation using HTR-8/SVneo cells during HR-induced oxidative 
stress, spheroid formation/invasion assays were carried out. As observed in chapter 6, HR-
induced oxidative stress significantly reduced the area of invasion by the HTR-8/SVneo 
spheroid growth area. However, pre-treatment with selected flavonoids, (their metabolites 
alone or in combinations) significantly increased the spheroid area of invasion. These data 
may suggest that flavonoids play a significant role in stem cell protection against oxidative 
stress. Oxidative stress can significantly affect stem cell self-renewal function, and their 
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differentiation into multiple cells types (Tower, 2012; Denu and Hematti, 2016). This present 
study has showed that HR-induced oxidative stress can affect this spheroidal stem cell 
formation which may suggest that cytotrophoblast stem cell ability to self-renew and ability 
to differentiate into other trophoblast linages can be impaired, hence leading to poor 
placental development and pregnancy complications. Flavonoids’ ability to significantly 
improve spheroid formation in HTR-8/SVneo cells subjected to HR insult can be attributed 
to their antioxidant properties as antioxidant treatments have been demonstrated to increase 
proliferation, enhanced mitochondrial integrity and suppressH2O2-induced oxidative stress 
in human mesenchymal stem cells (Chia Jung Li et al., 2017). It was also revealed that HR-
induced oxidative stress not only influenced spheroid formation, but also reduced spheroid 
invasion (see chapter 6). Again, pre-treatment of HTR-8/SVneo cells with 
flavonoids/metabolites significantly enhanced spheroid invasion. The role of 
cytotrophoblast stem cells during placentation involves continuous cell division from day 2 
of fertilization until after 10-12 week, when the spiral arteries are remodelled. There are no 
previous studies on the effects of flavonoids or their metabolites prior to HR-induced 
oxidative stress on spheroid invasion. The mechanism(s) behind their ability to increase 
invasion/growth of spheroids originated from HTR-8/SVneo cells is not fully understood.  
However, it is known  that overproduction of ROS leading to oxidative stress affects stem 
cell function by causing stress-induced premature senescence via telomere erosion, DNA 
damage and promotion of apoptosis (Tower, 2012; Dayem et al., 2010). The role of 
flavonoids in spheroidal growth and invasion during H/R insult can also be attributed to their 
antioxidative properties (observed in this present study). There could also be the possibility 
that flavonoids mediate stem cell oxidative stress protection/response pathways such as 
FOXO transcription factors, WNT pathway, Nrf2/Keap1 pathway, OCT-4 transcription, 
lamin A signalling, NF κB transcription factor, HIF and Hippo pathways (see section 7.7 for 
detail) (Dayem et al., 2010). These key stem cells stress response pathways plays a crucial 
role in the maintenance and differentiation of stem cells (Denu and Hematti, 2016). 
Therefore, more studies need to be carried out to exploit the mechanism(s) involved in 
flavonoids-enhanced invasion and spheroid growth. 
7.6 Conclusion 
This present study has provided novel data for possible preventive measures for pregnancy 
complications associated with oxidative stress, specifically by the ingestion of fruits of 
vegetable rich in flavonoids. For the first time, investigation into the effects of dietary 
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flavonoids, their metabolites alone or in combination on trophoblast oxidative stress was 
carried out using HTR-8/SVneo cells as a model for in vivo trophoblast impairment.  
The data from this study suggest that concentrations 1 and 3 µM of the indicated 
flavonoids/metabolites were non-toxic to HTR-8/SVneo cells, and concentrations above 10 
µM triggered cytotoxicity. The finding also showed that pre-treatment (24 h) with selected 
flavonoids, their metabolites or combinations prior to HR-induced oxidative stress 
significantly enhance HTR-8/SVneo cell viability, suggesting that flavonoids may enhance 
the activities of intracellular molecules that protect against oxidative stress. Exploring the 
possible mechanism(s) for flavonoid-mediated cytoprotection revealed that flavonoids are 
active scavengers of ROS (H2O2), regulate the redox state by restoring GSH/GSSG and 
NADP/NADPH ratios. Further investigations showed that flavonoids inhibit apoptosis by 
reducing HR-induced caspase 3/7 activation and inhibition of HR-mediated protein kinase 
phosphorylation. Overall these findings suggest that regular ingestions of flavonoid rich 
fruits/vegetables during the entire gestational period (especially early first trimester) may be 
beneficial to placental/foetal development and health. 
7.7 Future works 
This study needs to be extended using other first trimester trophoblast cell lines such as TEV-
1 and Swan 71, and trophoblast primary cells to fully validate the data of the present study 
and to show that flavonoid-mediated cytoprotection/antioxidative effects are not cell line 
specific. This can be achieved using the methodologies already established in the current 
study using HTR-8/SVneo cells. It will be important to try lower concentration (below 1 
µM) of flavonoids/metabolites or combinations to check for protective effects against H/R 
insult as concentration 0.3 or 0.5 µM did not indicate any protection in HTR-8/SVneo cells. 
In addition, it is essential to explore other potential mechanisms involved in flavonoid-
mediated cytoprotection and enhanced invasion such as exploiting their involvement in key 
regulators of trophoblast development and implantation (Notch signalling, wnt signalling, 
HIF family, VEG family, TGF-β superfamily, and HCF/c-Met pathway) and stem cell 
oxidative stress pathways (FOXO transcription factors, WNT pathway, Nrf2/Keap1 
pathway, OCT-4 transcription, lamin A signalling, NF κB transcription factor, HIF and 
Hippo pathways). The status of these pathways can be investigated using western blot 
(protein expression), immunofluorescence (protein localization) and RT-PCR (gene 
expression analysis) for the potential pathways mentioned above.  Protein expression by 
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western blot or immunofluorescence should be used to assess the regulation of these key 
regulators. 
Interestingly, spheroid invasion after 72 h, showed that flavonoids can enhance spheroid 
invasion. However, a time course and real time image capture using confocal microscopy or 
IncuCtye® S3 live-cell analysis system to capture images every 12 h to monitor the exact 
time the effects of flavonoids kick in will be of optimum importance.  
Most importantly, it will be essential to explore changes in protein expression by carrying 
out mass spectrometry analysis of normal cells and spheroids. This might shed more light 
into other unknown possible mechanisms and then validate the data with western blotting. 
A parallel, balanced randomised placebo controlled clinical study/trial will be conducted 
using approximately 500 women for the initial study in the Niger Delta region of Nigeria. 
Participants for this study will include pregnant women aged 18 – 42 years with gestational 
ages between 12 – 22 weeks. Factors such as first-time pregnancy, single or multiple foetus, 
body mass index, previous preeclampsia, chronic hypertension, gestational diabetes and 
interval between pregnancies will all be considered. The pregnant women will be 
randomised to take oranges/orange juices or apple that are rich in quercetin or hesperidin or 
placebo daily until they deliver. Dose-finding will be carried out as described by Ursino et 
al., 2017, to evaluate the safety of the selected flavonoids and their maximum tolerated dose 
(MTD).  Participants, caregiver and those assessing the outcomes will be blinded to the study 
allocation. Primary outcome, which is the main aim of this trial (using flavonoids compounds 
to reduce the incidence of PE) and secondary outcomes such as no effect, clinical worsening 
or maternal/foetal complications will be recorded.  
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Appendix 
 
A.1 
 
Figure A.1: Determination of HTR-8/SVneo seeding density for CellTiter-Glo® Assay. 
HTR-8/SVneo was seeded at ascending density to determine the linear sensitivity of 
CellTiter-Glo® assay 
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A.2 
 
Figure A.2: Effect of flavonoids on HTR-8/SVneo cell migration after HR-induced 
oxidation stress. 
HTR-8/SVneo cells were pre-treated with 3 µM of the selected flavonoids in for 24 h before 
exposure to HR-induced oxidative stress. Cell migration was assessed using Corning® 
BioCoat™ tumour invasion system. (A) Representative image of cells invasion after 24 h. 
Image were taken from the bottom coated membrane using EVOS FL with objective 
magnification 20X (Scale bar = 200 µM). (B) Quantitative analysing of number of cells 
migrated using WimCounting and GraphPad prism software. Data are expressed as number 
of cells invaded (B) and percentage of control (C) and represent the mean ± SEM of at least 
three independent experiments.  
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A.3 
 
Figure A.3: Effect of metabolites on HTR-8/SVneo cell migration after HR-induced 
oxidation stress. 
HTR-8/SVneo cells were pre-treated with 1 µM of the metabolites in for 24 h before 
exposure to HR-induced oxidative stress. Cell migration was assessed using Corning® 
BioCoat™ tumour invasion system. (A) Representative image of cells invasion after 24 h. 
Image were taken from the bottom coated membrane using EVOS FL with objective 
magnification 20X (Scale bar = 200 µM). (B) Quantitative analysing of number of cells 
migrated using WimCounting and GraphPad prism software. Data are expressed as number 
of cells invaded (B) and percentage of control (C) and represent the mean ± SEM of at least 
three independent experiments. **P<0.05 versus HR  
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A.4 
 
Figure A.4: Effect of flavonoids-metabolites combinations on HTR-8/SVneo cell 
migration after HR-induced oxidation stress. 
HTR-8/SVneo cells were pre-treated with combination of 3 µM of flavonoid and 1 µM of 
the metabolite in for 24 h before exposure to HR-induced oxidative stress. Cell migration 
was assessed using Corning® BioCoat™ tumour invasion system. (A) Representative image 
of cells invasion after 24 h. Image were taken from the bottom coated membrane using 
EVOS FL with objective magnification 20X (Scale bar = 200 µM). (B) Quantitative 
analysing of number of cells migrated using WimCounting and GraphPad prism software. 
Data are expressed as number of cells invaded (B) and percentage of control (C) and 
represent the mean ± SEM of at least three independent experiments. **P<0.05, ***P<0.001 
and ****P<0.0001, (a) versus control and (b) versus HR. 
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A.5 
 
Figure A.5: Effect of flavonoid combinations on HTR-8/SVneo cell migration after 
HR-induced oxidation stress. 
HTR-8/SVneo cells were pre-treated with combinations of flavonoid at 3 µM for 24 h before 
exposure to HR-induced oxidative stress. Cell migration was assessed using Corning® 
BioCoat™ tumour invasion system. (A) Representative image of cells invasion after 24 h. 
Image were taken from the bottom coated membrane using EVOS FL with objective 
magnification 20X (Scale bar = 200 µM). (B) Quantitative analysing of number of cells 
migrated using WimCounting and GraphPad prism software. Data are expressed as number 
of cells invaded (B) and percentage of control (C) and represent the mean ± SEM of at least 
three independent experiments. **P<0.05, ***P<0.001 and ****P<0.0001, (a) versus 
control and (b) versus HR. 
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A.6 
 
Figure A.6: The effect of Q3G on HR-induce oxidative stress on the generation of 
spheroidal stem cells in HTR-8/SVneo cells. 
HTR-8/SVneo cells were treated with or without Q3G (1 µM) prior to HR-induced oxidative 
stress exposure. Images were taken using Nikon Eclipse TS100 microscopy attached with 
Nikon DS-Fi2 camera. Objective magnification (A) 4X and (B) 10X (Scale bar = 200 µM). 
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A.7 
 
Figure A.7: The effect of Q3G/quercetin combination on HR-induce oxidative stress 
on the generation of spheroidal stem cells in HTR-8/SVneo cells. 
HTR-8/SVneo cells were treated with or without the combination of Q3G (1 µM) and 
quercetin (3 µM) prior to HR-induced oxidative stress exposure. Images were taken using 
Nikon Eclipse TS100 microscopy attached with Nikon DS-Fi2 camera. Objective 
magnification (A) 4X and (B) 10X (Scale bar = 200 µM). 
A.8 
 
Figure A.8: The effect of quercetin/morin combination on HR-induce oxidative stress 
on the generation of spheroidal stem cells in HTR-8/SVneo cells 
HTR-8/SVneo cells were treated with or without the combination of quercetin and morin (3 
µM) and prior to HR-induced oxidative stress exposure. Images were taken using Nikon 
Eclipse TS100 microscopy attached with Nikon DS-Fi2 camera. Objective magnification 
(A) 4X and (B) 10X (Scale bar = 200 µM). 
A.9 
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Figure A.9: Effects of 24 h flavonoids treatment on TEV-1 cells’ viability. 
TEV-1 cells were treated with the indicated concentrations (1-40 µM) of quercetin, morin, 
naringin and hesperidin for 24 h. Following flavonoid exposure, cell viability was measured 
by MTT reduction assay (A-D). Statistical analysis was carried out using one-way ANOVA 
(Dunnett’s multiple comparisons test against control). Data are expressed as the percentage 
of control cells and represent the mean ± SEM of six independent experiments performed in 
quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001 versus control. 
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A.10 
 
Figure A.10: Effects of 24 h metabolites treatment on TEV-1 cells’ viability. 
TEV-1 cells were treated with the indicated concentrations (1-40 µM) of Q3G, naringenin 
and hesperetin for 24 h. Following metabolite exposure, cell viability was measured by MTT 
reduction assay (A-D). Statistical analysis was carried out using one-way ANOVA 
(Dunnett’s multiple comparisons test against control). Data are expressed as the percentage 
of control cells and represent the mean ± SEM of six independent experiments performed in 
quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001 versus control. 
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A.11 
 
 
Figure A.11: The effects of hypoxia alone or hypoxia/re-oxygenation on trophoblast 
cell lines survival  
Trophoblast cells were exposed to hypoxia (0.5% O2) for 2 h followed by re-oxygenation 
for up to 6 h in glucose- and serum- free medium. Cell viability was assessed by MTT 
reduction assay. (A) TEV-1 cell line and (B) SW 71 cell line. Statistical analysis was carried 
out using one-way ANOVA (Tukey’s multiple comparisons test). Data are expressed as the 
percentage of normoxic control cells and data represent the mean ± SEM of six independent 
experiments performed in quadruplicate. **P<0.01, ***P<0.001 and ****P<0.0001, (a) 
versus normoxia control and (b) versus hypoxia alone. 
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A.12 
 
Figure A.12: Effect of 24 h flavonoid treatment on the viability of TVE-1 cells 
subjected to HR-induced oxidative stress. 
TEV-1 cells were pre-treated with either 1 or 3 µM of quercetin, morin, naringin and 
hesperidin for 24 h prior to HR-induced oxidative stress exposure. Cell viability was 
measured by MTT reduction assay (A-D). Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparisons test). Data are expressed as the percentage of 
control cells and represent the mean ± SEM of six independent experiments performed in 
quadruplicate. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001, (a) versus control, (b) 
versus H/R alone.
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